UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2024
(Exact name of registrant as specified in its charter)
No. 11, Dongjiao East Road, Shuangxi, Shunchang, Nanping City
Fujian Province, People’s Republic of China
+86-0599-782-8808
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Explanatory Note
Paranovus Entertainment Technology Limited (the “Company”) is furnishing this Form 6-K to provide its financial results for the six months ended September 30, 2023.
The Company hereby furnishes the following documents as exhibits to this report: “Unaudited Condensed Consolidated Financial Statements for the Six Months Ended September 30, 2023 and 2022” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations”.
Exhibits
| Exhibit No. | Description | |
| 99.1 | Unaudited Condensed Consolidated Financial Statements for the Six Months Ended September 30, 2023 and 2022 | |
| 99.2 | Management’s Discussion and Analysis of Financial Condition and Results of Operations | |
| 101.INS | Inline XBRL Instance Document. | |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. | |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
1
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Paranovus Entertainment Technology Limited | ||
| Date: January 12, 2024 | By: | /s/ Xuezhu Wang |
| Name: | Xuezhu Wang | |
| Title: | Chief Executive Officer | |
2
Exhibit 99.1
PARANOVUS ENTERTAINMENT TECHNOLOGY LTD.
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
AS OF SEPTEMBER 30, 2023, AND MARCH 31, 2023
AND
FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
PARANOVUS ENTERTAINMENT TECHNOLOGY LTD.
TABLE OF CONTENTS
F-1
PARANOVUS ENTERTAINMENT TECHNOLOGY LTD.
CONSOLIDATED BALANCE SHEETS
AS OF SEPTEMBER 30, 2023, AND MARCH 31, 2023
(UNAUDITED)
(IN U.S. DOLLARS)
| As of September 30, | As of March 31, | |||||
| 2023 | 2023 | |||||
| ASSETS | ||||||
| Current assets | ||||||
| Cash and cash equivalents | $ | $ | ||||
| Accounts receivable, net | - | |||||
| Inventories | - | |||||
| Prepaid expenses and other current assets | ||||||
| Current assets from discontinued operations - disposal | - | |||||
| Total current assets | ||||||
| Property, plant and equipment, net | ||||||
| Intangible assets, net | ||||||
| Goodwill | ||||||
| Prepaid assets | ||||||
| Non-current assets from discontinued operations - disposal | - | |||||
| Total non-current assets | ||||||
| TOTAL ASSETS | $ | $ | ||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||
| Current liabilities | ||||||
| Accounts payable | $ | $ | ||||
| Other payables and accrued liabilities | - | |||||
| Income tax payable | ||||||
| Current liabilities from discontinued operations - disposal | - | |||||
| Total current liabilities | ||||||
| Non-current liabilities from discontinued operations - disposal | - | |||||
| Total non-current liability | - | |||||
| TOTAL LIABILITIES | ||||||
| COMMITMENTS AND CONTINGENCIES (NOTE 16) | ||||||
| SHAREHOLDERS’ EQUITY | ||||||
| Class A Ordinary shares, $ |
||||||
| Preferred shares, $ |
||||||
| Additional paid-in capital | ||||||
| Statutory reserve | - | |||||
| Accumulated deficit | ( | ) | ( | ) | ||
| Accumulated other comprehensive loss | ( | ) | ( | ) | ||
| Total Paranovus Entertainment Technology Ltd.’s shareholders’ equity | ||||||
| Non-controlling interests | - | ( | ) | |||
| Total shareholders’ equity | ||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ | $ | ||||
F-2
PARANOVUS ENTERTAINMENT TECHNOLOGY LTD.
CONSOLIDATED STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)
FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
(UNAUDITED)
(IN U.S. DOLLARS)
| For the six months ended September 30, | ||||||
| 2023 | 2022 | |||||
| Revenues | $ | $ | ||||
| Cost of revenues | ( | ) | ( | ) | ||
| Gross profit | ||||||
| Operating expenses: | ||||||
| Selling and marketing | ||||||
| General and administrative | ||||||
| Research and development | ||||||
| Gain on disposal of subsidiaries | ( | ) | ( | ) | ||
| Total operating expenses | ( | ) | ||||
| Operating income (loss) | ( | ) | ||||
| Other income (expenses): | ||||||
| Interest income | ||||||
| Interest expense | ( | ) | ||||
| Other loss, net | ( | ) | ( | ) | ||
| Total other loss, net | ( | ) | ( | ) | ||
| Gain (loss) from continuing operations before income taxes | ( | ) | ||||
| Provision for tax expenses | ( | ) | ||||
| Net gain (loss) from continuing operations | $ | $ | ( | ) | ||
| Net loss from discontinued operations - disposal | ( | ) | ( | ) | ||
| Net gain (loss) | ( | ) | ||||
| Other comprehensive loss: | ||||||
| Foreign currency translation adjustments | ( | ) | ( | ) | ||
| Comprehensive income (loss) | $ | $ | ( | ) | ||
| Less: comprehensive loss attributable to non-controlling interests: | ( | ) | ( | ) | ||
| Comprehensive income (loss) attributable to Paranovus Entertainment Technology Ltd. | ( | ) | ||||
| Basic and diluted earnings (loss) per ordinary share | ||||||
| $ | $ | ( | ) | |||
| Basic and diluted loss per ordinary share | ||||||
| $ | ( | ) | $ | ( | ) | |
| Weighted average number of ordinary shares outstanding | ||||||
F-3
PARANOVUS ENTERTAINMENT TECHNOLOGY LTD.
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’
EQUITY
FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
(UNAUDITED)
(IN U.S. DOLLARS)
| Class A Ordinary shares | Class A Ordinary shares amount | Class B Ordinary shares | Class B Ordinary shares amount | Additional paid-in capital | Statutory surplus reserve | Retained earnings | Accumulated other comprehensive income (loss) | Total Paranovus Entertainment Technology Ltd. shareholders’ equity | Non- controlling interests | Total equity | ||||||||||||||||||||||||||||||||||
| Balance at March 31, 2023 | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | $ | |||||||||||||||||||||||||||||
| Share cancellation | ( | ) | ( | ) | - | ( | ) | ( | ) | ( | ) | |||||||||||||||||||||||||||||||||
| Net income | - | - | ||||||||||||||||||||||||||||||||||||||||||
| Discontinued operations - disposal | - | - | ( | ) | - | ( | ) | ( | ) | |||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments | - | - | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||||||
| Balance at September 30, 2023 | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | $ | $ | |||||||||||||||||||||||||||||||
| Class A Ordinary shares | Class A Ordinary shares amount | Class
B | Class B Ordinary shares amount | Additional paid-in capital | Statutory surplus reserve | Retained earnings | Accumulated other comprehensive income (loss) | Total Happiness Development Group Limited shareholders’ equity | Non- controlling interests | Total equity | ||||||||||||||||||||||||||||||||||
| Balance at March 31, 2022 | $ | $ | $ | $ | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||||||||||||||||||
| Contribution from non-controlling shareholders | - | - | ||||||||||||||||||||||||||||||||||||||||||
| Net loss | - | - | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments | - | - | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||||||
| Balance at September 30, 2022 | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | $ | |||||||||||||||||||||||||||||
F-4
PARANOVUS ENTERTAINMENT TECHNOLOGY LTD.
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
(UNAUDITED)
(IN U.S. DOLLARS)
| For the six months ended September 30, | ||||||
| 2023 | 2022 | |||||
| Cash Flows from Operating Activities: | ||||||
| Net income (loss) | $ | $ | ( | ) | ||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ||||||
| Depreciation and amortization | ||||||
| Loss on disposal of equipment | ||||||
| Gain on disposal of subsidiaries | ( | ) | ( | ) | ||
| Deferred taxes | ||||||
| Changes in operating assets and liabilities: | - | - | ||||
| Accounts receivable | ( | ) | ||||
| Notes receivable | ||||||
| Inventories | ( | ) | ( | ) | ||
| Prepaid expenses and other current assets | ||||||
| Other assets | ||||||
| Accounts payable | ( | ) | ||||
| Other payables and accrued liabilities | ( | ) | ( | ) | ||
| Income taxes payable | ( | ) | ||||
| Net cash used in operating activities from continuing operations | ( | ) | ( | ) | ||
| Net cash (used in) provided by operating activities from discontinued operations | ( | ) | ||||
| Net cash used in operating activities | ( | ) | ( | ) | ||
| Cash Flows from Investing Activities: | ||||||
| Proceeds from disposal of subsidiaries | ||||||
| Net cash provided by investing activities from continuing operations | ) | |||||
| Net cash used in investing activities from discontinued operations | ( | ) | ||||
| Net cash provided by (used in) investing activities | ( | ) | ||||
| Cash Flows from Financing Activities: | ||||||
| Net cash provided by financing activities from continuing operations | ||||||
| Net cash provided by financing activities from discontinued operations | ||||||
| Net cash provided by financing activities | ||||||
| Effect of exchange rate changes on cash and cash equivalents | ( | ) | ( | ) | ||
| Net decrease in cash and cash equivalents | ( | ) | ( | ) | ||
| Cash and cash equivalents at the beginning of period | ||||||
| Cash and cash equivalents at the end of period | $ | $ | ||||
| Supplemental disclosures of cash flows information: | ||||||
| Cash paid for income taxes | $ | $ | ||||
| Cash paid for interest expense | $ | $ | ||||
F-5
PARANOVUS ENTERTAINMENT TECHNOLOGY LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 1 – ORGANIZATION AND NATURE OF OPERATIONS
Paranovus Entertainment Technology Limited (“Paranovus Cayman”) is a holding company. It was incorporated on February 13, 2018 under the laws of the Cayman Islands and previously named Happiness Biotech Group Limited. On November 5, 2021, the Company changed its name to Happiness Development Group Limited under the special resolution dated October 21, 2021. On March 13, 2023 the Company changed its name to Paranovus Entertainment Technology Limited under the special resolution dated March 13, 2023. The Company has no substantive operations other than holding all of the outstanding share capital of Happiness Holding Group Limited(“Happiness Hong Kong”), previous named as Happiness Biology Technology Group Limite, and Paranovus Entertainment Technology Limited (“Paranovus NewYork”). Happiness Hong Kong is a holding company of all of the equity or ownership of Happiness (Fuzhou) E-commerce Co., Ltd (“Happiness Fuzhou”) and Happiness (Shunchang) E-commerce Co. Ltd (“Happiness Shunchang”). 2Lab3 LLC was established in the state of Delaware on December 8, 2022 and was acquired by Paranovus Cayman in March 2023.
Happiness Shunchang is a holding company of all of the equity or ownership of Fuzhou Happiness Enterprise Management Consulting Co., Ltd. (“Fujian Consulting”) and Taochejun (Fujian) Automobile Sales Co., Ltd. (“Fujian Taochejun”).
Reorganization
A Reorganization of the legal structure was completed
in August 2018. The Reorganization involved the incorporation of PARANOVUS ENTERTAINMENT TECHNOLOGY LIMITED, a Cayman Islands holding
company; Happiness Biology Technology Group Limited, a holding company established in Hong Kong, PRC; Happiness (Fuzhou) E-commerce Co.,
Ltd, a holding company established in Fujian, PRC; and the transfer of
Prior to the reorganization, Mr. Wang Xuezhu,
Chief Executive Officer owns
Since the Company is effectively controlled by the same Controlling Shareholder before and after the reorganization, it is considered under common control. Therefore, the above-mentioned transactions were accounted for as a recapitalization. The reorganization has been accounted for at historical cost and prepared on the basis as if the aforementioned transactions had become effective as of the beginning of the first period presented in the accompanying financial statements of the Company.
On March 4, 2019, the Company subdivided its
F-6
| Name of Entity | Date of Incorporation | Place of Incorporation |
Registered Capital |
% of Ownership |
Principal Activities | |||||||
| Happiness (Fuzhou) E-commerce Co., Ltd (“Happiness Fuzhou”) | |
|||||||||||
| Happiness (Shunchang) E-commerce Co. Ltd (“Happiness Shunchang”) | ||||||||||||
| Fuzhou Happiness Enterprise Management Consulting Co., Ltd. | ||||||||||||
| Taochejun (Hainan) New Energy Technology Co., Ltd. | ||||||||||||
| Taochejun (Fujian) automobiles Co., Ltd | ||||||||||||
| Fujian Happiness Biotech Co., Ltd (“Fujian Happiness”) (a) | ||||||||||||
| Fujian Happiness comes Medical Equipment Manufacturing Co., Ltd. (a) | ||||||||||||
| Shunchang Happiness comes Health Products Co., Ltd. (a) | ||||||||||||
| Fujian Shennongjiagu Development Co., Ltd.(“Shennong”) (a) | ||||||||||||
| Fuzhou Hekangyuan Trading Co., Ltd. (“Hekangyuan”) (a) | ||||||||||||
| Happy Buy (Fujian) Network Technology Co., Ltd. (“Happy Buy”) (b) | ||||||||||||
| Fujian Happy Studio Network Technology Co. LTD (c) | ||||||||||||
| Shunchang Haiwushuo Brand Management Co., Ltd. (“Shunchang Haiwushuo”) (c) | ||||||||||||
| Taochejun (Hangzhou) New Energy Technology Co., Ltd. (“Hangzhou Taochejun”) (d) | ||||||||||||
| Sichuan Taochejun New Energy Technology Co., Ltd. (d) |
| (a) | |
| (b) | |
| (c) | |
| (d)
|
F-7
NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Principles of Consolidation
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and have been consistently applied. The accompanying consolidated financial statements include the financial statements of Happiness Development and its subsidiaries (collectively, the “Company”). All inter-company balances and transactions have been eliminated upon consolidation.
Non-controlling interests
For the Company’s non-wholly owned subsidiaries, a non-controlling interest is recognized to reflect the portion of equity that is not attributable, directly or indirectly, to the Company. Non-controlling interests are classified as a separate line item in the equity section of the Company’s consolidated balance sheets and have been separately disclosed in the Company’s consolidated statements of comprehensive (loss)/income to distinguish the interests from that of the Company. Cash flows related to transactions with non-controlling interests are presented under financing activities in the consolidated statements of cash flows.
Use of Estimates
In preparing the consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information as of the date of the consolidated financial statements. Significant estimates required to be made by management include, but are not limited to, the valuation of accounts receivable and related allowance for doubtful accounts, useful lives of property and equipment and intangible assets, the recoverability of long-lived assets, inventory reserve, allowance for credit losses, goodwill impairment, income taxes related to realization of deferred tax assets and uncertain tax position, provisions necessary for contingent liabilities and purchase price allocation in connection with the business combination. The current economic environment has increased the degrees of uncertainty inherent in those estimates and assumptions, actual results could differ from those estimates.
F-8
Business combination
Business combinations are recorded using the acquisition method of accounting. The assets acquired, the liabilities assumed, and any non-controlling interests of the acquiree at the acquisition date, if any, are measured at their fair values as of the acquisition date. Goodwill is recognized and measured as the excess of the total consideration transferred plus the fair value of any non-controlling interest of the acquiree and fair value of previously held equity interest in the acquiree, if any, at the acquisition date over the fair values of the identifiable net assets acquired. Common forms of the consideration made in acquisitions include cash and common equity instruments. Consideration transferred in a business acquisition is measured at the fair value as of the date of acquisition. Acquisition-related expenses and restructuring costs are expensed as incurred.
Accounting Standards Codification (“ASC”)
805 establishes a measurement period to provide the Company with a reasonable amount of time to obtain the information necessary to identify
and measure various items in a business combination and cannot extend beyond
Cash and Cash Equivalents
The Company considers all highly liquid investment instruments with an original maturity of three months or less from the date of purchase to be cash equivalents. The Company maintains all bank accounts in the PRC. Cash balances in bank accounts in PRC are not insured by the Federal Deposit Insurance Corporation or other programs.
Accounts receivable, net
Accounts receivable, net are recognized and carried at original invoiced amount less an estimated allowance for uncollectible accounts. The Company determines the adequacy of reserves for doubtful accounts based on individual account analysis and historical collection trends. The Company establishes a provision for doubtful receivables when there is objective evidence that the Company may not be able to collect amounts due. The allowance is based on management’s best estimates of specific losses on individual exposures, as well as a provision on historical trends of collections. Based on management of customers’ credit and ongoing relationship, management makes conclusions whether any balances outstanding at the end of the period will be deemed uncollectible on an individual basis and on aging analysis basis. The provision is recorded against accounts receivables balances, with a corresponding charge recorded in the consolidated statements of income and comprehensive income. Delinquent account balances are written-off against the allowance for doubtful accounts after management has determined that the likelihood of collection is not probable.
Inventories
Inventories are stated at the lower of cost or net realizable value. Cost of inventories is determined using the weighted-average method. In addition to cost of raw materials, work in progress and finished goods include direct labor costs and overheads. The Company periodically assesses the recoverability of all inventories to determine whether adjustments are required to record inventories at the lower of cost or market value. Inventories that the Company determines to be obsolete or in excess of forecasted usage are reduced to its estimated realizable value based on assumptions about future demand and market conditions. If actual demand is lower than the forecasted demand, additional inventory write-downs may be required.
Prepaid expenses and other current assets
Prepaid expenses and other current assets mainly represents cash prepaid to the suppliers, the technical providers and the investment receivables from the investors.
Prepaid expenses and other current assets primarily consist of advances to vendors for purchasing goods, advances to the technical provides that have not been received or provided. Prepaid expenses and other current assets are classified as current or non-current based on the terms of the respective agreements. These advances are unsecured and are reviewed periodically to determine whether their carrying value has become impaired. The Company considers the assets to be impaired if the collectability of the advance becomes doubtful. The Company uses the aging method to estimate the allowance for uncollectible balances. The allowance is also based on management’s best estimate of specific losses on individual exposures, as well as a provision on historical trends of collections and utilizations. Actual amounts received or utilized may differ from management’s estimate of credit worthiness and the economic environment.
F-9
Goodwill
Goodwill represents the excess of the purchase price over the fair value of the identifiable assets and liabilities acquired in a business combination.
Goodwill is not depreciated or amortized but is tested for impairment on an annual basis as of March 31, and in between annual tests when an event occurs or circumstances change that could indicate that the asset might be impaired. In accordance with the FASB ASC 350 guidance on “Testing of Goodwill for Impairment”, a company first has the option to assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the company decides, as a result of its qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test is mandatory. Otherwise, no further testing is required. The quantitative impairment test consists of a comparison of the fair value of each reporting unit with its carrying amount, including goodwill. If the carrying amount of each reporting unit exceeds its fair value, an impairment loss equal to the difference between the fair value of the reporting unit and the carrying amount will be recorded. Application of a goodwill impairment test requires significant management judgment, including the identification of reporting units, assigning assets and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value of each reporting unit. The judgment in estimating the fair value of reporting units includes estimating future cash flows, determining appropriate discount rates and making other assumptions. Changes in these estimates and assumptions could materially affect the determination of fair value for each reporting unit.
As of September 30, 2023, goodwill resulting from business acquisitions has only one reporting unit, including 2Lab3. The Company evaluates if goodwill impairment may be indicated on quarterly basis and performs the annual goodwill impairment assessment as of March 31. The Company performed qualitative assessments for the goodwill. Based on the requirements of ASC 350-20, the Company evaluated all relevant factors including, but not limited to, macroeconomic conditions, industry and market conditions, financial performance, and the share price of the Company. The Company weighed all factors in their entirety and concluded that it was not more-likely-than-not the fair value was less than the carrying amount of goodwill, and further impairment testing on goodwill was unnecessary as of September 30, 2023.
Property, Plant and Equipment
Property, plant and equipment are stated at cost.
| Useful Lives | ||
| Buildings | ||
| Machinery | ||
| Furniture, fixture and electronic equipment | ||
| Vehicles |
Expenditures for maintenance and repairs, which do not materially extend the useful lives of the assets, are charged to expense as incurred. Expenditures for major renewals and betterment which substantially extend the useful life of assets are capitalized. The cost and related accumulated depreciation of assets retired or sold are removed from the respective accounts, and any gain or loss is recognized in the consolidated statements of income and other comprehensive income in other income or expenses.
F-10
Intangible Assets
Intangible assets with definite lives are initially recorded at cost. Amortization of definite-lived intangible assets is computed using the straight-line method over the estimated average useful lives. Intangible assets with indefinite lives should not be amortized but should be tested for impairment at least annually or when event occurs or circumstances that could indicate that the asset might be impaired.
| Useful life | ||
| Land use right | ||
| Licensed software | ||
| Trademark | ||
| Customer relationship | ||
| Proprietary technology |
Impairment of Long-lived Assets other than goodwill
The Company reviews long-lived assets, including definite-lived intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the estimated cash flows from the use of the asset and its eventual disposition are below the asset’s carrying value, then the asset is deemed to be impaired and written down to its fair value. There were no impairments of these assets as of September 30, 2023 and March 31, 2023.
Short-term bank borrowings
Short-term bank borrowings represent the amounts due to various banks that are due within one year.
Short-term bank borrowings are presented as current liabilities unless the Company has an unconditional right to defer settlement for at least 12 months after the financial year end date, in which case they are presented as non-current liabilities.
Short-term bank borrowings are initially recognized at fair value (net of transaction costs) and subsequently carried at amortized cost. Any difference between the proceeds (net of transaction costs) and the redemption value is recognized in profit or loss over the period of the borrowings using effective interest method.
Short-term bank borrowings costs are recognized in profit or loss using the effective interest method.
Fair Value of Financial Instruments
The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 820, Fair Value Measurement and Disclosures, requires certain disclosures regarding the fair value of financial instruments. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:
| ● | Level 1 - Quoted prices in active markets for identical assets and liabilities. |
| ● | Level 2 - Quoted prices in active markets for similar assets and liabilities, or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. |
| ● | Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs. |
F-11
The Company considers the recorded value of its financial assets and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other receivable, accounts payable, short-term borrowings, accounts payable, income tax assets and liabilities and income taxes payable and to approximate the fair value of the respective assets and liabilities at September 30, 2023 and March 31, 2023 based upon the short-term nature of the assets and liabilities.
Discontinued operations
In accordance with ASC 205-20, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity, a disposal of a component of an entity or a group of components of an entity is required to be reported as a discontinued operation if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when the components of an entity meets the criteria in paragraph 205-20-45-1E to be classified as held for sale. When all of the criteria to be classified as held for sale are met, including management, having the authority to approve the action, commits to a plan to sell the entity, the major current assets, other assets, current liabilities, and non-current liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations in accordance with ASC 205-20-45.
On April 10, 2023, the Company entered into an
agreement to transfer
On August 28, 2023, the Company’s indirect
wholly owned subsidiary (the “Seller”), Happy Buy (Fujian) Network Technology Co., Ltd. (“Happy Buy”) and Shunchang
Jinyifu trading Co., Ltd ("Shunchang Jinyi”), a PRC company which is not affiliate of the Company or any of its directors
or officers (the “Purchaser”) entered into certain share purchase agreement (the “Disposition SPA”). Pursuant
to the Disposition SPA, the Purchaser agreed to purchase the Happy Buy in exchange for cash consideration of RMB
F-12
Revenue Recognition
The Company generates its revenue mainly from sales of healthcare products, automobiles, online store sales and internet information and advertising services.
The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is the transaction price the Company expects to be entitled to in exchange for the promised services in a contract in the ordinary course of the Company’s activities and is recorded net of value-added tax (“VAT”). To achieve that core principle, the Company applies the following steps:
Step 1: Identify the contract (s) with a customer
Step 2: Identify the performance obligations in the contract
Step 3: Determine the transaction price
Step 4: Allocate the transaction price to the performance obligations in the contract
Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation
Company generates revenues from sales of healthcare products, automobiles, online store sales and internet information and advertising services. No practical expedients were used when adoption ASC 606. Revenue recognition policies for each type of revenue stream are as follows:
Healthcare products
The Company sells nutraceutical and dietary supplements to third-party distributors and experience stores. Experience stores are owned by third parties, which are located in tourist sites where the sales consultants gave in-depth presentation of the origin, tradition and history of the Company’s products. Tourists are guided to enjoy a presentation of traditional Chinese herb culture offered by the distributors in the experience store and be presented with the Company’s healthcare products. The Company is a principal for the healthcare product sales as i) the Company produce or obtain control of the specified goods before transferring to the customers; ii) the Company has the right to determine the sales price; iii) the Company bears the risk of inventories and collection of consideration. For all sales, the Company requires a signed contract and sales order, which specifies pricing, quantity and product specifications. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to transfer the control of the promised products to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those products, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The transfer of control of the products is satisfied at a point in time, which is the delivery of the products to distributors’ or the experience stores’ premises and evidenced by signed acknowledgment. The selling price, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the delivery of the products to distributors or experience stores and the signing of their acknowledgment. Distributors and experience stores are required to pay under the customary payment terms, which is generally less than six months. According to the sales agreement, the healthcare product sold cannot be returned after the acknowledgement.
F-13
Automobiles
The Company sold automobiles in fiscal year 2023. For all sales, the Company requires a signed contract and sales order, which specifies pricing, quantity and product specifications. The Company is a principal for the automobiles sales as i) the Company produce or obtain control of the specified goods before transferring to the customers; ii) the Company has the right to determine the sales price; iii) the Company bears the risk of inventories and collection of consideration. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to transfer the control of the promised products to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those products, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The transfer of control of the products is satisfied at a point in time, which is the delivery of the products to customers’ premises and evidenced by signed customer acknowledgment. According to the contract, the automobile sold cannot be returned after the customer acknowledgement. The selling price, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the delivery of the products to customers and the signing of the customer acknowledgment, which is within 3 months after sales.
Online store
The Company sells various goods through its online store business in fiscal year 2023. For all sales, the Company requires a sales order generated by the online store platform, which specifies pricing, quantity and product specifications. The Company is a principal for the online store sales as i) the Company produce or obtain control of the specified goods before transferring to the customers; ii) the Company has the right to determine the sales price; iii) the Company bears the risk of inventories and collection of consideration. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to transfer the control of the promised products to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those products, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The transfer of control of the products is satisfied at a point in time, which is the delivery of the products to customers’ premises and evidenced by signed customer acknowledgment. The selling price, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the delivery of the products to customers and the signing of the customer acknowledgment unless the customers require sales return within 7 days after the acknowledgement. Customers are required to pay to the third-party platform before the goods were send out and the Company will receive the amount from the third-party platform after the customer sign off the acceptance form on the platform.
Internet information and advertising service
The Company provides internet information and advertising service online. For all sales, the Company requires a signed contract and sales order, which specifies the price and service range. The Company is a principal for the services as i) the Company has the right to determine the sales price; ii) the Company bears the collection risks; iii) the Company is responsible to the service provided. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to provide specified information and advertising service to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those services, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The information and advertising service provided is satisfied at a point in time, which is the time when the information and advertising service is performed. No sales return is permitted after the service performed according to the contract signed. The selling price per click, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the completion of the service. Customers are required to pay to the Company in advance according to the contract.
All of the Company’s revenues from contracts with customers represent products transferred at a point in time as control is transferred to the customer and are generated in PRC. All of the Company’s revenues are recognized on a gross basis and presented as revenue on the consolidated statements of operations and comprehensive income/(loss).
F-14
| For the six months ended September 30, | ||||||||
| 2023 | 2022 | |||||||
| Healthcare products | $ | $ | ||||||
| Online store | ||||||||
| Internet information and advertising | ||||||||
| Automobiles | ||||||||
| Revenue from discontinued operations (Note 15) | ( | ) | ( | ) | ||||
| Revenue | $ | $ | ||||||
Cost of Revenues
Healthcare products
Cost of revenue of healthcare product is mainly composed of the cost of product sales, employees, depreciation expenses and other manufacturing overhead expenses that are directly attributable to the business.
Automobile
Cost of revenue of automobiles is mainly composed of the cost of automobiles and other miscellaneous expenses that are directly attributable to the business.
Online store
Cost of revenue of online store is mainly composed of the cost of goods sales and other miscellaneous expenses that are directly attributable to the business.
Internet information and advertising service
Cost of revenue of internet information and advertising service is mainly composed of the cost of service provide and other miscellaneous expenses that are directly attributable to the business.
Government Grants
Government grants are recognized when received and all the conditions for their receipt have been met. Government grants as compensation for the Company’s research and development efforts.
Research and Development Costs
Research and development activities are directed toward the development of new products as well as improvements in existing processes. These costs, which primarily include salaries, contract services, raw materials, and supplies, are expensed as incurred.
Shipping and Handling Costs
Shipping and handling costs are expensed when
incurred as selling and marketing expense. Shipping and handling costs were $
Advertising Costs
Advertising costs expensed as economic benefits
are consumed in accordance with ASC 720-35, “Other Expenses-Advertising Costs”. Advertising costs were $
F-15
Stock-Based Compensation
The Company accounts for stock-based compensation to employees in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including the equity incentive plan, based on the grant date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period. Stock option forfeitures are recognized at the date of employee termination. Effective April 1, 2019, the Company adopted ASU 2018-07 for the accounting of share-based payments granted to non-employees for goods and services and no material impacts to the Financial Statements.
Options
The fair value of options issued pursuant to the Company’s option plans at the grant date was estimated using the Black-Scholes option pricing model. This model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of highly subjective assumptions, including the expected term of the options, the estimated forfeiture rates and the expected stock price volatility. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The Group uses projected volatility rates based upon the Group’s historical volatility rates. These assumptions are inherently uncertain. Different assumptions and judgments would affect the Company’s calculation of the fair value of the underlying ordinary shares for the options granted, and the valuation results and the amount of option would also vary accordingly.
Income Taxes
The Company accounts for current income taxes in accordance with the laws of the relevant tax authorities. Deferred income taxes are recognized when temporary differences exist between the tax bases of assets and liabilities and their reported amounts in the consolidated financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period including the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
The provisions of ASC 740-10, “Accounting for Uncertainty in Income Taxes”, prescribe a more-likely-than-not threshold for consolidated financial statement recognition and measurement of a tax position taken (or expected to be taken) in a tax return. This interpretation also provides guidance on the recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, and related disclosures. The Company does not believe that there was any uncertain tax position at September 30, 2023 and March 31, 2023.
To the extent applicable, the Company records interest and penalties as a general and administrative expense. All of the tax returns of the Company and its subsidiaries remain subject to examination by PRC tax authorities for five years from the date of filing.
The Company is subject to Chinese tax laws. We are not subject to U.S. tax laws and local state tax laws. Our income and our related entities must be computed in accordance with Chinese and foreign tax laws, as applicable, and we are subject to Chinese tax laws, all of which may be changed in a manner that could adversely affect the amount of distributions to shareholders. There can be no assurance that Income Tax Laws of China will not be changed in a manner that adversely affects shareholders. In particular, any such change could increase the amount of tax payable by us, reducing the amount available to pay dividends to the holders of our ordinary shares.
F-16
We are a holding company with no material operations
of our own. We conduct our operations through our subsidiaries in China. As a result, our ability to pay dividends and to finance any
debt we may incur depends upon dividends paid by our subsidiaries. Under applicable PRC regulations, foreign-invested enterprises in China
may pay dividends only out of their accumulated profits, if any, determined in accordance with PRC accounting standards and regulations.
In addition, a foreign-invested enterprise in China is required to set aside at least
As of September 30, 2023, our PRC subsidiaries
had an accumulated deficit of approximately RMB
Value-added Tax
Value-added taxes (“VAT”) collected
from customers relating to product sales and remitted to governmental authorities are presented on a net basis. VAT collected from customers
is excluded from revenue. The Company is generally subject to the VAT for merchandise sales and services performed. Before May 1, 2018,
the applicable VAT rate was
Earnings/ Loss per Share
Basic earnings/loss per share is computed by dividing net profit/loss attributable to holders of ordinary shares by the weighted average number of ordinary shares outstanding during the year using the two-class method. Using the two class method, net profit/loss is allocated between Class A ordinary shares, Class B ordinary shares and other participating securities (i.e. preferred shares) based on their participating rights.
The Company computes earnings per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies with complex capital structures to present basic and diluted EPS. Basic EPS is measured as Net profit divided by the weighted average common shares outstanding for the period. Diluted earnings/loss per share is calculated by dividing net profit/loss attributable to ordinary shareholders as adjusted for the effect of dilutive ordinary equivalent shares, if any, by the weighted average number of ordinary and dilutive ordinary equivalents shares outstanding during the year/period. Dilutive equivalent shares are excluded from the computation of diluted earnings/loss per share if their effects would be anti-dilutive. Ordinary share equivalents consist of the ordinary shares issuable in connection with the Group’s convertible redeemable preferred shares using the if-converted method, and ordinary shares issuable upon the conversion of the stock options, using the treasury stock method. Except for voting rights, the Class A and Class B ordinary shares have all the same rights and therefore the earning/loss per share for both classes of shares are identical. The earning/loss per share amounts are the same for Class A and Class B ordinary shares because the holders of each class are entitled to equal per share dividends or distributions in liquidation.
F-17
Foreign Currency Translation
The Company and its subsidiaries’ principal country of operations is the PRC. The Company maintained its financial record using the United States dollar (“US dollar”) as the functional currency, while the subsidiaries of the Company in Hong Kong and mainland China maintained their financial records using RMB as the functional currencies. The consolidated statements of income and comprehensive income and cash flows denominated in foreign currency are translated at the average rate of exchange during the reporting period. Assets and liabilities denominated in foreign currencies at the balance sheet date are translated at the applicable rates of exchange in effect at that date. The equity denominated in the functional currency is translated at the historical rate of exchange at the time of capital contribution. Because cash flows are translated based on the average rate of exchange, amounts related to assets and liabilities reported on the consolidated statements of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets. Translation adjustments arising from the use of different exchange rates from period to period are included as a separate component of accumulated other comprehensive income (loss) included in consolidated statements of changes in shareholders’ equity. Gains and losses from foreign currency transactions are included in the consolidated statement of income and comprehensive income.
The value of RMB against US$ and other currencies
may fluctuate and is affected by, among other things, changes in the PRC’s political and economic conditions. Any significant revaluation
of RMB may materially affect the Company’s financial condition in terms of US$ reporting.
| September 30, 2023 | March 31, 2023 | September 30, 2022 | ||||
| Period-end spot rate | ||||||
| Average rate |
Comprehensive Income
Comprehensive income includes net income and foreign currency translation adjustments and is reported in the consolidated statements of income and comprehensive income.
Segment Reporting
The Company uses the “management approach” in determining reportable operating segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision maker (“CODM”) for making operating decisions and assessing performance as the source for determining the Company’s reportable segments. The Company’s CODM has been identified as the chief executive officer of the Company who reviews financial information of separate operating segments based on U.S. GAAP. For the six months ended September 30, 2023, the CODM reviews financial information analyzed by customer, which only presented at the gross profit level with no allocation of operating expenses. Thus, the Company determined that it operates in four operating segments: (1) Healthcare products; (2) Automobiles; (3) Online store; and (4) Internet information and advertising service. The Company’s reportable segments are strategic business units that offer different products and services. They are managed separately because each business requires different marketing strategies.
As the Company’s long-lived assets are substantially all located in the PRC and all of the Company’s revenue and expense are derived from within the PRC, no geographical segments are presented.
F-18
Concentration of Risks
Exchange Rate Risks
The Company operates in China, which may give rise to significant foreign
currency risks from fluctuations and the degree of volatility of foreign exchange rates between the US$ and the RMB. As of September 30,
2023 and March 31, 2023, cash and cash equivalents of $
Currency Convertibility Risks
Substantially all of the Company’s operating activities are transacted in RMB, which is not freely convertible into foreign currencies. All foreign exchange transactions take place either through the People’s Bank of China or other banks authorized to buy and sell foreign currencies at the exchange rates quoted by the People’s Bank of China. Approval of foreign currency payments by the People’s Bank of China or other regulatory institutions requires submitting a payment application form together with other information such as suppliers’ invoices, shipping documents and signed contracts.
Concentration of Credit Risks
Financial instruments that potentially subject the Company to concentration of credit risks consist primarily of cash and cash equivalents and accounts receivable, the balances of which are stated on the consolidated balance sheets which represent the Company’s maximum exposure. The Company places its cash and cash equivalents in good credit quality financial institutions in China. Concentration of credit risks with respect to accounts receivables is linked to the concentration of revenue. To manage credit risk, the Company performs ongoing credit evaluations of customers’ financial condition.
Interest Rate Risks
The Company is subject to interest rate risk. Bank interest bearing loans are charged at variable interest rates within the reporting period. The Company is subject to the risk of adverse changes in the interest rates charged by the banks when these loans are refinanced.
Risks and Uncertainties
The operations of the Company are located in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by political, economic, and legal environments in the PRC, as well as by the general state of the PRC economy. The Company’s results may be adversely affected by changes in the political, regulatory and social conditions in the PRC. Although the Company has not experienced losses from these situations and believes that it is in compliance with existing laws and regulations including its organization and structure disclosed in Note 1, this may not be indicative of future results.
COVID-19 Pandemic
The outbreak of COVID-19 began in January 2020 and was quickly declared as a Public Health Emergency of International Concern and subsequently a pandemic by the World Health Organization. A series of prevention and control measures including quarantines, travel restrictions, and the temporary closure of facilities were implemented across the country.
The Company was impacted by the COVID-19 pandemic in many ways, including the plump of closures of experience stores, diving sales by distribution channels, and shut down or partly shut down of production facilities for several months.
Despite the fact that China has largely brought the pandemic under control, there is still a high degree of uncertainty as to how the pandemic will evolve going forward. A new outbreak in China could cause new disruptions of our production, distribution and sales, and have an adverse impact on our business, financial condition and results of operations for the remainder of the six months ended September 30, 2023, which cannot be reasonably estimated at the current stage. The Company will regularly assess its business conditions and adopt measures to mitigate any new impact of the ongoing pandemic.
F-19
Related Parties
The Company accounts for related party transactions in accordance with ASC 850 (“Related Party Disclosures”). A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party. There were no related party transactions as of September 30, 2023.
Recent Accounting Pronouncements
In August 2020, the FASB issued ASU No. 2020-06 (“ASU 2020-06”) “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.” ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. For public business entities, the amendments in ASU 2020-06 are effective for public entities which meet the definition of a smaller reporting company are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023. The Company will adopt ASU 2020-06 effective January 1, 2024. Management is currently evaluating the effect of the adoption of ASU 2020-06 on the consolidated financial statements. The effect will largely depend on the composition and terms of the financial instruments at the time of adoption.
In October 2021, the FASB issued ASU No. 2021-08, “‘Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers” (“ASU 2021-08”). This ASU requires entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. The amendments improve comparability after the business combination by providing consistent recognition and measurement guidance for revenue contracts with customers acquired in a business combination and revenue contracts with customers not acquired in a business combination. The amendments are effective for the Company beginning after December 15, 2023, and are applied prospectively to business combinations that occur after the effective date. The Company does not expect the adoption of ASU 2021-04 will have a material effect on the consolidated financial statements.
In June 2022, the FASB issued ASU 2022-03, “Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”, which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. This guidance also requires certain disclosures for equity securities subject to contractual sale restrictions. The new guidance is required to be applied prospectively with any adjustments from the adoption of the amendments recognized in earnings and disclosed on the date of adoption. This guidance is effective for the Company for the fiscal year ending March 31, 2025 and interim reporting periods during the fiscal year beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect that the adoption of this guidance will have a material impact on the financial position, results of operations and cash flows.
F-20
NOTE 3 – ACCOUNTS RECEIVABLE, NET
| As of September 30, | As of March 31, | |||||||
| 2023 | 2023 | |||||||
| Accounts receivable | $ | $ | ||||||
| Less: allowance for doubtful accounts | ( | ) | ||||||
| Accounts receivable from discontinued operations (Note 15) | ( | ) | ||||||
| Accounts receivable, net | $ | $ | ||||||
| As of September 30, | As of March 31, | |||||||
| 2023 | 2023 | |||||||
| Beginning balance | $ | $ | ||||||
| Provision for doubtful accounts | ||||||||
| Written-off | ( | ) | ( | ) | ||||
| Allowance for doubtful accounts from discontinued operations | ( | ) | ||||||
| Ending balance | $ | $ | ||||||
NOTE 4 – INVENTORIES
| As of September 30, | As of March 31, | |||||||
| 2023 | 2023 | |||||||
| Raw materials | $ | $ | ||||||
| Work in process | ||||||||
| Finished goods | ||||||||
| Inventories from discontinued operations (Note 15) | ( | ) | ||||||
| Total | $ | $ | ||||||
lower of cost or net realizable value adjustment was recorded as of September 30, 2023 and March 31, 2023, respectively.
inventory provision or write-downs for the six months ended September 30, 2023 and 2022.
NOTE 5 – PREPAID EXPENSES AND OTHER CURRENT ASSETS
| As of September 30, | As of March 31, | |||||||
| 2023 | 2023 | |||||||
| Prepayments to suppliers | $ | $ | ||||||
| Loans receivables (a) | ||||||||
| Prepayments to technical provider | ||||||||
| VAT deductibles | ||||||||
| Investment receivables from the investors | ||||||||
| Others | ||||||||
| Prepaid expenses and other current assets from discontinued operations (Note 15) | ( | ) | ||||||
| Total | $ | $ | ||||||
F-21
NOTE 6 – PROPERTY, PLANT AND EQUIPMENT, NET
| As of September 30, | As of March 31, | |||||||
| 2023 | 2023 | |||||||
| Buildings | $ | $ | ||||||
| Machinery | ||||||||
| Furniture, fixture and electronic equipment | ||||||||
| Vehicles | ||||||||
| Total property plant and equipment, at cost | ||||||||
| Less: accumulated depreciation | ( | ) | ( | ) | ||||
| Property, plant and equipment, net from discontinued operations (Note 15) | ( | ) | ||||||
| Property, plant and equipment, net | $ | $ | ||||||
As of September 30, 2023, no building has been
pledged. As of March 31, 2023, the Company pledged its building with a carrying value of approximately $
Depreciation expense was $
The carrying amount of disposed property, plant
and equipment recognized for the six months ended September 30, 2023 and 2022 were amounted to and $
NOTE 7 – INTANGIBLE ASSETS, NET
| As of September 30, | As of March 31, | |||||||
| 2023 | 2023 | |||||||
| Land use right, cost | $ | $ | ||||||
| Customer relationship (Note 14) | ||||||||
| Proprietary technology | ||||||||
| Trademark | ||||||||
| Software, cost | ||||||||
| Total | ||||||||
| Less: accumulated amortization | ( | ) | ( | ) | ||||
| Intangible assets, net from discontinued operations (Note 15) | ( | ) | ||||||
| Intangible assets, net | $ | $ | ||||||
As of September 30, 2023, no land use right has
been pledged. As of March 31, 2023, the Company pledged its land use right on its land with a carrying value of $
For the six months ended September 30, 2023 and 2022, no new intangible assets was purchased. For the six months ended September 30, 2023 and 2022, the Company recorded no disposal of intangible assets.
As of September 30, 2023, the company concluded that there was no impairment of intangible assets.
Amortization expense was $
F-22
| Six months ending September 30, | Amortization expense | |||
| 2024 | $ | |||
| 2025 | ||||
| 2026 | ||||
| 2027 | ||||
| 2028 | ||||
| $ | ||||
NOTE 8 – GOODWILL
| As of September 30, | As of March 31, | |||||||
| 2023 | 2023 | |||||||
| Goodwill, gross (Note 14) | $ | $ | ||||||
| Less: impairment | ||||||||
| Goodwill, net | $ | $ | ||||||
| As of September 30, | As of March 31, | |||||||
| 2023 | 2023 | |||||||
| Goodwill | $ | $ | ||||||
| Acquisitions (Note 14) | ||||||||
| Disposal | ( | ) | ( | ) | ||||
| Impairment | ( | ) | ||||||
| Exchange gain and loss | ( | ) | ||||||
| Goodwill, net from discontinued operations (Note 15) | ( | ) | ||||||
| Goodwill, net | $ | $ | ||||||
The goodwill generated from the expected synergies from the output capacity of the transaction and service scenario of the multi-industry, full-link and full-closed-loop of Shennong, and cooperation of developing the health commodities business stably, combining the production and supply, jointly build a perfect supply chain system with Hekangyuan, new development of consulting, marketing, design, and software development services to empower our clients to adapt and thrive in the Web 3.0 era.
As of September 30, 2023, the company concluded that there was no impairment of goodwill.
F-23
NOTE 9 – PREPAID ASSETS
| As of September 30, | As of March 31, | |||||||
| 2023 | 2023 | |||||||
| Prepayments for advertising or marketing | $ | $ | ||||||
| Prepayment of celebrity endorsement fee | ||||||||
| Prepaid assets from discontinued operations (Note 15) | ( | ) | ||||||
| Total | $ | $ | ||||||
NOTE 10 – SHORT-TERM BANK BORROWINGS
As of September 30, | As of March 31, | |||||||
| 2023 | 2023 | |||||||
| Industrial Bank Co., Ltd | $ | $ | ||||||
| Postal Saving Bank of Chin | ||||||||
| Rural Credit Cooperative (ShunChang) | ||||||||
| Short-term bank borrowings from discontinued operations (Note 15) | ) | |||||||
| Total | $ | $ | ||||||
On May 4, 2018, the Company entered into a bank
loan agreement with Industrial Bank Co., Ltd to borrow $
On June 24, 2019, the Company entered into a loan
facility framework agreement with Postal Saving Bank of China. The agreement allows the Company to access a total borrowing of approximately
$
On May 16, 2022, the Company entered into a loan
agreement with Guangfa Bank of China. The agreement allows the Company to access a total borrowing of approximately $
F-24
As
of | As
of | |||||||
| 2023 | 2023 | |||||||
| Buildings, net | $ | $ | ||||||
| Land use rights, net | ||||||||
| Total | $ | $ | ||||||
For the six months ended September 30, 2023 and
2022, interest expense on all short-term bank loans amounted to $
NOTE 11 – SHARE BASED COMPENSATION
2020 Equity incentive plan
In February 2022, the Company adopted the 2020
Equity incentive plan which allows the Company to offer incentive awards to employee, directors and consultants (collectively, “the
Participants”). Under the 2020 Equity incentive plan, the Company may issue incentive awards to the Participants to purchase no
more than
No share-based compensation expense was recognized in general and administrative expenses for the six months ended September 30, 2023 and 2022.
The fair values of share units are determined based on the fair value of the grant date of the Company’s ordinary shares.
NOTE 12 – SHAREHOLDERS’ EQUITY
Ordinary shares
Paranovus Cayman was incorporated under the laws
of the Cayman Islands on February 9, 2018. The Company issued
A Reorganization of the legal structure was completed
in August 2018. The Reorganization involved the incorporation of PARANOVUS ENTERTAINMENT TECHNOLOGY LIMITED, a Cayman Islands holding
company; Happiness Biology Technology Group Limited, a holding company established in Hong Kong, PRC; Happiness (Fuzhou) E-commerce Co.,
Ltd, a holding company established in Fujian, PRC; and the transfer of
In May 2018, the Company received $
On March 4, 2019, the Company subdivided its
On October 25, 2019, the Company announced the
closing of its initial public offering of
The Company entered several Securities Purchase
Agreement from September 2020 through March 2021. Pursuant to which, the Company issued
F-25
On March 15, 2021, the Company issued
On June 21, 2021, the Company issued an aggregate
of
On June 25, 2021, the Company entered several
Securities Purchase Agreement with non-US investors. Pursuant to which, the Company issued
On October 14, 2021, the Company issued an aggregate
of
On October 20, 2021, the Company entered into
a certain equity agreement with Shennong for the purchase of
On October 21, 2021, the Company held its annual
meeting of shareholders for its fiscal year ending March 31, 2021. The Company approved as a special resolution an alteration to the share
capital of the Company by: a: the conversion of each issued paid up Ordinary Share with a par value of $
On January 12, 2022, the Company issued an aggregate
of
On January 20, 2022, the Company entered several
Securities Purchase Agreement with non-US persons. Pursuant to which, the Company issued
On March 4, 2022, the Company entered into a certain equity transfer
agreement with Hekangyuan for the purchase of
On March 10, 2022, the Company entered several
Securities Purchase Agreement with non-US investors. Pursuant to which, the Company issued
On April 21, 2022,
F-26
On October 10, 2022,
On December 27, 2022, the Company entered into
certain securities purchase agreement (the “SPA”) with certain sophisticated purchasers (the “Purchasers”), pursuant
to which the Company agreed to sell
On March 14, 2023, the Company entered into a
certain equity transfer agreement with 2Lab3 LLC for the purchase of
Non-controlling Interest
Non-controlling interests represent the interest
of non-controlling shareholders in Paranovus Entertainment Technology Ltd. based on their proportionate interests in the equity of that
company adjusted for their proportionate share, which is
Statutory reserve
The Company is required to make appropriations
to certain reserve funds, comprising the statutory reserve and the discretionary reserve, based on after-tax net income determined in
accordance with generally accepted accounting principles of the PRC (“PRC GAAP”).
Under PRC laws and regulations, statutory reserves
are restricted to set-off against losses, expansion of production and operation and increasing registered capital of the respective company,
and are not distributable other than upon liquidation. The reserves are not allowed to be transferred to the Company in terms of cash
dividends, loans or advances, nor allowed for distribution except under liquidation. Amounts restricted include paid-in capital, additional
paid-in capital and statutory reserves of the Company in PRC amounted $
As of September 30, 2023, our PRC subsidiaries
had an accumulated deficit of approximately RMB
F-27
Warrants
In October 2019,
| Number Outstanding | Weighted Average Exercise Price | Contractual Life in Years | Intrinsic Value | |||||||||||||
| Warrants Outstanding as of March 31, 2020 | $ | $ | ||||||||||||||
| Warrants granted | $ | |||||||||||||||
| Warrants forfeited | ||||||||||||||||
| Warrants exercised | $ | |||||||||||||||
| Warrants Outstanding as of March 31, 2021 | $ | $ | ||||||||||||||
| Warrants Outstanding as of March 31, 2022 | $ | $ | ||||||||||||||
| Warrants Outstanding as of March 31, 2023 | ||||||||||||||||
| Warrants Outstanding as of September 30, 2023 | - | |||||||||||||||
NOTE 13 – TAXES
(a) Corporate Income Taxes (“CIT”)
The Company was incorporated in the Cayman Islands and is not subject to tax on income or capital gain under the laws of the Cayman Islands.
Happiness Hong Kong was incorporated in Hong Kong
and is subject to a statutory income tax rate of
Under the Law of the People’s Republic of
China on Enterprise Income Tax (“New EIT Law”), which was
The Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions. As of September 30, 2023 and March 31, 2023, the Company did not have any significant unrecognized uncertain tax positions. The Company did not incur any interest and penalties related to potential underpaid income tax expenses for the six months ended September 30, 2023 and 2022, respectively, and also did not anticipate any significant increases or decreases in unrecognized tax benefits in the next 12 months from September 30, 2023.
| For the six months ended September 30 | ||||||||
| 2023 | 2022 | |||||||
| PRC statutory income tax rate | % | % | ||||||
| Effect of PRC preferential tax rate | ( | ) | ( | )% | ||||
| Effect of other un-deductible expenses | ( | )% | ( | )% | ||||
| Effect of other deductible expenses | % | % | ||||||
| Total | % | % | ||||||
F-28
| For the six months ended September 30, | ||||||||
| 2023 | 2022 | |||||||
| Current income tax provision | $ | ( | ) | $ | ( | ) | ||
| Deferred income tax provision | ( | ) | ||||||
| Income tax expenses from discontinued operations (Note 15) | ||||||||
| Total | $ | $ | ( | ) | ||||
As
of | As
of | |||||||
| 2023 | 2023 | |||||||
| Net accumulated loss-carry forward | $ | $ | ||||||
| Less: valuation allowance | ( | ) | ||||||
| Net deferred tax assets | $ | $ | ||||||
| As of September 30, | As of March 31, | |||||||
| 2023 | 2023 | |||||||
| Intangible assets arising from acquisition | $ | $ | ( | ) | ||||
| Deferred tax liabilities from discontinued operations (Note 15) | $ | $ | ||||||
| Total deferred tax liabilities | $ | $ | ||||||
Deferred income taxes reflect the net effects
of temporary difference between the carrying amounts of assets and liabilities for financial statement purposes and the amounts used for
income tax purposes. No deferred tax assets and deferred tax liabilities was recorded as of September 30, 2023. The Company recorded deferred
tax assets of and deferred tax liabilities of $
(b) Taxes Payable
| As of September 30 | As of March 31, | |||||||
| 2023 | 2023 | |||||||
| Income tax payable | $ | $ | ||||||
| VAT payable | ||||||||
| Other tax payables | ||||||||
| Other tax payables | ( | ) | ||||||
| Total | $ | $ | ||||||
F-29
NOTE 14 – BUSINESS COMBINATION
Acquisition of 2Lab3
On March 28, 2023, the Company acquired
The Company engaged an independent valuation firm to assist management in valuing assets acquired, liabilities assumed, intangible assets identified and contingent consideration as of the acquisition day.
The identifiable intangible assets acquired upon acquisition were proprietary technology with definite useful life. All other current assets and current liabilities carrying value approximated fair value at the time of acquisition. The fair value of the consideration was based on closing market price of the Company’s common share on the acquisition date.
| Fair value of total consideration transferred: | ||||
| Equity instrument ( | $ | |||
| Subtotal | $ | |||
| Recognized amounts of identifiable assets acquired and liability assumed: | ||||
| Cash | $ | |||
| Intangible asset –proprietary technology | ||||
| Current liabilities | ( | ) | ||
| Total identifiable net assets | $ | |||
| Fair value of non-controlling interests | ||||
| Goodwill* | $ | |||
| * |
Acquisition of Shennong
On November 12, 2021, the Company acquired
F-30
The Company engaged an independent valuation firm to assist management in valuing assets acquired, liabilities assumed, intangible assets identified, contingent consideration and non-controlling interests as of the acquisition day.
The identifiable intangible assets acquired upon acquisition were customer relationships with definite useful life. All other current assets and current liabilities carrying value approximated fair value at the time of acquisition. The fair value of the consideration was based on closing market price of the Company’s common share on the acquisition date.
According to the independent valuation report, the purchase price was allocated to the assets acquired and liabilities assumed based on their fair values. Fair value of the non-controlling interests was evaluated based on the equity value of Shennong derived by the discounted cash flow method after considering a discount for lack of control:
| Fair value of total consideration transferred: | ||||
| Equity instrument ( | $ | |||
| Cash consideration | ||||
| Subtotal | $ | |||
| Recognized amounts of identifiable assets acquired and liability assumed: | ||||
| Cash | $ | |||
| Current assets other than cash | ||||
| Intangible asset – customer relationships | ||||
| Current liabilities | ( | ) | ||
| Deferred tax liabilities | ( | ) | ||
| Total identifiable net assets | $ | |||
| Fair value of non-controlling interests* | ||||
| Goodwill* | $ | |||
| * |
Non-controlling interest was recognized and measured at fair value on the acquisition date by the Company.
Acquisition of Hekangyuan
On March 4, 2022, the Company acquired
The Company engaged an independent valuation firm to assist management in valuing assets acquired, liabilities assumed, intangible assets identified and contingent consideration as of the acquisition day.
The identifiable intangible assets acquired upon acquisition were customer relationships with definite useful life. All other current assets and current liabilities carrying value approximated fair value at the time of acquisition. The fair value of the consideration was based on closing market price of the Company’s common share on the acquisition date.
F-31
According to the independent valuation report, the purchase price was allocated to the assets acquired and liabilities assumed based on their fair values was as follows:
| Fair value of total consideration transferred: | ||||
| Equity instrument ( | $ | |||
| Cash consideration | ||||
| Subtotal | $ | |||
| Recognized amounts of identifiable assets acquired and liability assumed: | ||||
| Cash | $ | |||
| Current assets other than cash | ||||
| Property, plant and equipment, net | ||||
| Intangible asset – customer relationships | ||||
| Current liabilities | ( | ) | ||
| Deferred tax liabilities | ( | ) | ||
| Total identifiable net assets | $ | |||
| Fair value of non-controlling interests | ||||
| Goodwill* | $ | |||
| * |
The business combination accounting is provisionally complete for all assets and liabilities acquired on the acquisition date and the Company will continue to evaluate the asset values within the 1-year timeframe according to ASC 805.
NOTE 15 – DISCONTINUED OPERATIONS
Disposition of the healthcare and E-commerce segment
On July 31, 2023, the Company terminated all of healthcare business
for approximately $
On September 30, 2023, the Company terminated all of E-commerce business
for approximately $
From October 1, 2023, the Company no longer retained any financial interest over healthcare and E-commerce business and accordingly deconsolidated both two business’ financial statements from the Company’s consolidated financial statements. The disposal of these two business represented a strategic shift and has a major effect on the Company’s result of operations.
F-32
For
the | ||||
| Consideration | $ | |||
| Cash and cash equivalents | ||||
| Accounts receivable, net | ||||
| Prepaid expenses and other current assets | ||||
| Property, plant and equipment, net | ||||
| Intangible assets, net | ||||
| Goodwill | ||||
| Other assets | ||||
| Accounts payable | ( | ) | ||
| Other payables and accrued liabilities | ( | ) | ||
| Income tax payable | ( | |||
| Short-term bank borrowings | ( | ) | ||
| Deferred tax liability | ( | ) | ||
| Net assets of discontinued business | ( | ) | ||
| Non-controlling interest of discontinued business | $ | ( | ) | |
| Less: net assets of discontinued business contributable to the Company | ( | |||
| Gain on disposal of discontinued business | $ | |||
March
31, | ||||
| Current assets for discontinued operations | ||||
| Cash and cash equivalents | $ | |||
| Accounts receivable, net | ||||
| Inventories | ||||
| Prepaid expenses and other current assets | ||||
| Total | $ | |||
| Non-current assets for discontinued operations | ||||
| Property, plant and equipment, net | $ | |||
| Intangible assets, net | ||||
| Goodwill | ||||
| Other assets | ||||
| Total | $ | |||
| Current liabilities for discontinued operations | ||||
| Accounts payable | $ | |||
| Other payables and accrued liabilities | ||||
| Income tax payable | ||||
| Short-term bank borrowings | ||||
| Total | $ | |||
| Non-current liabilities for discontinued operations | ||||
| Deferred tax liability | $ | |||
| Total | $ | |||
F-33
| For the six months ended September 30, | ||||||||
| 2023 | 2022 | |||||||
| Major classes of line items constituting pre-tax profit of discontinued operations | ||||||||
| Revenues | $ | $ | ||||||
| Cost of revenues | ( | ) | ( | ) | ||||
| Selling and marketing | ( | ) | ( | ) | ||||
| General and administrative | ( | ) | ( | ) | ||||
| Research and development | ( | ) | ( | ) | ||||
| Other expense that are not major | ( | ) | ( | ) | ||||
| Loss from discontinued operations, before income tax | ( | ) | ( | ) | ||||
| Income tax benefit (expense) | ( | ) | ||||||
| Loss from discontinued operations, net of income tax | ( | ) | ( | ) | ||||
| Gain on deconsolidation of the subsidiary, net of income tax | ||||||||
| Net gain (loss) from discontinued operations, net of income tax | ( | ) | ||||||
NOTE 16 – COMMITMENTS AND CONTINGENCIES
As of September 30, 2023 and March 30, 2023, Company has no significant leases or unused letters of credit.
From time to time, the Company is involved in various legal proceedings, claims and other disputes arising from commercial operations, employees, and other matters which, in general, are subject to uncertainties and in which the outcomes are not predictable. The Company determines whether an estimated loss from a contingency should be accrued by assessing whether a loss is deemed probable and can be reasonably estimated. Although the Company can give no assurances about the resolution of pending claims, litigation or other disputes and the effect such outcomes may have on the Company, the Company believes that any ultimate liability resulting from the outcome of such proceedings, to the extent not otherwise provided or covered by insurance, will not have a material adverse effect on our consolidated financial position or results of operations or liquidity. As of September 30, 2023 and March 31, 2023, Company has no pending legal proceedings.
NOTE 17 – SEGMENT REPORTING
Before March 31, 2022, the Company’s CODM, chief executive officer, measures the performance of the Company based on metrics of revenue only and doesn’t focus on any profit of the business. Starting from April 1, 2022, the Company’s CODM, chief executive officer, measures the performance of each segment based on metrics of revenue and gross profit and uses these results to evaluate the performance of, and to allocate resources to each of the segments. As most of the Company’s long-lived assets are located in the PRC and most of the Company’s revenues are derived from the PRC, no geographical information is presented. The Company does not allocate assets and operating expenses to its segments as the CODM does not evaluate the performance of segments using asset and operating expenses information.
For the six months ended September 30, 2023, the Company has determined that it operates in four operating segments: (1) Healthcare products; (2) Automobile; (3) Online store; and (4) Internet information and advertising service. The Company’s reportable segments are strategic business units that offer different products and services. They are managed separately because each business requires different marketing strategies.
F-34
| Six months ended September 30, 2023 | ||||||||||||||||||||
| Healthcare products | Automobile | Online store | Discontinued Operations | Consolidated | ||||||||||||||||
| Revenues | $ | $ | $ | $ | ( | ) | $ | |||||||||||||
| Cost | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | |||||||
| Segment gross profit | $ | $ | $ | $ | ( | ) | $ | |||||||||||||
| Segment gross profit margin | % | % | % | ( | )% | % | ||||||||||||||
NOTE 18 – CUSTOMER AND SUPPLIER CONCENTRATION
The Company’s sales are made to customers
that are located primarily in China. For the six month ended September 30, 2023, Hebei Xiangtuan Car Service Co., Lt and Fuzhou Manyiyou
Industrial Co. Ltd contributed approximately
For the six months ended September 30, 2023 and
2022, no individual suppliers accounted for more than
NOTE 19 – SUBSEQUENT EVENTS
On October 7, 2023, Happiness (Fuzhou) E-commerce Co., Ltd was dissolved.
On November 9, 2023, the Company signed a promissory note purchase
agreement (the “Purchase Agreement”) with a non-U.S. investor (the “Investor”), pursuant to which, the Company
issued an
On November 12, 2023, Paranovus Entertainment Technology Limited, (the
“Company”) entered into a software development agreement (the “Development Agreement”) with Blueline Studios Inc.
(“Blueline”), a company incorporated in Vancouver, Canada. Pursuant to the Development Agreement, Blueline shall be responsible
for developing and delivering certain interactive game application (“Hollywood Sunshine”), including the underlying software,
documentation, and technical data, under the terms and conditions of the Development Agreement, and agreed to assign to the Company all
the right, title, and interest in Hollywood Sunshine, excluding any Background Technology (as defined in the Development Agreement). Blueline
will deliver the initial full-featured version for the PC platform (the “PC Release”) six months after the Start Date as defined
in the Development Agreement, followed by the delivery of iOS version (the “iOS Release”) three months after the PC Release.
In exchange, the Company agreed to pay a total of $
F-35
Exhibit 99.2
FORWARD LOOKING STATEMENT
This Current on Form 6-K filed by Paranovus Entertainment Technology Ltd. (together with our subsidiaries, unless the context indicates otherwise, “we,” “us,” “our,” or the “Company”), contains forward-looking statements within the meaning of the Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events or the Company’s future financial performance. The Company has attempted to identify forward-looking statements by terminology including “anticipates,” “believes,” “expects,” “can,” “continue,” “could,” “estimates,” “intends,” “may,” “plans,” “potential,” “predict,” “should” or “will” or the negative of these terms or other comparable terminology. These statements are only predictions, uncertainties and other factors may cause the Company’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels or activity, performance or achievements expressed or implied by these forward-looking statements. The information in this Report on Form 6-K is not intended to project future performance of the Company. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company does not guarantee future results, levels of activity, performance or achievements. The Company expectations are as of the date this Form 6-K is filed, and the Company does not intend to update any of the forward-looking statements after the date this Report on Form 6-K is filed to confirm these statements to actual results, unless required by law.
Recent Development
Development Agreement
On November 12, 2023, Paranovus Entertainment Technology Limited, (the “Company”) entered into a software development agreement (the “Development Agreement”) with Blueline Studios Inc. (“Blueline”), a company incorporated in Vancouver, Canada. The Company has entered into a non-binding letter of intent in September 2023 with Blueline to acquire 100% of Blueline’s equity interests. This letter of intent has expired as of the date of this report. The Company decided to focus on the transaction with Blueline as contemplated in the Development Agreement first.
Pursuant to the Development Agreement, Blueline shall be responsible for developing and delivering certain interactive game application (“Hollywood Sunshine”), including the underlying software, documentation, and technical data, under the terms and conditions of the Development Agreement, and agreed to assign to the Company all the right, title, and interest in Hollywood Sunshine, excluding any Background Technology (as defined in the Development Agreement). Blueline agreed to deliver the initial full-featured version for the PC platform (the “PC Release”) six months after the Start Date as defined in the Development Agreement, followed by the delivery of iOS version (the “iOS Release”) three months after the PC Release. In exchange, the Company agreed to pay a total of $1,500,000 development fee to Blueline for the PC Release, and $400,000 development fee for the iOS Release, in accordance with the schedule set forth in the Development Agreement. As of January 9, 2024, the Company has paid $750,000 to Blueline according to the schedule as set forth in the Development Agreement. The decision to develop the iOS Release is at the discretion of the Company. Furthermore, once Hollywood Sunshine starts generating revenues, the Company agreed to pay Blueline 9% of the net revenue after deducting all the licensing fees owned to all talent partners.
Promissory Note Offering
On November 9, 2023, the Company signed a promissory note purchase agreement (the “Purchase Agreement”) with a non-U.S. investor (the “Investor”), pursuant to which, the Company issued an 8% promissory note with principal amount of $750,000 (the “Note”) to such Investor on November 14, 2023, the closing date of this transaction. The Note will mature in 12-month after its issuance and can be pre-paid in part or in whole by the Company prior to its maturity date. The proceeds from the Note are used to fund the Hollywood Sunshine and the general corporate activities of the Company.
Suspension of some operations in China
On April 10, 2023, the Company entered into an agreement to transfer 100% of the equity interests in the Fujian Happiness Biotech Co., Limited (“Fujian Happiness”) and its subsidiaries to the third-party Fujian Hengda Beverage Co., Ltd (“Fujian Hengda”), a PRC company which is not affiliate of the Company or any of its directors or officers. Pursuant to the Disposition SPA, the Purchaser agreed to purchase the Fujian Happiness in exchange for cash consideration of RMB 78 million (approximately $11.3 million). Upon the closing of the transaction (the “Disposition”) contemplated by the Disposition SPA on July 31, 2023, Fujian Hengda became the sole shareholder of Fujian Happiness and as a result, assumed all assets and liabilities of Fujian Happiness and subsidiaries owned or controlled by Fujian Happiness.
On August 28, 2023, the Company’s indirect wholly owned subsidiary, Happy Buy (Fujian) Internet Technology Co., Limited (“Happy Buy” or “Seller”), and Shunchang Jinyifu trading Co., Ltd (“Shunchang Jinyi”), a PRC company which is not affiliate of the Company or any of its directors or officers (the “Purchaser”) entered into certain share purchase agreement (the “Disposition SPA”). Pursuant to the Disposition SPA, the Purchaser purchased the Happy Buy in exchange for cash consideration of RMB 5 million (approximately $0.7 million, the “Purchase Price”). Upon the closing of the transaction (the “Disposition”) contemplated by the Disposition SPA on September 1, 2023, the Buyer became the sole shareholder of Happy Buy and as a result, assumed all assets and liabilities of Happy Buy and subsidiaries owned or controlled by Happy Buy.
On September 3, 2023, the Board of Directors of the Company approved and ratified suspension of the Company’s e-commerce and internet information and advertising business conducted mainly through Happy Buy. As of March 31, 2023, the e-commerce and internet information and advertising business incurred loss of approximately $21.42 million comparing to loss of approximate $7.60 million as of March 31, 2022. Due to the lingering adverse impacts of COVID-19 and sluggish macro-economic condition in China, the management does not expect short-term turn-over of these businesses and therefore the Board decided to suspend these loss-incurring businesses.
Management plans to transition the Company into the entertainment and AI powered entertainment industries and will continue to identify other prospective acquisition opportunity of target business in such industries. In addition, the Company’s wholly owned subsidiary 2Lab3 has recently shifted its focus towards the development of AI-powered applications.
After disposition of its nutraceutical and dietary supplements business in April 2023 and suspension of the e-commerce and internet information and advertising business expected in September 2023, the Company’s only remaining operating business based in China is the automobile sales business, a B2B business committed to optimizing the auto supply chain by connecting car dealers via an online automobile sales platform and offering overall services for automobile purchasing.
2
Results of Operations
The following information was derived from our Unaudited Financial Results for the six months ended September 30, 2023 and 2022, attached hereto as Exhibit 99.1.
3
PARANOVUS ENTERTAINMENT TECHNOLOGY LTD.
CONSOLIDATED STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)
FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
(UNAUDITED)
(IN U.S. DOLLARS)
| For the six months ended September 30, | ||||||||
| 2023 | 2022 | |||||||
| Revenues | $ | 6,293,965 | $ | 16,880,316 | ||||
| Cost of revenues | (6,288,714 | ) | (16,489,032 | ) | ||||
| Gross profit | 5,251 | 391,284 | ||||||
| Operating expenses: | ||||||||
| Selling and marketing | 9,245,430 | 1,633,262 | ||||||
| General and administrative | 1,483,419 | 823,832 | ||||||
| Research and development | - | 5,741 | ||||||
| Gain on disposal of subsidiaries | (23,473,558 | ) | (67,501 | ) | ||||
| Total operating expenses | (12,744,709 | ) | 2,395,334 | |||||
| Operating income (loss) | 12,749,960 | (2,004,050 | ) | |||||
| Other income (expenses): | ||||||||
| Interest income | 1,220 | 614 | ||||||
| Interest expense | - | (500 | ) | |||||
| Other loss, net | (3,003,670 | ) | (84,773 | ) | ||||
| Total other loss, net | (3,002,450 | ) | (84,659 | ) | ||||
| Gain (loss) from continuing operations before income taxes | 9,747,510 | (2,088,709 | ) | |||||
| Provision for tax expenses | - | (44,280 | ) | |||||
| Net gain (loss) from continuing operations | $ | 9,747,510 | $ | (2,132,989 | ) | |||
| Net loss from discontinued operations – disposal* | (1,551,740 | ) | (20,605,694 | ) | ||||
| Net gain (loss) | 8,195,770 | (22,738,683 | ) | |||||
| Other comprehensive loss: | ||||||||
| Foreign currency translation adjustments | (1,768,661 | ) | (4,606,029 | ) | ||||
| Comprehensive income (loss) | $ | 6,427,109 | $ | (27,344,712 | ) | |||
| Less: comprehensive loss attributable to non-controlling interests: | (886,008 | ) | (80,764 | ) | ||||
| Comprehensive income (loss) attributable to Paranovus Entertainment Technology Ltd. | 7,313,117 | (27,263,948 | ) | |||||
| Basic and diluted earnings (loss) per ordinary share | ||||||||
| Continuing operations basic and diluted | $ | 2.06 | $ | (0.05 | ) | |||
| Basic and diluted loss per ordinary share | ||||||||
| Discontinued operations basic and diluted | $ | (0.33 | ) | $ | (0.51 | ) | ||
| Weighted average number of ordinary shares outstanding | ||||||||
| Basic and diluted | 4,732,726 | 40,485,912 | ||||||
4
Revenues
We generated $6,293,965 in revenues for the six months ended September 30, 2023, representing a decrease of $10,586,351 or 62.71%, as compared with $16,880,316 for the six months ended September 30, 2022. The decrease was primarily due to the strategic shift of the Company’s business. The Company disposed the healthcare and e-commerce business during the six months ended September 30, 2023, at the same time, the automobiles business was gradually decreasing. The revenue generated from the healthcare and e-commerce was reclassified into the gain/ (loss) from discontinued operations - disposal account.
The automobile sales had decreased by $9,743,797, from $16,037,762 for the six months ended September 30, 2022 to $6,293,965 for the six months ended September 30, 2023. The total revenue of automobiles gradually decreased during the six months ended September 30, 2023. Therefore the Company is considering suspending the automobile business.
Cost of Revenue
Cost of revenue decreased by $10,200,318 or 61.86%, from $16,489,032 for the six months ended September 30, 2022 to $6,288,714 for the six months ended September 30, 2023. Gross margin were 0.08% and 2.32% for the six months ended September 30, 2023 and 2022, respectively. The gross profit of automobiles sales gradually decreased and the Company is contemplating the possibility of the suspension of the automobile sales business in the future, considering various factors, including but not limited to, the performance and operating results of this business.
Selling and Marketing Expenses
The selling expenses increased by $7,612,168, or 466.07%, from $1,633,262 for the six months ended September 30, 2022 to $9,245,430 for the six months ended September 30, 2023, the increase was primarily because Happiness Biology Technology Group Limited (“Happiness Hong Kong” or “WFOE”) invested more cash in exhibition and advertising to attract new potential customers through different platforms such as we-media, exhibitions, streaming advertising and etc., to promote its business of healthcare, e-commerce and automobiles.
General and Administrative Expenses
The general and administrative expenses increased from $823,832 for the six months ended September 30, 2022 to $1,483,419 for the six months ended September 30, 2023, representing an increase of $0.66 million, or 80.06%. The increase was mainly due to the office expenses, staff cost and service expenses incurred from the Company’s subsidiaries in the United States, including 2Lab3 LLC and Paranovus New York.
Research and Development Expenses
The research and development expenses decreased from $5,741 for the six months ended September 30, 2022 to nil for the six months ended September 30, 2023, representing a decrease of $5,741 million, or 100.0%. The decrease in the cost of research and development expense was due to the disposal of the healthcare segment.
Gain (loss) from continuing operations before income taxes
The gain from continuing operations of $9,747,510 for the six months ended September 30, 2023, compared to loss from continuing operations of $2,088,709 for the six months ended September 30, 2022. The gain generated in 2023 was mainly attributed to the disposal of healthcare and e-commerce segments and the respective operating entities amounted to $23,473,558. The loss incurred during the six months ended September 30, 2022 was resulted from the poor performance of the healthcare products segment, which was result from the impacts of COVID-19, including the lockdown and mass testing policies in China. We had gradually optimized and made the strategy shift to avoid further losses.
5
Income Tax
We incurred no income tax expense for the six months ended September 30, 2023, representing a decrease of $44,280 or 100%, compared to $44,280 for the six months ended September 30, 2022. The change was primary attributable to the disposal of the business of healthcare and e-commerce. No provision of income tax for the remaining business.
Net gain (loss) from continuing operations
As a result of the foregoing, net gain amounted to $9,747,510 for the six months ended September 30, 2023, compared to net loss of $2,132,989 for the six months ended September 30, 2022.
Net loss from discontinued operations – disposal
On July 31, 2023, the Company sold all of healthcare business for approximately $11.3 million (RMB 78 million) consideration and disposed of its healthcare-related business.
By September 30, 2023, the Company has sold all of e-commerce business for approximately $0.7 million (RMB 5 million) consideration and disposed of its e-commerce-related business.
From October 1, 2023, the Company no longer retained any financial interest over healthcare and e-commerce business and accordingly deconsolidated both two business’ financial statements from the Company’s consolidated financial statements. The disposal of these two business represented a strategic shift and has a major effect on the Company’s result of operations.
| * | The Company calculated a gain resulting from the above-mentioned dispositions as follows: |
| For the
six months ended September 30, 2023 |
||||
| Consideration | $ | 11,656,321 | ||
| Cash and cash equivalents | 408,239 | |||
| Accounts receivable, net | 4,016,356 | |||
| Prepaid expenses and other current assets | 4,098,502 | |||
| Property, plant and equipment, net | 6,203,413 | |||
| Intangible assets, net | 6,749,192 | |||
| Goodwill | 1,227,292 | |||
| Other assets | 3,047,886 | |||
| Accounts payable | (16,619,622 | ) | ||
| Other payables and accrued liabilities | (16,436,012 | ) | ||
| Income tax payable | (28,571 | |||
| Short-term bank borrowings | (2,162,739 | ) | ||
| Deferred tax liability | (1,330,061 | ) | ||
| Net assets of discontinued business | (10,826,125 | ) | ||
| Non-controlling interest of discontinued business | $ | (991,112 | ) | |
| Less: net assets of discontinued business contributable to the Company | (11,817,237 | |||
| Gain on disposal of discontinued business | $ | 23,473,558 | ||
6
PARANOVUS ENTERTAINMENT TECHNOLOGY LTD.
CONSOLIDATED BALANCE SHEETS
AS OF SEPTEMBER 30, 2023, AND MARCH 31, 2023
(UNAUDITED)
(IN U.S. DOLLARS)
| As of September 30, | As of March 31, | |||||||
| 2023 | 2023 | |||||||
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ | 1,036,536 | $ | 2,198,694 | ||||
| Accounts receivable, net | 16,505 | - | ||||||
| Inventories | 14,544 | - | ||||||
| Prepaid expenses and other current assets | 904,707 | 3,074,663 | ||||||
| Current assets from discontinued operations - disposal* | - | 4,512,614 | ||||||
| Total current assets | 1,972,292 | 9,785,971 | ||||||
| Property, plant and equipment, net | 3,178 | 13,470 | ||||||
| Intangible assets, net | 1,678,333 | 1,868,333 | ||||||
| Goodwill | 5,184,036 | 5,184,036 | ||||||
| Prepaid assets | 2,332,658 | 251 | ||||||
| Non-current assets from discontinued operations – disposal* | - | 19,488,148 | ||||||
| Total non-current assets | 9,198,205 | 26,554,238 | ||||||
| TOTAL ASSETS | $ | 11,170,497 | $ | 36,340,209 | ||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
| Current liabilities | ||||||||
| Accounts payable | $ | - | $ | - | ||||
| Other payables and accrued liabilities | 492,980 | - | ||||||
| Income tax payable | 102 | 8,987 | ||||||
| Current liabilities from discontinued operations – disposal* | - | 20,944,091 | ||||||
| Total current liabilities | 493,082 | 20,953,078 | ||||||
| Deferred tax liability | - | - | ||||||
| Non-current liabilities from discontinued operations – disposal* | - | 1,514,060 | ||||||
| Total non-current liabilities | - | 1,514,060 | ||||||
| TOTAL LIABILITIES | 493,082 | 22,467,138 | ||||||
| COMMITMENTS AND CONTINGENCIES | ||||||||
| SHAREHOLDERS’ EQUITY | ||||||||
| Class A Ordinary shares, $0.01 par value, 350,000,000 shares authorized, 6,724,675 shares issued and outstanding; $0.01 par value, 350,0,00,000 shares authorized, 7,724,675 shares issued and outstanding | 67,177 | 77,177 | ||||||
| Class B Ordinary shares, $0.01 par value, 100,000,000 shares authorized, 612,255 shares issued and outstanding; $0.01 par value, 100,000,000 shares authorized, 612,255 shares issued and outstanding | 6,123 | 6,123 | ||||||
| Preferred shares, $0.01 par value,500,000 shares authorized, 0 shares issued and outstanding | - | - | ||||||
| Additional paid-in capital | 64,918,726 | 66,908,726 | ||||||
| Statutory reserve | - | 7,622,765 | ||||||
| Accumulated deficit | (51,257,823 | ) | (59,453,593 | ) | ||||
| Accumulated other comprehensive loss | (3,056,788 | ) | (402,119 | ) | ||||
| Total Paranovus Entertainment Technology Ltd.’s shareholders’ equity | 10,677,415 | 14,759,079 | ||||||
| Non-controlling interests | - | (886,008 | ) | |||||
| Total shareholders’ equity | 10,677,415 | 13,873,071 | ||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ | 11,170,497 | $ | 36,340,209 | ||||
7
| * | The assets and liabilities for discontinued operations - disposal comprised the following items as of March 31, 2023: |
| March
31, 2023 | ||||
| Current assets for discontinued operations | ||||
| Cash and cash equivalents | $ | 1,156,793 | ||
| Accounts receivable, net | 1,706,279 | |||
| Inventories | 335,019 | |||
| Prepaid expenses and other current assets | 1,314,523 | |||
| Total | $ | 4,512,614 | ||
| Non-current assets for discontinued operations | ||||
| Property, plant and equipment, net | $ | 8,456,802 | ||
| Intangible assets, net | 7,577,922 | |||
| Goodwill | 1,271,746 | |||
| Other assets | 2,181,678 | |||
| Total | $ | 19,488,148 | ||
| Current liabilities for discontinued operations | ||||
| Accounts payable | $ | 13,462,008 | ||
| Other payables and accrued liabilities | 5,106,634 | |||
| Income tax payable | 134,373 | |||
| Short-term bank borrowings | 2,241,076 | |||
| Total | $ | 20,944,091 | ||
| Non-current liabilities for discontinued operations | ||||
| Deferred tax liability | $ | 1,514,060 | ||
| Total | $ | 1,514,060 | ||
Liquidity and Capital Resources
As of September 30, 2023 and March 31, 2023, we had cash and cash equivalents of $1,036,536 and $2,198,694, respectively. We did not have any other short-term investments.
As of September 30, 2023 and March 31, 2023, our current assets were $1,972,292 and $ 9,785,971, respectively, and our current liabilities were $493,082 and $20,953,078, respectively.
8
Cash Flows Summary
| For the Six Months Ended September 30, | ||||||||
| 2023 | 2022 | |||||||
| Net cash used in operating activities | $ | (11,705,628 | ) | $ | (8,183,863 | ) | ||
| Net cash (provided by) used in investing activities | 11,155,338 | (84,912 | ) | |||||
| Net cash provided by financing activities | - | 1,598,574 | ||||||
| Effect of exchange rate changes on cash | (1,768,661 | ) | (1,811,034 | ) | ||||
| Net decrease in cash | $ | (2,318,951 | ) | $ | (8,481,235 | ) | ||
Operating activities
Net cash used in operating activities was approximately $11.71 million for the six months ended September 30, 2023, compared to net cash used in approximately $8.18 million for the six months ended September 30, 2022.
Net cash used in operating activities from continuing operations for the six months ended September 30, 2023 was mainly due to the gain on disposal of discontinued operations amounted to approximately $23.47 million, increase of accounts receivable approximately $2.35 million, increase of prepayments and other current assets approximately $21.23 million, increase of the other assets approximately $4.08 million, increase of accounts payable approximately $3.63 million and increase of other payables and accrued liabilities approximately $12.01 million, , offset by decrease of inventories of approximately $0.34 million. Net cash used in operating activities from discontinued operations for the six months ended September 30, 2023 was approximately $8.15 million. The total net cash used in operating activities was approximately 11.71 million.
Investing activities
Net cash provided by investing activities was approximately $11.16 million for the six months ended September 30, 2023, as compared to the net cash used in investing activities amounted to approximately $0.08 million for the six months ended September 30, 2022. Net cash provided by investing activities from continuing operations was mainly generated from the proceeds of disposal of the healthcare and E-commerce business.
Financing activities
Net cash provided by financing activities was approximately $1.6 million for the six months ended September 30, 2022. No financing activities happened during the six months ended September 30, 2023.
Net cash provided by financing activities from discontinued operations for the six months ended September 30, 2022 was mainly due to repayment to the short-term bank loans of approximately $1.03 million, offset by an approximately $1.5 million capital contribution from non-controlling shareholders and the proceeds from short-term bank loans amounted to $1.2 million.
Statement Regarding Unaudited Financial Information
The unaudited financial information set forth above is subject to adjustments that may be identified when audit work is performed on the Company’s year-end financial statements, which could result in significant differences from this unaudited financial information.
9
Document And Entity Information |
6 Months Ended |
|---|---|
Sep. 30, 2023 | |
| Document Information Line Items | |
| Entity Registrant Name | PARANOVUS ENTERTAINMENT TECHNOLOGY LIMITED |
| Document Type | 6-K |
| Current Fiscal Year End Date | --03-31 |
| Amendment Flag | false |
| Entity Central Index Key | 0001751876 |
| Document Period End Date | Sep. 30, 2023 |
| Document Fiscal Year Focus | 2023 |
| Document Fiscal Period Focus | Q2 |
| Entity File Number | 001-39098 |
Consolidated Balance Sheets (Unaudited) (Parentheticals) - $ / shares |
Sep. 30, 2023 |
Mar. 31, 2023 |
|---|---|---|
| Ordinary shares, shares issued | 5,100,000 | |
| Preferred shares, par value (in Dollars per share) | $ 0.01 | $ 0.01 |
| Preferred shares, shares authorized | 500,000 | 500,000 |
| Preferred shares, shares issued | 0 | 0 |
| Preferred shares, shares outstanding | 0 | 0 |
| Class A Ordinary Shares | ||
| Ordinary shares, par value (in Dollars per share) | $ 0.01 | $ 0.01 |
| Ordinary shares, shares authorized | 350,000,000 | 350,000,000 |
| Ordinary shares, shares issued | 6,724,675 | 7,724,675 |
| Ordinary shares, shares outstanding | 6,724,675 | 7,724,675 |
| Class B Ordinary Shares | ||
| Ordinary shares, par value (in Dollars per share) | $ 0.01 | $ 0.0005 |
| Ordinary shares, shares authorized | 100,000,000 | 100,000,000 |
| Ordinary shares, shares issued | 612,255 | 612,255 |
| Ordinary shares, shares outstanding | 612,255 | 612,255 |
Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) (Unaudited) (Parentheticals) - $ / shares |
6 Months Ended | |
|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|
| Income Statement [Abstract] | ||
| Continuing operations diluted | $ 2.06 | $ (0.05) |
| Discontinued operations diluted | $ (0.33) | $ (0.51) |
| Diluted (in Shares) | 4,732,726 | 40,485,912 |
Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($) |
Class A
Ordinary shares
|
Class B
Ordinary shares
|
Additional paid-in capital |
Statutory surplus reserve |
Retained earnings |
Accumulated other comprehensive income (loss) |
Total Paranovus Entertainment Technology Ltd. shareholders’ equity |
Non- controlling interests |
Total |
|---|---|---|---|---|---|---|---|---|---|
| Balance at Mar. 31, 2022 | $ 33,502 | $ 6,048 | $ 53,871,226 | $ 7,622,765 | $ 12,285,281 | $ 4,306,536 | $ 78,125,358 | $ (710,754) | $ 77,414,604 |
| Balance (in Shares) at Mar. 31, 2022 | 67,004,583 | 12,095,100 | |||||||
| Contribution from non-controlling shareholders | 1,482,250 | 1,482,250 | |||||||
| Net income (loss) | (19,369,453) | (19,369,453) | (3,369,230) | (22,738,683) | |||||
| Foreign currency translation adjustments | (4,686,793) | (4,686,793) | 80,764 | (4,606,029) | |||||
| Balance at Sep. 30, 2022 | $ 33,502 | $ 6,048 | 53,871,226 | 7,622,765 | (7,084,172) | (380,257) | 54,069,112 | (2,516,970) | 51,552,142 |
| Balance (in Shares) at Sep. 30, 2022 | 67,004,583 | 12,095,100 | |||||||
| Balance at Mar. 31, 2023 | $ 77,177 | $ 6,123 | 66,908,726 | 7,622,765 | (59,453,593) | (402,119) | 14,759,079 | (886,008) | 13,873,071 |
| Balance (in Shares) at Mar. 31, 2023 | 7,724,675 | 612,255 | |||||||
| Share cancellation | $ (10,000) | (1,990,000) | (2,000,000) | (2,000,000) | |||||
| Share cancellation (in Shares) | (1,000,000) | ||||||||
| Net income (loss) | 8,195,770 | 8,195,770 | 8,195,770 | ||||||
| Discontinued operations - disposal | (7,622,765) | (7,622,765) | (7,622,765) | ||||||
| Foreign currency translation adjustments | (2,654,669) | (2,654,669) | 886,008 | (1,768,661) | |||||
| Balance at Sep. 30, 2023 | $ 67,177 | $ 6,123 | $ 64,918,726 | $ (51,257,823) | $ (3,056,788) | $ 10,677,415 | $ 10,677,415 | ||
| Balance (in Shares) at Sep. 30, 2023 | 6,724,675 | 612,255 |
Organization and Nature of Operations |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Organization and Nature of Operations [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ORGANIZATION AND NATURE OF OPERATIONS | NOTE 1 – ORGANIZATION AND NATURE OF OPERATIONS
Paranovus Entertainment Technology Limited (“Paranovus Cayman”) is a holding company. It was incorporated on February 13, 2018 under the laws of the Cayman Islands and previously named Happiness Biotech Group Limited. On November 5, 2021, the Company changed its name to Happiness Development Group Limited under the special resolution dated October 21, 2021. On March 13, 2023 the Company changed its name to Paranovus Entertainment Technology Limited under the special resolution dated March 13, 2023. The Company has no substantive operations other than holding all of the outstanding share capital of Happiness Holding Group Limited(“Happiness Hong Kong”), previous named as Happiness Biology Technology Group Limite, and Paranovus Entertainment Technology Limited (“Paranovus NewYork”). Happiness Hong Kong is a holding company of all of the equity or ownership of Happiness (Fuzhou) E-commerce Co., Ltd (“Happiness Fuzhou”) and Happiness (Shunchang) E-commerce Co. Ltd (“Happiness Shunchang”). 2Lab3 LLC was established in the state of Delaware on December 8, 2022 and was acquired by Paranovus Cayman in March 2023.
Happiness Shunchang is a holding company of all of the equity or ownership of Fuzhou Happiness Enterprise Management Consulting Co., Ltd. (“Fujian Consulting”) and Taochejun (Fujian) Automobile Sales Co., Ltd. (“Fujian Taochejun”).
Reorganization
A Reorganization of the legal structure was completed in August 2018. The Reorganization involved the incorporation of PARANOVUS ENTERTAINMENT TECHNOLOGY LIMITED, a Cayman Islands holding company; Happiness Biology Technology Group Limited, a holding company established in Hong Kong, PRC; Happiness (Fuzhou) E-commerce Co., Ltd, a holding company established in Fujian, PRC; and the transfer of 100% ownership of Fujian Happiness from the former shareholders to Happiness Fuzhou. Paranovus Cayman, Happiness Hong Kong and Happiness Fuzhou are all holding companies and had not commenced operation until August 21, 2018.
Prior to the reorganization, Mr. Wang Xuezhu, Chief Executive Officer owns 47.7% ownership of Fujian Happiness. On August 21, 2018, Mr. Wang Xuezhu and other shareholders of Fujian Happiness transferred their 100% ownership interests in Fujian Happiness to Happiness Fuzhou, which is 100% owned by Happiness Hong Kong. After the reorganization, Paranovus Cayman owns 100% equity interests of Fujian Happiness. Mr. Wang Xuezhu, who owns 52.37% ownership of Paranovus Cayman, became the ultimate controlling shareholder (“the Controlling Shareholder”) of the Company.
Since the Company is effectively controlled by the same Controlling Shareholder before and after the reorganization, it is considered under common control. Therefore, the above-mentioned transactions were accounted for as a recapitalization. The reorganization has been accounted for at historical cost and prepared on the basis as if the aforementioned transactions had become effective as of the beginning of the first period presented in the accompanying financial statements of the Company.
On March 4, 2019, the Company subdivided its 50,000 ordinary shares into 90,000,000 Ordinary shares and 10,000,000 Preferred shares. The authorized ordinary shares became 100,000,000 shares and the par value was changed from $1 to $0.0005. On the same day, the Company cancelled 77,223,100 ordinary shares and sold additional 223,100 ordinary shares. As of March 31, 2019, the Company has 23,000,000 ordinary shares issued and outstanding. The Company has retrospectively reflected the stock subdivision and cancellation in all periods presented in these financial statements.
During the reporting periods, the Company has several subsidiaries in PRC. Details of the Company and its operating subsidiaries are set out below:
|
Significant Accounting Policies |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SIGNIFICANT ACCOUNTING POLICIES | NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Principles of Consolidation
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and have been consistently applied. The accompanying consolidated financial statements include the financial statements of Happiness Development and its subsidiaries (collectively, the “Company”). All inter-company balances and transactions have been eliminated upon consolidation.
Non-controlling interests
For the Company’s non-wholly owned subsidiaries, a non-controlling interest is recognized to reflect the portion of equity that is not attributable, directly or indirectly, to the Company. Non-controlling interests are classified as a separate line item in the equity section of the Company’s consolidated balance sheets and have been separately disclosed in the Company’s consolidated statements of comprehensive (loss)/income to distinguish the interests from that of the Company. Cash flows related to transactions with non-controlling interests are presented under financing activities in the consolidated statements of cash flows.
Use of Estimates
In preparing the consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information as of the date of the consolidated financial statements. Significant estimates required to be made by management include, but are not limited to, the valuation of accounts receivable and related allowance for doubtful accounts, useful lives of property and equipment and intangible assets, the recoverability of long-lived assets, inventory reserve, allowance for credit losses, goodwill impairment, income taxes related to realization of deferred tax assets and uncertain tax position, provisions necessary for contingent liabilities and purchase price allocation in connection with the business combination. The current economic environment has increased the degrees of uncertainty inherent in those estimates and assumptions, actual results could differ from those estimates.
Business combination
Business combinations are recorded using the acquisition method of accounting. The assets acquired, the liabilities assumed, and any non-controlling interests of the acquiree at the acquisition date, if any, are measured at their fair values as of the acquisition date. Goodwill is recognized and measured as the excess of the total consideration transferred plus the fair value of any non-controlling interest of the acquiree and fair value of previously held equity interest in the acquiree, if any, at the acquisition date over the fair values of the identifiable net assets acquired. Common forms of the consideration made in acquisitions include cash and common equity instruments. Consideration transferred in a business acquisition is measured at the fair value as of the date of acquisition. Acquisition-related expenses and restructuring costs are expensed as incurred.
Accounting Standards Codification (“ASC”) 805 establishes a measurement period to provide the Company with a reasonable amount of time to obtain the information necessary to identify and measure various items in a business combination and cannot extend beyond one year from the acquisition date.
Cash and Cash Equivalents
The Company considers all highly liquid investment instruments with an original maturity of three months or less from the date of purchase to be cash equivalents. The Company maintains all bank accounts in the PRC. Cash balances in bank accounts in PRC are not insured by the Federal Deposit Insurance Corporation or other programs.
Accounts receivable, net
Accounts receivable, net are recognized and carried at original invoiced amount less an estimated allowance for uncollectible accounts. The Company determines the adequacy of reserves for doubtful accounts based on individual account analysis and historical collection trends. The Company establishes a provision for doubtful receivables when there is objective evidence that the Company may not be able to collect amounts due. The allowance is based on management’s best estimates of specific losses on individual exposures, as well as a provision on historical trends of collections. Based on management of customers’ credit and ongoing relationship, management makes conclusions whether any balances outstanding at the end of the period will be deemed uncollectible on an individual basis and on aging analysis basis. The provision is recorded against accounts receivables balances, with a corresponding charge recorded in the consolidated statements of income and comprehensive income. Delinquent account balances are written-off against the allowance for doubtful accounts after management has determined that the likelihood of collection is not probable.
Inventories
Inventories are stated at the lower of cost or net realizable value. Cost of inventories is determined using the weighted-average method. In addition to cost of raw materials, work in progress and finished goods include direct labor costs and overheads. The Company periodically assesses the recoverability of all inventories to determine whether adjustments are required to record inventories at the lower of cost or market value. Inventories that the Company determines to be obsolete or in excess of forecasted usage are reduced to its estimated realizable value based on assumptions about future demand and market conditions. If actual demand is lower than the forecasted demand, additional inventory write-downs may be required.
Prepaid expenses and other current assets
Prepaid expenses and other current assets mainly represents cash prepaid to the suppliers, the technical providers and the investment receivables from the investors.
Prepaid expenses and other current assets primarily consist of advances to vendors for purchasing goods, advances to the technical provides that have not been received or provided. Prepaid expenses and other current assets are classified as current or non-current based on the terms of the respective agreements. These advances are unsecured and are reviewed periodically to determine whether their carrying value has become impaired. The Company considers the assets to be impaired if the collectability of the advance becomes doubtful. The Company uses the aging method to estimate the allowance for uncollectible balances. The allowance is also based on management’s best estimate of specific losses on individual exposures, as well as a provision on historical trends of collections and utilizations. Actual amounts received or utilized may differ from management’s estimate of credit worthiness and the economic environment.
Goodwill
Goodwill represents the excess of the purchase price over the fair value of the identifiable assets and liabilities acquired in a business combination.
Goodwill is not depreciated or amortized but is tested for impairment on an annual basis as of March 31, and in between annual tests when an event occurs or circumstances change that could indicate that the asset might be impaired. In accordance with the FASB ASC 350 guidance on “Testing of Goodwill for Impairment”, a company first has the option to assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the company decides, as a result of its qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test is mandatory. Otherwise, no further testing is required. The quantitative impairment test consists of a comparison of the fair value of each reporting unit with its carrying amount, including goodwill. If the carrying amount of each reporting unit exceeds its fair value, an impairment loss equal to the difference between the fair value of the reporting unit and the carrying amount will be recorded. Application of a goodwill impairment test requires significant management judgment, including the identification of reporting units, assigning assets and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value of each reporting unit. The judgment in estimating the fair value of reporting units includes estimating future cash flows, determining appropriate discount rates and making other assumptions. Changes in these estimates and assumptions could materially affect the determination of fair value for each reporting unit.
As of September 30, 2023, goodwill resulting from business acquisitions has only one reporting unit, including 2Lab3. The Company evaluates if goodwill impairment may be indicated on quarterly basis and performs the annual goodwill impairment assessment as of March 31. The Company performed qualitative assessments for the goodwill. Based on the requirements of ASC 350-20, the Company evaluated all relevant factors including, but not limited to, macroeconomic conditions, industry and market conditions, financial performance, and the share price of the Company. The Company weighed all factors in their entirety and concluded that it was not more-likely-than-not the fair value was less than the carrying amount of goodwill, and further impairment testing on goodwill was unnecessary as of September 30, 2023.
Property, Plant and Equipment
Property, plant and equipment are stated at cost. The straight-line depreciation method is used to compute depreciation over the estimated useful lives of the assets, as follows:
Expenditures for maintenance and repairs, which do not materially extend the useful lives of the assets, are charged to expense as incurred. Expenditures for major renewals and betterment which substantially extend the useful life of assets are capitalized. The cost and related accumulated depreciation of assets retired or sold are removed from the respective accounts, and any gain or loss is recognized in the consolidated statements of income and other comprehensive income in other income or expenses.
Intangible Assets
Intangible assets with definite lives are initially recorded at cost. Amortization of definite-lived intangible assets is computed using the straight-line method over the estimated average useful lives. Intangible assets with indefinite lives should not be amortized but should be tested for impairment at least annually or when event occurs or circumstances that could indicate that the asset might be impaired.
The estimated useful lives of intangible assets are as follows:
Impairment of Long-lived Assets other than goodwill
The Company reviews long-lived assets, including definite-lived intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the estimated cash flows from the use of the asset and its eventual disposition are below the asset’s carrying value, then the asset is deemed to be impaired and written down to its fair value. There were no impairments of these assets as of September 30, 2023 and March 31, 2023.
Short-term bank borrowings
Short-term bank borrowings represent the amounts due to various banks that are due within one year.
Short-term bank borrowings are presented as current liabilities unless the Company has an unconditional right to defer settlement for at least 12 months after the financial year end date, in which case they are presented as non-current liabilities.
Short-term bank borrowings are initially recognized at fair value (net of transaction costs) and subsequently carried at amortized cost. Any difference between the proceeds (net of transaction costs) and the redemption value is recognized in profit or loss over the period of the borrowings using effective interest method.
Short-term bank borrowings costs are recognized in profit or loss using the effective interest method.
Fair Value of Financial Instruments
The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 820, Fair Value Measurement and Disclosures, requires certain disclosures regarding the fair value of financial instruments. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:
The Company considers the recorded value of its financial assets and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other receivable, accounts payable, short-term borrowings, accounts payable, income tax assets and liabilities and income taxes payable and to approximate the fair value of the respective assets and liabilities at September 30, 2023 and March 31, 2023 based upon the short-term nature of the assets and liabilities.
Discontinued operations
In accordance with ASC 205-20, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity, a disposal of a component of an entity or a group of components of an entity is required to be reported as a discontinued operation if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when the components of an entity meets the criteria in paragraph 205-20-45-1E to be classified as held for sale. When all of the criteria to be classified as held for sale are met, including management, having the authority to approve the action, commits to a plan to sell the entity, the major current assets, other assets, current liabilities, and non-current liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations in accordance with ASC 205-20-45.
On April 10, 2023, the Company entered into an agreement to transfer 100% of the equity interests in the Fujian Happiness Biotech Co., Limited (“Fujian Happiness”) and its subsidiaries to the third-party Fujian Hengda Beverage Co., Ltd (“Fujian Hengda”), a PRC company which is not affiliate of the Company or any of its directors or officers. Pursuant to the Disposition SPA, the Purchaser agreed to purchase the Fujian Happiness in exchange for cash consideration of RMB 78 million (approximately $11.3 million, the “Purchase Price”). Upon the closing of the transaction (the “Disposition”) contemplated by the Disposition SPA, Fujian Hengda will become the sole shareholder of Fujian Happiness and as a result, assume all assets and liabilities of Fujian Happiness and subsidiaries owned or controlled by Fujian Happiness. The closing was approved by a majority of the Company’s shareholders on July 31, 2023.
On August 28, 2023, the Company’s indirect wholly owned subsidiary (the “Seller”), Happy Buy (Fujian) Network Technology Co., Ltd. (“Happy Buy”) and Shunchang Jinyifu trading Co., Ltd ("Shunchang Jinyi”), a PRC company which is not affiliate of the Company or any of its directors or officers (the “Purchaser”) entered into certain share purchase agreement (the “Disposition SPA”). Pursuant to the Disposition SPA, the Purchaser agreed to purchase the Happy Buy in exchange for cash consideration of RMB 5 million (approximately $0.7 million, the “Purchase Price”). Upon the closing of the transaction (the “Disposition”) contemplated by the Disposition SPA, the Buyer will become the sole shareholder of Happy Buy and as a result, assume all assets and liabilities of Happy Buy and subsidiaries owned or controlled by Happy Buy. The transaction was closed on September 1, 2023.
Revenue Recognition
The Company generates its revenue mainly from sales of healthcare products, automobiles, online store sales and internet information and advertising services.
The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is the transaction price the Company expects to be entitled to in exchange for the promised services in a contract in the ordinary course of the Company’s activities and is recorded net of value-added tax (“VAT”). To achieve that core principle, the Company applies the following steps:
Step 1: Identify the contract (s) with a customer
Step 2: Identify the performance obligations in the contract
Step 3: Determine the transaction price
Step 4: Allocate the transaction price to the performance obligations in the contract
Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation
Company generates revenues from sales of healthcare products, automobiles, online store sales and internet information and advertising services. No practical expedients were used when adoption ASC 606. Revenue recognition policies for each type of revenue stream are as follows:
Healthcare products
The Company sells nutraceutical and dietary supplements to third-party distributors and experience stores. Experience stores are owned by third parties, which are located in tourist sites where the sales consultants gave in-depth presentation of the origin, tradition and history of the Company’s products. Tourists are guided to enjoy a presentation of traditional Chinese herb culture offered by the distributors in the experience store and be presented with the Company’s healthcare products. The Company is a principal for the healthcare product sales as i) the Company produce or obtain control of the specified goods before transferring to the customers; ii) the Company has the right to determine the sales price; iii) the Company bears the risk of inventories and collection of consideration. For all sales, the Company requires a signed contract and sales order, which specifies pricing, quantity and product specifications. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to transfer the control of the promised products to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those products, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The transfer of control of the products is satisfied at a point in time, which is the delivery of the products to distributors’ or the experience stores’ premises and evidenced by signed acknowledgment. The selling price, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the delivery of the products to distributors or experience stores and the signing of their acknowledgment. Distributors and experience stores are required to pay under the customary payment terms, which is generally less than six months. According to the sales agreement, the healthcare product sold cannot be returned after the acknowledgement.
Automobiles
The Company sold automobiles in fiscal year 2023. For all sales, the Company requires a signed contract and sales order, which specifies pricing, quantity and product specifications. The Company is a principal for the automobiles sales as i) the Company produce or obtain control of the specified goods before transferring to the customers; ii) the Company has the right to determine the sales price; iii) the Company bears the risk of inventories and collection of consideration. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to transfer the control of the promised products to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those products, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The transfer of control of the products is satisfied at a point in time, which is the delivery of the products to customers’ premises and evidenced by signed customer acknowledgment. According to the contract, the automobile sold cannot be returned after the customer acknowledgement. The selling price, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the delivery of the products to customers and the signing of the customer acknowledgment, which is within 3 months after sales.
Online store
The Company sells various goods through its online store business in fiscal year 2023. For all sales, the Company requires a sales order generated by the online store platform, which specifies pricing, quantity and product specifications. The Company is a principal for the online store sales as i) the Company produce or obtain control of the specified goods before transferring to the customers; ii) the Company has the right to determine the sales price; iii) the Company bears the risk of inventories and collection of consideration. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to transfer the control of the promised products to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those products, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The transfer of control of the products is satisfied at a point in time, which is the delivery of the products to customers’ premises and evidenced by signed customer acknowledgment. The selling price, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the delivery of the products to customers and the signing of the customer acknowledgment unless the customers require sales return within 7 days after the acknowledgement. Customers are required to pay to the third-party platform before the goods were send out and the Company will receive the amount from the third-party platform after the customer sign off the acceptance form on the platform.
Internet information and advertising service
The Company provides internet information and advertising service online. For all sales, the Company requires a signed contract and sales order, which specifies the price and service range. The Company is a principal for the services as i) the Company has the right to determine the sales price; ii) the Company bears the collection risks; iii) the Company is responsible to the service provided. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to provide specified information and advertising service to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those services, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The information and advertising service provided is satisfied at a point in time, which is the time when the information and advertising service is performed. No sales return is permitted after the service performed according to the contract signed. The selling price per click, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the completion of the service. Customers are required to pay to the Company in advance according to the contract.
All of the Company’s revenues from contracts with customers represent products transferred at a point in time as control is transferred to the customer and are generated in PRC. All of the Company’s revenues are recognized on a gross basis and presented as revenue on the consolidated statements of operations and comprehensive income/(loss).
The following table presents an overview of our sales from our product lines for the six months ended September 30, 2023 and 2022:
Cost of Revenues
Healthcare products
Cost of revenue of healthcare product is mainly composed of the cost of product sales, employees, depreciation expenses and other manufacturing overhead expenses that are directly attributable to the business.
Automobile
Cost of revenue of automobiles is mainly composed of the cost of automobiles and other miscellaneous expenses that are directly attributable to the business.
Online store
Cost of revenue of online store is mainly composed of the cost of goods sales and other miscellaneous expenses that are directly attributable to the business.
Internet information and advertising service
Cost of revenue of internet information and advertising service is mainly composed of the cost of service provide and other miscellaneous expenses that are directly attributable to the business.
Government Grants
Government grants are recognized when received and all the conditions for their receipt have been met. Government grants as compensation for the Company’s research and development efforts.
Research and Development Costs
Research and development activities are directed toward the development of new products as well as improvements in existing processes. These costs, which primarily include salaries, contract services, raw materials, and supplies, are expensed as incurred.
Shipping and Handling Costs
Shipping and handling costs are expensed when incurred as selling and marketing expense. Shipping and handling costs were $4,183 and $18,543 for the six months ended September 30, 2023 and 2022, respectively.
Advertising Costs
Advertising costs expensed as economic benefits are consumed in accordance with ASC 720-35, “Other Expenses-Advertising Costs”. Advertising costs were $9,952,033 and $15,943,891 or the six months ended September 30, 2023 and 2022, respectively.
Stock-Based Compensation
The Company accounts for stock-based compensation to employees in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including the equity incentive plan, based on the grant date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period. Stock option forfeitures are recognized at the date of employee termination. Effective April 1, 2019, the Company adopted ASU 2018-07 for the accounting of share-based payments granted to non-employees for goods and services and no material impacts to the Financial Statements.
Options
The fair value of options issued pursuant to the Company’s option plans at the grant date was estimated using the Black-Scholes option pricing model. This model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of highly subjective assumptions, including the expected term of the options, the estimated forfeiture rates and the expected stock price volatility. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The Group uses projected volatility rates based upon the Group’s historical volatility rates. These assumptions are inherently uncertain. Different assumptions and judgments would affect the Company’s calculation of the fair value of the underlying ordinary shares for the options granted, and the valuation results and the amount of option would also vary accordingly.
Income Taxes
The Company accounts for current income taxes in accordance with the laws of the relevant tax authorities. Deferred income taxes are recognized when temporary differences exist between the tax bases of assets and liabilities and their reported amounts in the consolidated financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period including the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
The provisions of ASC 740-10, “Accounting for Uncertainty in Income Taxes”, prescribe a more-likely-than-not threshold for consolidated financial statement recognition and measurement of a tax position taken (or expected to be taken) in a tax return. This interpretation also provides guidance on the recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, and related disclosures. The Company does not believe that there was any uncertain tax position at September 30, 2023 and March 31, 2023.
To the extent applicable, the Company records interest and penalties as a general and administrative expense. All of the tax returns of the Company and its subsidiaries remain subject to examination by PRC tax authorities for five years from the date of filing.
The Company is subject to Chinese tax laws. We are not subject to U.S. tax laws and local state tax laws. Our income and our related entities must be computed in accordance with Chinese and foreign tax laws, as applicable, and we are subject to Chinese tax laws, all of which may be changed in a manner that could adversely affect the amount of distributions to shareholders. There can be no assurance that Income Tax Laws of China will not be changed in a manner that adversely affects shareholders. In particular, any such change could increase the amount of tax payable by us, reducing the amount available to pay dividends to the holders of our ordinary shares.
We are a holding company with no material operations of our own. We conduct our operations through our subsidiaries in China. As a result, our ability to pay dividends and to finance any debt we may incur depends upon dividends paid by our subsidiaries. Under applicable PRC regulations, foreign-invested enterprises in China may pay dividends only out of their accumulated profits, if any, determined in accordance with PRC accounting standards and regulations. In addition, a foreign-invested enterprise in China is required to set aside at least 10% of its after-tax profit based on PRC accounting standards each year to its general reserves until the accumulative amount of such reserves reaches 50% of its registered capital. These reserves are not distributable as cash dividends.
As of September 30, 2023, our PRC subsidiaries had an accumulated deficit of approximately RMB180.3 million (US$28.89 million) under PRC GAAP. With respect to retained earnings accrued after such date, our Board of Directors may declare dividends after taking into account our operations, earnings, financial condition, cash requirements and availability and other factors as it may deem relevant at such time. Any declaration and payment, as well as the amount, of dividends will be subject to our By-Laws, charter and applicable Chinese and U.S. state and federal laws and regulations, including the approval from the shareholders of each subsidiary which intends to declare such dividends, if applicable.
Value-added Tax
Value-added taxes (“VAT”) collected from customers relating to product sales and remitted to governmental authorities are presented on a net basis. VAT collected from customers is excluded from revenue. The Company is generally subject to the VAT for merchandise sales and services performed. Before May 1, 2018, the applicable VAT rate was 17%, while after May 1, 2018 and before April 1, 2019, the Company is subject to a VAT rate of 16%. After April 1, 2019, the Company is subject to a VAT rate of 13% based on the new Chinese tax law.
Earnings/ Loss per Share
Basic earnings/loss per share is computed by dividing net profit/loss attributable to holders of ordinary shares by the weighted average number of ordinary shares outstanding during the year using the two-class method. Using the two class method, net profit/loss is allocated between Class A ordinary shares, Class B ordinary shares and other participating securities (i.e. preferred shares) based on their participating rights.
The Company computes earnings per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies with complex capital structures to present basic and diluted EPS. Basic EPS is measured as Net profit divided by the weighted average common shares outstanding for the period. Diluted earnings/loss per share is calculated by dividing net profit/loss attributable to ordinary shareholders as adjusted for the effect of dilutive ordinary equivalent shares, if any, by the weighted average number of ordinary and dilutive ordinary equivalents shares outstanding during the year/period. Dilutive equivalent shares are excluded from the computation of diluted earnings/loss per share if their effects would be anti-dilutive. Ordinary share equivalents consist of the ordinary shares issuable in connection with the Group’s convertible redeemable preferred shares using the if-converted method, and ordinary shares issuable upon the conversion of the stock options, using the treasury stock method. Except for voting rights, the Class A and Class B ordinary shares have all the same rights and therefore the earning/loss per share for both classes of shares are identical. The earning/loss per share amounts are the same for Class A and Class B ordinary shares because the holders of each class are entitled to equal per share dividends or distributions in liquidation.
Foreign Currency Translation
The Company and its subsidiaries’ principal country of operations is the PRC. The Company maintained its financial record using the United States dollar (“US dollar”) as the functional currency, while the subsidiaries of the Company in Hong Kong and mainland China maintained their financial records using RMB as the functional currencies. The consolidated statements of income and comprehensive income and cash flows denominated in foreign currency are translated at the average rate of exchange during the reporting period. Assets and liabilities denominated in foreign currencies at the balance sheet date are translated at the applicable rates of exchange in effect at that date. The equity denominated in the functional currency is translated at the historical rate of exchange at the time of capital contribution. Because cash flows are translated based on the average rate of exchange, amounts related to assets and liabilities reported on the consolidated statements of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets. Translation adjustments arising from the use of different exchange rates from period to period are included as a separate component of accumulated other comprehensive income (loss) included in consolidated statements of changes in shareholders’ equity. Gains and losses from foreign currency transactions are included in the consolidated statement of income and comprehensive income.
The value of RMB against US$ and other currencies may fluctuate and is affected by, among other things, changes in the PRC’s political and economic conditions. Any significant revaluation of RMB may materially affect the Company’s financial condition in terms of US$ reporting. The following table outlines the currency exchange rates that were used in creating the consolidated financial statements in this report:
Comprehensive Income
Comprehensive income includes net income and foreign currency translation adjustments and is reported in the consolidated statements of income and comprehensive income.
Segment Reporting
The Company uses the “management approach” in determining reportable operating segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision maker (“CODM”) for making operating decisions and assessing performance as the source for determining the Company’s reportable segments. The Company’s CODM has been identified as the chief executive officer of the Company who reviews financial information of separate operating segments based on U.S. GAAP. For the six months ended September 30, 2023, the CODM reviews financial information analyzed by customer, which only presented at the gross profit level with no allocation of operating expenses. Thus, the Company determined that it operates in four operating segments: (1) Healthcare products; (2) Automobiles; (3) Online store; and (4) Internet information and advertising service. The Company’s reportable segments are strategic business units that offer different products and services. They are managed separately because each business requires different marketing strategies.
As the Company’s long-lived assets are substantially all located in the PRC and all of the Company’s revenue and expense are derived from within the PRC, no geographical segments are presented.
Concentration of Risks
Exchange Rate Risks
The Company operates in China, which may give rise to significant foreign currency risks from fluctuations and the degree of volatility of foreign exchange rates between the US$ and the RMB. As of September 30, 2023 and March 31, 2023, cash and cash equivalents of $537,425 (RMB 3,858,606) and $2,198,694 (RMB 12,542,139), respectively, is denominated in RMB and is held in PRC.
Currency Convertibility Risks
Substantially all of the Company’s operating activities are transacted in RMB, which is not freely convertible into foreign currencies. All foreign exchange transactions take place either through the People’s Bank of China or other banks authorized to buy and sell foreign currencies at the exchange rates quoted by the People’s Bank of China. Approval of foreign currency payments by the People’s Bank of China or other regulatory institutions requires submitting a payment application form together with other information such as suppliers’ invoices, shipping documents and signed contracts.
Concentration of Credit Risks
Financial instruments that potentially subject the Company to concentration of credit risks consist primarily of cash and cash equivalents and accounts receivable, the balances of which are stated on the consolidated balance sheets which represent the Company’s maximum exposure. The Company places its cash and cash equivalents in good credit quality financial institutions in China. Concentration of credit risks with respect to accounts receivables is linked to the concentration of revenue. To manage credit risk, the Company performs ongoing credit evaluations of customers’ financial condition.
Interest Rate Risks
The Company is subject to interest rate risk. Bank interest bearing loans are charged at variable interest rates within the reporting period. The Company is subject to the risk of adverse changes in the interest rates charged by the banks when these loans are refinanced.
Risks and Uncertainties
The operations of the Company are located in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by political, economic, and legal environments in the PRC, as well as by the general state of the PRC economy. The Company’s results may be adversely affected by changes in the political, regulatory and social conditions in the PRC. Although the Company has not experienced losses from these situations and believes that it is in compliance with existing laws and regulations including its organization and structure disclosed in Note 1, this may not be indicative of future results.
COVID-19 Pandemic
The outbreak of COVID-19 began in January 2020 and was quickly declared as a Public Health Emergency of International Concern and subsequently a pandemic by the World Health Organization. A series of prevention and control measures including quarantines, travel restrictions, and the temporary closure of facilities were implemented across the country.
The Company was impacted by the COVID-19 pandemic in many ways, including the plump of closures of experience stores, diving sales by distribution channels, and shut down or partly shut down of production facilities for several months.
Despite the fact that China has largely brought the pandemic under control, there is still a high degree of uncertainty as to how the pandemic will evolve going forward. A new outbreak in China could cause new disruptions of our production, distribution and sales, and have an adverse impact on our business, financial condition and results of operations for the remainder of the six months ended September 30, 2023, which cannot be reasonably estimated at the current stage. The Company will regularly assess its business conditions and adopt measures to mitigate any new impact of the ongoing pandemic.
Related Parties
The Company accounts for related party transactions in accordance with ASC 850 (“Related Party Disclosures”). A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party. There were no related party transactions as of September 30, 2023.
Recent Accounting Pronouncements
In August 2020, the FASB issued ASU No. 2020-06 (“ASU 2020-06”) “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.” ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. For public business entities, the amendments in ASU 2020-06 are effective for public entities which meet the definition of a smaller reporting company are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023. The Company will adopt ASU 2020-06 effective January 1, 2024. Management is currently evaluating the effect of the adoption of ASU 2020-06 on the consolidated financial statements. The effect will largely depend on the composition and terms of the financial instruments at the time of adoption.
In October 2021, the FASB issued ASU No. 2021-08, “‘Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers” (“ASU 2021-08”). This ASU requires entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. The amendments improve comparability after the business combination by providing consistent recognition and measurement guidance for revenue contracts with customers acquired in a business combination and revenue contracts with customers not acquired in a business combination. The amendments are effective for the Company beginning after December 15, 2023, and are applied prospectively to business combinations that occur after the effective date. The Company does not expect the adoption of ASU 2021-04 will have a material effect on the consolidated financial statements.
In June 2022, the FASB issued ASU 2022-03, “Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”, which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. This guidance also requires certain disclosures for equity securities subject to contractual sale restrictions. The new guidance is required to be applied prospectively with any adjustments from the adoption of the amendments recognized in earnings and disclosed on the date of adoption. This guidance is effective for the Company for the fiscal year ending March 31, 2025 and interim reporting periods during the fiscal year beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect that the adoption of this guidance will have a material impact on the financial position, results of operations and cash flows. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounts Receivable, Net |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounts Receivable, Net [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ACCOUNTS RECEIVABLE, NET | NOTE 3 – ACCOUNTS RECEIVABLE, NET
Accounts receivable consisted of the following as of September 30, 2023 and March 31, 2023:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventories [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| INVENTORIES | NOTE 4 – INVENTORIES
All the inventories are located in China. Inventories consisted of the following as of September 30, 2023 and March 31, 2023:
lower of cost or net realizable value adjustment was recorded as of September 30, 2023 and March 31, 2023, respectively.
inventory provision or write-downs for the six months ended September 30, 2023 and 2022. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prepaid Expenses and Other Current Assets |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Prepaid Expenses and Other Current Assets [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PREPAID EXPENSES AND OTHER CURRENT ASSETS | NOTE 5 – PREPAID EXPENSES AND OTHER CURRENT ASSETS
Prepaid expenses and other current assets consisted of the following as of September 30, 2023 and March 31, 2023:
F-21 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property, Plant and Equipment, Net |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Property, Plant and Equipment, Net [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PROPERTY, PLANT AND EQUIPMENT, NET | NOTE 6 – PROPERTY, PLANT AND EQUIPMENT, NET
Property, plant and equipment consisted of the following as of September 30, 2023 and March 31, 2023:
As of September 30, 2023, no building has been pledged. As of March 31, 2023, the Company pledged its building with a carrying value of approximately $1.2 million as the collateral for short-term bank loans (see Note 10).
Depreciation expense was $1,631,109 and $737,542 for the six months ended September 30, 2023 and 2022, respectively.
The carrying amount of disposed property, plant and equipment recognized for the six months ended September 30, 2023 and 2022 were amounted to and $90,636, respectively. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Intangible Assets, Net |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| INTANGIBLE ASSETS, NET | NOTE 7 – INTANGIBLE ASSETS, NET
As of September 30, 2023, no land use right has been pledged. As of March 31, 2023, the Company pledged its land use right on its land with a carrying value of $83,520 (12,120 square meters) as the collateral for a short-term bank loan (see Note 10).
For the six months ended September 30, 2023 and 2022, no new intangible assets was purchased. For the six months ended September 30, 2023 and 2022, the Company recorded no disposal of intangible assets.
As of September 30, 2023, the company concluded that there was no impairment of intangible assets.
Amortization expense was $710,486 and $771,357 for the six months ended September 30, 2023 and 2022, respectively.
Estimated future amortization expense is as follows as of September 30, 2023:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GOODWILL | NOTE 8 – GOODWILL
Goodwill consisted of the following as of September 30, 2023 and March 31, 2023:
The changes in the carrying amount of goodwill for the years ended September 30, 2023 and March 31, 2023 were as follow:
The goodwill generated from the expected synergies from the output capacity of the transaction and service scenario of the multi-industry, full-link and full-closed-loop of Shennong, and cooperation of developing the health commodities business stably, combining the production and supply, jointly build a perfect supply chain system with Hekangyuan, new development of consulting, marketing, design, and software development services to empower our clients to adapt and thrive in the Web 3.0 era.
As of September 30, 2023, the company concluded that there was no impairment of goodwill. F-23 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prepaid Assets |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Prepaid Assets [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PREPAID ASSETS | NOTE 9 – PREPAID ASSETS
Prepaid assets consisted of the following as of September 30, 2023 and March 31, 2023:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-Term Bank Borrowings |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SHORT-TERM BANK BORROWINGS | NOTE 10 – SHORT-TERM BANK BORROWINGS
Short-term bank borrowings consisted of the following as of September 30, 2023 and March 31, 2023:
On May 4, 2018, the Company entered into a bank loan agreement with Industrial Bank Co., Ltd to borrow $1,039,578 (RMB 7.0 million) as working capital for one year with due date on April 21, 2019 and it was renewed in 2019 for another year. The loan bears a fixed interest rate of 1-year Loan Prime Rate (“LPR”) +2.19% on the date of drawing per annum. The loan facility agreement is personally guaranteed by Mr. Xuezhu Wang, Mr. Xianfu Wang, and Mrs. Yanying Lin. Based on guarantee contract the maximum guaranteed amount was RMB 7.0 million. The Company also pledged its building and land use rights as collaterals. Based on the pledge agreement, the maximum pledged amount was RMB 17.4 million. There were no loan guarantee fees paid to the personal guarantors. In April 2020, Fujian Happiness renewed the loan agreement with Industrial Bank Co. Ltd for $1,065,238 (RMB 7.0 million) bearing interest rate at LPR plus 1.45% per annum, payable monthly. The loan was expired and paid off in April 2021. In addition, the Company entered into a loan agreement of $1,065,238 (RMB 7.0 million) bearing interest rate at LPR plus 0.75% on June 9, 2021 and repaid it on June 5, 2022. On June 1, 2022, the Company entered into a new one-year loan agreement of $985,943 (RMB 7.0 million) bearing interest rate at LPR plus 0.9% with Industrial Bank Co., Ltd.
On June 24, 2019, the Company entered into a loan facility framework agreement with Postal Saving Bank of China. The agreement allows the Company to access a total borrowing of approximately $3.4 million (RMB 24.4 million) for short-term loans. The loan facility agreement is valid until June 23, 2025 and subject to renewal. The loan facility agreement is personally guaranteed by Mr. Xuezhu Wang and Happiness Fuzhou. The Company also pledged its building and land use right as collaterals. Pursuant to the loan facility agreement with Postal Saving Bank of China, which is valid from June 24, 2019 to June 23, 2025. On January 12, 2022 and January 13, 2022, the Company entered into a loan agreement of $846,848 (RMB 6.0 million) and $197,597 (RMB 1.4 million) short-term loans bearing fixed interest rate of 4.25%, which was due on January 10, 2023 and February 12, 2023, respectively. In addition, on April 7, 2020 and January 15, 2021, the Company entered into a loan agreement of RMB 1.7 million and RMB 6.0 million with Postal Saving Bank of China as working capital for one year, respectively. The loans bear a fixed interest rate of LPR+20 BP. The Company repaid RMB 1.7 million on April 6, 2021 and April 8, 2021, and repaid RMB 6.0 million on January 12, 2022.
On May 16, 2022, the Company entered into a loan agreement with Guangfa Bank of China. The agreement allows the Company to access a total borrowing of approximately $119,722 (RMB 85 million) for short-term loans. The loan facility agreement is valid until November 15, 2022. The loan facility agreement is personally guaranteed by Mr. Wenhui Lin.
The carrying values of the Company’s pledged assets to secure short-term borrowings by the Company are as follows:
For the six months ended September 30, 2023 and 2022, interest expense on all short-term bank loans amounted to $29,278 and $35,054, respectively. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share Based Compensation |
6 Months Ended |
|---|---|
Sep. 30, 2023 | |
| Share Based Compensation [Abstract] | |
| SHARE BASED COMPENSATION | NOTE 11 – SHARE BASED COMPENSATION
2020 Equity incentive plan
In February 2022, the Company adopted the 2020 Equity incentive plan which allows the Company to offer incentive awards to employee, directors and consultants (collectively, “the Participants”). Under the 2020 Equity incentive plan, the Company may issue incentive awards to the Participants to purchase no more than 3,500,000 ordinary shares with no restrictive legend affixed.
No share-based compensation expense was recognized in general and administrative expenses for the six months ended September 30, 2023 and 2022.
The fair values of share units are determined based on the fair value of the grant date of the Company’s ordinary shares. |
Shareholders' Equity |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shareholders' Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SHAREHOLDERS' EQUITY | NOTE 12 – SHAREHOLDERS’ EQUITY
Ordinary shares
Paranovus Cayman was incorporated under the laws of the Cayman Islands on February 9, 2018. The Company issued 50,000 ordinary shares with par value of $1 to exchange for the ownership in Fujian Happiness from the former shareholders to Happiness Fuzhou.
A Reorganization of the legal structure was completed in August 2018. The Reorganization involved the incorporation of PARANOVUS ENTERTAINMENT TECHNOLOGY LIMITED, a Cayman Islands holding company; Happiness Biology Technology Group Limited, a holding company established in Hong Kong, PRC; Happiness (Fuzhou) E-commerce Co., Ltd, a holding company established in Fujian, PRC; and the transfer of 100% ownership of Fujian Happiness from the former shareholders to Happiness Fuzhou.
In May 2018, the Company received $627,628 (RMB 4.0 million) from two investors into Fujian Happiness.
On March 4, 2019, the Company subdivided its 50,000 ordinary shares into 90,000,000 Ordinary shares and 10,000,000 Preferred shares. The authorized ordinary shares became 100,000,000 shares and the par value changed from $1 to $0.0005. On the same day, the Company cancelled 77,223,100 ordinary shares and sold additional 223,100 ordinary shares. The Company has retrospectively reflected the stock subdivision and cancellation in all periods presented in these financial statements.
On October 25, 2019, the Company announced the closing of its initial public offering of 2,000,000 ordinary shares, US$0.0005 par value per share (“Ordinary Shares”) at an offering price of $5.50 per share for a total of $11,000,000 in gross proceeds. The Company raised total net proceeds of $9,342,339 after deducting underwriting discounts and commissions and offering expenses.
The Company entered several Securities Purchase Agreement from September 2020 through March 2021. Pursuant to which, the Company issued 5,100,000 ordinary shares to the purchasers with a total consideration amounted $10,965,703. The Company collected total net proceeds of $10,725,700 after deducting commissions and offering expenses.
On March 15, 2021, the Company issued 381,580 ordinary shares to its management and employees for their service. The Company recorded compensation cost $778,423 according to the fair value of the shares issued.
On June 21, 2021, the Company issued an aggregate of 231,445 Class A ordinary shares of the Company to certain employees and a director for their services. The total compensation cost was $351,796.
On June 25, 2021, the Company entered several Securities Purchase Agreement with non-US investors. Pursuant to which, the Company issued 1,240,000 Class A ordinary shares to the purchasers with a total consideration amounted $2,157,600. The Company collected total net proceeds of $2,157,600 after deducting commissions and offering expenses.
On October 14, 2021, the Company issued an aggregate of 113,458 Class A ordinary shares of the Company to certain employees and a director for their services. The total compensation cost was $99,843.
On October 20, 2021, the Company entered into a certain equity agreement with Shennong for the purchase of 70% of the equity interest of Shennong at a consideration of RMB 103.0 million (approximately $16.1 million). The total consideration paid for the Shennong’s 100% equity interests were RMB 48.0 million (approximately $7.5 million) in cash and 4,200,000 Class A ordinary shares of the Company. The Company issued an aggregate of 4,200,000 ordinary shares of the Company to certain transaction on November 12, 2021. The total compensation cost was $3,736,320.
On October 21, 2021, the Company held its annual meeting of shareholders for its fiscal year ending March 31, 2021. The Company approved as a special resolution an alteration to the share capital of the Company by: a: the conversion of each issued paid up Ordinary Share with a par value of $0.0005 each into stock (the “Stock”); b: the alteration of the authorized issued share capital of the Company from (i) US$50,000 divided into 90,000,000 Ordinary Shares with a par value of US$0.0005 each and 10,000,000 Preferred Shares with a par value of US$0.0005 each; to (ii) 70,000,000 Class A Ordinary Shares with a par value of $0.0005 each, 20,000,000 Class B Ordinary Shares with a par value of US$0.0005 each and 10,000,000 Preferred Shares with a par value of US$0.0005 each. Class A Ordinary Shares was entitled to one vote per share and to receive notice of, attend at and vote as a member at any general meeting of the Company; and be entitled to such dividends as the Board may from time to time declare; and generally be entitled to enjoy all of the rights attaching to shares. Class B Ordinary Shares was entitled to twenty (20) votes per share and to receive notice of, attend at and vote as a member at any general meeting of the Company; be entitled to such dividends as the Board may from time to time declare; and generally be entitled to enjoy all of the rights attaching to shares.
On January 12, 2022, the Company issued an aggregate of 1,133,200 Class A ordinary shares of the Company to certain employees for their services. The total compensation cost was $634,592.
On January 20, 2022, the Company entered several Securities Purchase Agreement with non-US persons. Pursuant to which, the Company issued 12,500,000 Class A ordinary shares to the purchasers with a total consideration amounted $10,000,000. The Company collected total net proceeds of $10,000,000 after deducting commissions and offering expenses.
On March 4, 2022, the Company entered into a certain equity transfer agreement with Hekangyuan for the purchase of 100% of the equity interest of Hekangyuan at a consideration of $12.0 million. The total consideration paid for Hekangyuan’s 100% equity interests were $8.0 million in cash and 10,000,000 Class A ordinary shares of the Company. The Company issued an aggregate of 10,000,000 ordinary shares of the Company to certain transaction on March 7, 2022. The total compensation cost was $3,560,000.
On March 10, 2022, the Company entered several Securities Purchase Agreement with non-US investors. Pursuant to which, the Company issued 19,200,000 Class A ordinary shares to the purchasers with a total consideration amounted $6,720,000. The Company collected total net proceeds of $6,720,000 after deducting commissions and offering expenses.
On April 21, 2022, 150,000 Class A Ordinary Shares owned by Xuezhu Wang were reconverted into Class B Ordinary Shares.
On October 10, 2022, a Share Consolidation of the Company’s ordinary shares at a ratio of one-for-twenty (the “Share Consolidation”) was effected as determined by the Board of Directors. At the time the Share Consolidation is effective, our authorized ordinary shares will be consolidated at the same ratio. The authorized share capital of the Company shall be decreased from an authorized share capital of US$50,000 divided into 70,000,000 Class A ordinary shares, par value US$0.0005 each, 20,000,000 Class B ordinary shares, par value US$0.0005 each, and 10,000,000 preferred shares with a par value of US$0.0005 each to an authorized share capital of US$50,000 divided into 3,500,000 Class A ordinary shares, par value US$0.01 each, 1,000,000 Class B ordinary shares, par value US$0.01 each, and 500,000 preferred shares, par value US$0.01 each.
On December 27, 2022, the Company entered into certain securities purchase agreement (the “SPA”) with certain sophisticated purchasers (the “Purchasers”), pursuant to which the Company agreed to sell 3,000,000 Class A ordinary shares, (the “Shares”) par value $0.01 per share (the “Ordinary Shares”), at a per share purchase price of $2.00. The gross proceeds to the Company from this transaction were approximately $6.0 million.
On March 14, 2023, the Company entered into a certain equity transfer agreement with 2Lab3 LLC for the purchase of 100% of the equity interest of 2Lab3 LLC at a consideration of approximately $6 million. The total consideration paid for 2lab3 LLC’s 100% equity interest was 1,375,000 Class A ordinary shares of the Company. The Company issued an aggregate of 1,375,000 Class A ordinary shares of the Company to certain transaction on March 28, 2023. The total compensation cost was $7,081,250.
Non-controlling Interest
Non-controlling interests represent the interest of non-controlling shareholders in Paranovus Entertainment Technology Ltd. based on their proportionate interests in the equity of that company adjusted for their proportionate share, which is 30% to 49% of the particular subsidiaries, of income or losses from operations. See Note 1 for details of the Company and its operating subsidiaries ownership.
Statutory reserve
The Company is required to make appropriations to certain reserve funds, comprising the statutory reserve and the discretionary reserve, based on after-tax net income determined in accordance with generally accepted accounting principles of the PRC (“PRC GAAP”). Appropriations to the statutory surplus reserve are required to be at least 10% of the after-tax net income determined in accordance with PRC GAAP until the reserve is equal to 50% of the entity’s registered capital. Appropriations to the discretionary surplus reserve are made at the discretion of the Board of Directors. In 2022, $5,558,669 was appropriated by Fujian Happiness to the statutory surplus reserve and the statutory reserve reached 50% of its registered capital. The statutory reserve has reached 50% of its registered capital amounted to $7,622,765 as of March 31, 2022. The reserved amounts as determined pursuant to PRC statutory laws amounted and $7,622,765 as of September 30, 2023 and March 31, 2023.
Under PRC laws and regulations, statutory reserves are restricted to set-off against losses, expansion of production and operation and increasing registered capital of the respective company, and are not distributable other than upon liquidation. The reserves are not allowed to be transferred to the Company in terms of cash dividends, loans or advances, nor allowed for distribution except under liquidation. Amounts restricted include paid-in capital, additional paid-in capital and statutory reserves of the Company in PRC amounted $18,285,864 and $20,714,673 as of September 30, 2023 and March 31, 2023, respectively.
As of September 30, 2023, our PRC subsidiaries had an accumulated deficit of approximately RMB180.3 million (US$28.89 million) under PRC GAAP. With respect to retained earnings accrued after such date, our Board of Directors may declare dividends after taking into account our operations, earnings, financial condition, cash requirements and availability and other factors as it may deem relevant at such time.
Warrants
In October 2019, the Company granted to the underwriters warrants to purchase up to a total of 184,000 ordinary shares (equal to 8% of the aggregate number of ordinary shares sold in the offering, if over-allotment shares are placed by the underwriters. Without over-allotment share issuance, a total of 160,000 warrants will be granted). The warrants will be exercisable at an exercise price equal to one hundred twenty percent (120%) of the offering price, in whole or in parts, at any time from issuance and expire five (5) years from the effective date of the offering.
The Company’s outstanding and exercisable warrants as of September 30, 2023 are presented below:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Taxes |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Taxes [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TAXES | NOTE 13 – TAXES
(a) Corporate Income Taxes (“CIT”)
The Company was incorporated in the Cayman Islands and is not subject to tax on income or capital gain under the laws of the Cayman Islands.
Happiness Hong Kong was incorporated in Hong Kong and is subject to a statutory income tax rate of 16.5%.
Under the Law of the People’s Republic of China on Enterprise Income Tax (“New EIT Law”), which was effective from January 1, 2008, both domestically-owned enterprises and foreign-invested enterprises are subject to a uniform tax rate of 25% while preferential tax rates, tax holidays and even tax exemption may be granted on case-by-case basis. EIT grants preferential tax treatment to High and New Technology Enterprises (“HNTEs”). Under this preferential tax treatment, HNTEs are entitled to an income tax rate of 15%, subject to a requirement that they re-apply for HNTE status every three years. Fujian Happiness, the Company’s main operating entity in PRC, was approved as HNTEs and is entitled to a reduced income tax rate of 15% from December 2019 to December 2023.
The Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions. As of September 30, 2023 and March 31, 2023, the Company did not have any significant unrecognized uncertain tax positions. The Company did not incur any interest and penalties related to potential underpaid income tax expenses for the six months ended September 30, 2023 and 2022, respectively, and also did not anticipate any significant increases or decreases in unrecognized tax benefits in the next 12 months from September 30, 2023.
The following table reconciles the statutory rate to the Company’s effective tax rate:
The provision for income tax consisted of the following:
The deferred income tax assets and liabilities as below:
Deferred income taxes reflect the net effects of temporary difference between the carrying amounts of assets and liabilities for financial statement purposes and the amounts used for income tax purposes. No deferred tax assets and deferred tax liabilities was recorded as of September 30, 2023. The Company recorded deferred tax assets of and deferred tax liabilities of $ 1,514,060 as of March 31, 2023.
(b) Taxes Payable
The Company’s taxes payable as of September 30, 2023 and March 31, 2023 consisted of the following:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combination |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Combinations [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BUSINESS COMBINATION | NOTE 14 – BUSINESS COMBINATION
Acquisition of 2Lab3
On March 28, 2023, the Company acquired 100% equity interest of 2Lab3 with 1,375,000 Class A Ordinary Shares of the Company for investing with non-cash transactions. The Class A Ordinary Shares were registered on March 28, 2023, valued at $5.15 per share. 2Lab3 is a company incorporated in Delaware of United States. It provides consulting, marketing, design, and software development services to empower its clients to adapt and thrive in the Web 3.0 era. The acquisition has further strengthened the transaction and service scenario of the Web 3.0 era of the Company. The results of 2Lab3 have been included in the consolidated financial statements of the Company since the acquisition date of March 28, 2023.
The Company engaged an independent valuation firm to assist management in valuing assets acquired, liabilities assumed, intangible assets identified and contingent consideration as of the acquisition day.
The identifiable intangible assets acquired upon acquisition were proprietary technology with definite useful life. All other current assets and current liabilities carrying value approximated fair value at the time of acquisition. The fair value of the consideration was based on closing market price of the Company’s common share on the acquisition date.
According to the independent valuation report, the purchase price was allocated to the assets acquired and liabilities assumed based on their fair values was as follows:
Acquisition of Shennong
On November 12, 2021, the Company acquired 70% equity interest of Shennong with total cash consideration of $7.5 million (RMB 48.0 million) and 4,200,000 Class A ordinary shares of the Company. The Class A Ordinary Shares were registered on November 12, 2021, valued at $0.8896 per share. Shennong is a company incorporated in Fujian, the PRC and focus on agriculture products, electronic products and hardware products. Acquisition of Shennong has strengthen the supply-chain as well as the industrial integration of online store. According to the share transfer agreement signed with the transferer, the Company owns the right to require the transferer purchasing back all the equity interests in cash of RMB72.1 million if the target company doesn’t meet the profit target. In the year ended March 31, 2021, the Company has paid $9.1 million (RMB 60.0 million) to the transferer as a deposit of this acquisition. And the overpaid RMB 12.0 million (approximately $1.9 million with $0.3 million exchange gain) has been collected back in the year ended March 31, 2022. The results of Shennong have been included in the consolidated financial statements of the Company since the acquisition date of November 12, 2021.
The Company engaged an independent valuation firm to assist management in valuing assets acquired, liabilities assumed, intangible assets identified, contingent consideration and non-controlling interests as of the acquisition day.
The identifiable intangible assets acquired upon acquisition were customer relationships with definite useful life. All other current assets and current liabilities carrying value approximated fair value at the time of acquisition. The fair value of the consideration was based on closing market price of the Company’s common share on the acquisition date.
According to the independent valuation report, the purchase price was allocated to the assets acquired and liabilities assumed based on their fair values. Fair value of the non-controlling interests was evaluated based on the equity value of Shennong derived by the discounted cash flow method after considering a discount for lack of control:
Non-controlling interest was recognized and measured at fair value on the acquisition date by the Company.
Acquisition of Hekangyuan
On March 4, 2022, the Company acquired 100% equity interest of Hekangyuan with total cash consideration of $8 million and 10,000,000 Class A Ordinary Shares of the Company. The Class A Ordinary Shares were registered on March 4, 202, valued at $0.365 per share. Hekangyuan is a company incorporated in Fujian, the PRC and focus on the sales of healthcare products and optical glasses. The acquisition has further strengthened the distribution network of the Company. According to the share transfer agreement signed with the transferer, the Company owns the right to require the transferer purchasing back all the equity interests in cash of $12.0 million if the target company doesn’t meet the profit target. The results of Hekangyuan have been included in the consolidated financial statements of the Company since the acquisition date of March 4, 2022.
The Company engaged an independent valuation firm to assist management in valuing assets acquired, liabilities assumed, intangible assets identified and contingent consideration as of the acquisition day.
The identifiable intangible assets acquired upon acquisition were customer relationships with definite useful life. All other current assets and current liabilities carrying value approximated fair value at the time of acquisition. The fair value of the consideration was based on closing market price of the Company’s common share on the acquisition date.
According to the independent valuation report, the purchase price was allocated to the assets acquired and liabilities assumed based on their fair values was as follows:
The business combination accounting is provisionally complete for all assets and liabilities acquired on the acquisition date and the Company will continue to evaluate the asset values within the 1-year timeframe according to ASC 805. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued Operations |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Discontinued Operations [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Operating Results from Discontinued Operations | NOTE 15 – DISCONTINUED OPERATIONS
Disposition of the healthcare and E-commerce segment
On July 31, 2023, the Company terminated all of healthcare business for approximately $11.3 million (RMB 78 million) consideration and disposed of its healthcare-related business.
On September 30, 2023, the Company terminated all of E-commerce business for approximately $0.7 million (RMB 5 million) consideration and disposed of its E-commerce-related business.
From October 1, 2023, the Company no longer retained any financial interest over healthcare and E-commerce business and accordingly deconsolidated both two business’ financial statements from the Company’s consolidated financial statements. The disposal of these two business represented a strategic shift and has a major effect on the Company’s result of operations.
The Company calculated a gain resulting from the above-mentioned dispositions as follows:
The assets and liabilities for discontinued operations comprised the following items as of March 31, 2023:
The operating results from discontinued operations included in the Company’s consolidated statements of comprehensive loss were as follows for the six months ended September 30, 2023 and 2022.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies |
6 Months Ended |
|---|---|
Sep. 30, 2023 | |
| Commitments and Contingencies [Abstract] | |
| COMMITMENTS AND CONTINGENCIES | NOTE 16 – COMMITMENTS AND CONTINGENCIES
As of September 30, 2023 and March 30, 2023, Company has no significant leases or unused letters of credit.
From time to time, the Company is involved in various legal proceedings, claims and other disputes arising from commercial operations, employees, and other matters which, in general, are subject to uncertainties and in which the outcomes are not predictable. The Company determines whether an estimated loss from a contingency should be accrued by assessing whether a loss is deemed probable and can be reasonably estimated. Although the Company can give no assurances about the resolution of pending claims, litigation or other disputes and the effect such outcomes may have on the Company, the Company believes that any ultimate liability resulting from the outcome of such proceedings, to the extent not otherwise provided or covered by insurance, will not have a material adverse effect on our consolidated financial position or results of operations or liquidity. As of September 30, 2023 and March 31, 2023, Company has no pending legal proceedings. |
Segment Reporting |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SEGMENT REPORTING | NOTE 17 – SEGMENT REPORTING
Before March 31, 2022, the Company’s CODM, chief executive officer, measures the performance of the Company based on metrics of revenue only and doesn’t focus on any profit of the business. Starting from April 1, 2022, the Company’s CODM, chief executive officer, measures the performance of each segment based on metrics of revenue and gross profit and uses these results to evaluate the performance of, and to allocate resources to each of the segments. As most of the Company’s long-lived assets are located in the PRC and most of the Company’s revenues are derived from the PRC, no geographical information is presented. The Company does not allocate assets and operating expenses to its segments as the CODM does not evaluate the performance of segments using asset and operating expenses information.
For the six months ended September 30, 2023, the Company has determined that it operates in four operating segments: (1) Healthcare products; (2) Automobile; (3) Online store; and (4) Internet information and advertising service. The Company’s reportable segments are strategic business units that offer different products and services. They are managed separately because each business requires different marketing strategies.
The following tables present the summary of each reportable segment’s revenue and gross profit, which is considered as a segment operating performance measure, for the six months ended September 30, 2023:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Customer and Supplier Concentration |
6 Months Ended |
|---|---|
Sep. 30, 2023 | |
| Customer and Supplier Concentration [Abstract] | |
| CUSTOMER AND SUPPLIER CONCENTRATION | NOTE 18 – CUSTOMER AND SUPPLIER CONCENTRATION
Significant customers and suppliers are those that account for greater than 10% of the Company’s revenues and purchases.
The Company’s sales are made to customers that are located primarily in China. For the six month ended September 30, 2023, Hebei Xiangtuan Car Service Co., Lt and Fuzhou Manyiyou Industrial Co. Ltd contributed approximately 23% and 11% of total revenue of the Company, respectively. No individual customer accounted for more than 10% of the Company’s total revenues for the six months ended September 30, 2022.
For the six months ended September 30, 2023 and 2022, no individual suppliers accounted for more than 10% of the Company’s total purchases. |
Subsequent Events |
6 Months Ended |
|---|---|
Sep. 30, 2023 | |
| Subsequent Events [Abstract] | |
| SUBSEQUENT EVENTS | NOTE 19 – SUBSEQUENT EVENTS
On October 7, 2023, Happiness (Fuzhou) E-commerce Co., Ltd was dissolved.
On November 9, 2023, the Company signed a promissory note purchase agreement (the “Purchase Agreement”) with a non-U.S. investor (the “Investor”), pursuant to which, the Company issued an 8% promissory note with principal amount of $750,000 (the “Note”) to such Investor on November 14, 2023, the closing date of this transaction. The Note will mature in 12-month after its issuance and can be pre-paid in part or in whole by the Company prior to its maturity date. The proceeds from the Note will be used to fund the Hollywood Sunshine and the general corporate activities of the Company.
On November 12, 2023, Paranovus Entertainment Technology Limited, (the “Company”) entered into a software development agreement (the “Development Agreement”) with Blueline Studios Inc. (“Blueline”), a company incorporated in Vancouver, Canada. Pursuant to the Development Agreement, Blueline shall be responsible for developing and delivering certain interactive game application (“Hollywood Sunshine”), including the underlying software, documentation, and technical data, under the terms and conditions of the Development Agreement, and agreed to assign to the Company all the right, title, and interest in Hollywood Sunshine, excluding any Background Technology (as defined in the Development Agreement). Blueline will deliver the initial full-featured version for the PC platform (the “PC Release”) six months after the Start Date as defined in the Development Agreement, followed by the delivery of iOS version (the “iOS Release”) three months after the PC Release. In exchange, the Company agreed to pay a total of $1,500,000 development fee to Blueline for the PC Release, and $400,000 development fee for the iOS Release, in accordance with the schedule set forth in the Development Agreement. The decision to develop the iOS Release is at the discretion of the Company. Furthermore, once Hollywood Sunshine starts generating revenues, the Company agreed to pay Blueline 9% of the net revenue after deducting all the licensing fees owned to all talent partners.
F-35 |
Accounting Policies, by Policy (Policies) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Basis of Presentation and Principles of Consolidation | Basis of Presentation and Principles of Consolidation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and have been consistently applied. The accompanying consolidated financial statements include the financial statements of Happiness Development and its subsidiaries (collectively, the “Company”). All inter-company balances and transactions have been eliminated upon consolidation. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-controlling interests | Non-controlling interests For the Company’s non-wholly owned subsidiaries, a non-controlling interest is recognized to reflect the portion of equity that is not attributable, directly or indirectly, to the Company. Non-controlling interests are classified as a separate line item in the equity section of the Company’s consolidated balance sheets and have been separately disclosed in the Company’s consolidated statements of comprehensive (loss)/income to distinguish the interests from that of the Company. Cash flows related to transactions with non-controlling interests are presented under financing activities in the consolidated statements of cash flows. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Use of Estimates | Use of Estimates In preparing the consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information as of the date of the consolidated financial statements. Significant estimates required to be made by management include, but are not limited to, the valuation of accounts receivable and related allowance for doubtful accounts, useful lives of property and equipment and intangible assets, the recoverability of long-lived assets, inventory reserve, allowance for credit losses, goodwill impairment, income taxes related to realization of deferred tax assets and uncertain tax position, provisions necessary for contingent liabilities and purchase price allocation in connection with the business combination. The current economic environment has increased the degrees of uncertainty inherent in those estimates and assumptions, actual results could differ from those estimates.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business combination | Business combination Business combinations are recorded using the acquisition method of accounting. The assets acquired, the liabilities assumed, and any non-controlling interests of the acquiree at the acquisition date, if any, are measured at their fair values as of the acquisition date. Goodwill is recognized and measured as the excess of the total consideration transferred plus the fair value of any non-controlling interest of the acquiree and fair value of previously held equity interest in the acquiree, if any, at the acquisition date over the fair values of the identifiable net assets acquired. Common forms of the consideration made in acquisitions include cash and common equity instruments. Consideration transferred in a business acquisition is measured at the fair value as of the date of acquisition. Acquisition-related expenses and restructuring costs are expensed as incurred. Accounting Standards Codification (“ASC”) 805 establishes a measurement period to provide the Company with a reasonable amount of time to obtain the information necessary to identify and measure various items in a business combination and cannot extend beyond one year from the acquisition date. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all highly liquid investment instruments with an original maturity of three months or less from the date of purchase to be cash equivalents. The Company maintains all bank accounts in the PRC. Cash balances in bank accounts in PRC are not insured by the Federal Deposit Insurance Corporation or other programs. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounts receivable, net | Accounts receivable, net Accounts receivable, net are recognized and carried at original invoiced amount less an estimated allowance for uncollectible accounts. The Company determines the adequacy of reserves for doubtful accounts based on individual account analysis and historical collection trends. The Company establishes a provision for doubtful receivables when there is objective evidence that the Company may not be able to collect amounts due. The allowance is based on management’s best estimates of specific losses on individual exposures, as well as a provision on historical trends of collections. Based on management of customers’ credit and ongoing relationship, management makes conclusions whether any balances outstanding at the end of the period will be deemed uncollectible on an individual basis and on aging analysis basis. The provision is recorded against accounts receivables balances, with a corresponding charge recorded in the consolidated statements of income and comprehensive income. Delinquent account balances are written-off against the allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventories | Inventories Inventories are stated at the lower of cost or net realizable value. Cost of inventories is determined using the weighted-average method. In addition to cost of raw materials, work in progress and finished goods include direct labor costs and overheads. The Company periodically assesses the recoverability of all inventories to determine whether adjustments are required to record inventories at the lower of cost or market value. Inventories that the Company determines to be obsolete or in excess of forecasted usage are reduced to its estimated realizable value based on assumptions about future demand and market conditions. If actual demand is lower than the forecasted demand, additional inventory write-downs may be required. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Prepaid expenses and other current assets | Prepaid expenses and other current assets Prepaid expenses and other current assets mainly represents cash prepaid to the suppliers, the technical providers and the investment receivables from the investors. Prepaid expenses and other current assets primarily consist of advances to vendors for purchasing goods, advances to the technical provides that have not been received or provided. Prepaid expenses and other current assets are classified as current or non-current based on the terms of the respective agreements. These advances are unsecured and are reviewed periodically to determine whether their carrying value has become impaired. The Company considers the assets to be impaired if the collectability of the advance becomes doubtful. The Company uses the aging method to estimate the allowance for uncollectible balances. The allowance is also based on management’s best estimate of specific losses on individual exposures, as well as a provision on historical trends of collections and utilizations. Actual amounts received or utilized may differ from management’s estimate of credit worthiness and the economic environment.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill | Goodwill Goodwill represents the excess of the purchase price over the fair value of the identifiable assets and liabilities acquired in a business combination. Goodwill is not depreciated or amortized but is tested for impairment on an annual basis as of March 31, and in between annual tests when an event occurs or circumstances change that could indicate that the asset might be impaired. In accordance with the FASB ASC 350 guidance on “Testing of Goodwill for Impairment”, a company first has the option to assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the company decides, as a result of its qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test is mandatory. Otherwise, no further testing is required. The quantitative impairment test consists of a comparison of the fair value of each reporting unit with its carrying amount, including goodwill. If the carrying amount of each reporting unit exceeds its fair value, an impairment loss equal to the difference between the fair value of the reporting unit and the carrying amount will be recorded. Application of a goodwill impairment test requires significant management judgment, including the identification of reporting units, assigning assets and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value of each reporting unit. The judgment in estimating the fair value of reporting units includes estimating future cash flows, determining appropriate discount rates and making other assumptions. Changes in these estimates and assumptions could materially affect the determination of fair value for each reporting unit. As of September 30, 2023, goodwill resulting from business acquisitions has only one reporting unit, including 2Lab3. The Company evaluates if goodwill impairment may be indicated on quarterly basis and performs the annual goodwill impairment assessment as of March 31. The Company performed qualitative assessments for the goodwill. Based on the requirements of ASC 350-20, the Company evaluated all relevant factors including, but not limited to, macroeconomic conditions, industry and market conditions, financial performance, and the share price of the Company. The Company weighed all factors in their entirety and concluded that it was not more-likely-than-not the fair value was less than the carrying amount of goodwill, and further impairment testing on goodwill was unnecessary as of September 30, 2023. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Property, Plant and Equipment | Property, Plant and Equipment Property, plant and equipment are stated at cost. The straight-line depreciation method is used to compute depreciation over the estimated useful lives of the assets, as follows:
Expenditures for maintenance and repairs, which do not materially extend the useful lives of the assets, are charged to expense as incurred. Expenditures for major renewals and betterment which substantially extend the useful life of assets are capitalized. The cost and related accumulated depreciation of assets retired or sold are removed from the respective accounts, and any gain or loss is recognized in the consolidated statements of income and other comprehensive income in other income or expenses.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Intangible Assets | Intangible Assets Intangible assets with definite lives are initially recorded at cost. Amortization of definite-lived intangible assets is computed using the straight-line method over the estimated average useful lives. Intangible assets with indefinite lives should not be amortized but should be tested for impairment at least annually or when event occurs or circumstances that could indicate that the asset might be impaired. The estimated useful lives of intangible assets are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Impairment of Long-lived Assets other than goodwill | Impairment of Long-lived Assets other than goodwill The Company reviews long-lived assets, including definite-lived intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the estimated cash flows from the use of the asset and its eventual disposition are below the asset’s carrying value, then the asset is deemed to be impaired and written down to its fair value. There were no impairments of these assets as of September 30, 2023 and March 31, 2023. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Short-term bank borrowings | Short-term bank borrowings Short-term bank borrowings represent the amounts due to various banks that are due within one year. Short-term bank borrowings are presented as current liabilities unless the Company has an unconditional right to defer settlement for at least 12 months after the financial year end date, in which case they are presented as non-current liabilities. Short-term bank borrowings are initially recognized at fair value (net of transaction costs) and subsequently carried at amortized cost. Any difference between the proceeds (net of transaction costs) and the redemption value is recognized in profit or loss over the period of the borrowings using effective interest method. Short-term bank borrowings costs are recognized in profit or loss using the effective interest method. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value of Financial Instruments | Fair Value of Financial Instruments The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 820, Fair Value Measurement and Disclosures, requires certain disclosures regarding the fair value of financial instruments. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:
The Company considers the recorded value of its financial assets and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other receivable, accounts payable, short-term borrowings, accounts payable, income tax assets and liabilities and income taxes payable and to approximate the fair value of the respective assets and liabilities at September 30, 2023 and March 31, 2023 based upon the short-term nature of the assets and liabilities. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Discontinued operations | Discontinued operations In accordance with ASC 205-20, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity, a disposal of a component of an entity or a group of components of an entity is required to be reported as a discontinued operation if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when the components of an entity meets the criteria in paragraph 205-20-45-1E to be classified as held for sale. When all of the criteria to be classified as held for sale are met, including management, having the authority to approve the action, commits to a plan to sell the entity, the major current assets, other assets, current liabilities, and non-current liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations in accordance with ASC 205-20-45. On April 10, 2023, the Company entered into an agreement to transfer 100% of the equity interests in the Fujian Happiness Biotech Co., Limited (“Fujian Happiness”) and its subsidiaries to the third-party Fujian Hengda Beverage Co., Ltd (“Fujian Hengda”), a PRC company which is not affiliate of the Company or any of its directors or officers. Pursuant to the Disposition SPA, the Purchaser agreed to purchase the Fujian Happiness in exchange for cash consideration of RMB 78 million (approximately $11.3 million, the “Purchase Price”). Upon the closing of the transaction (the “Disposition”) contemplated by the Disposition SPA, Fujian Hengda will become the sole shareholder of Fujian Happiness and as a result, assume all assets and liabilities of Fujian Happiness and subsidiaries owned or controlled by Fujian Happiness. The closing was approved by a majority of the Company’s shareholders on July 31, 2023. On August 28, 2023, the Company’s indirect wholly owned subsidiary (the “Seller”), Happy Buy (Fujian) Network Technology Co., Ltd. (“Happy Buy”) and Shunchang Jinyifu trading Co., Ltd ("Shunchang Jinyi”), a PRC company which is not affiliate of the Company or any of its directors or officers (the “Purchaser”) entered into certain share purchase agreement (the “Disposition SPA”). Pursuant to the Disposition SPA, the Purchaser agreed to purchase the Happy Buy in exchange for cash consideration of RMB 5 million (approximately $0.7 million, the “Purchase Price”). Upon the closing of the transaction (the “Disposition”) contemplated by the Disposition SPA, the Buyer will become the sole shareholder of Happy Buy and as a result, assume all assets and liabilities of Happy Buy and subsidiaries owned or controlled by Happy Buy. The transaction was closed on September 1, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Revenue Recognition | Revenue Recognition The Company generates its revenue mainly from sales of healthcare products, automobiles, online store sales and internet information and advertising services. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is the transaction price the Company expects to be entitled to in exchange for the promised services in a contract in the ordinary course of the Company’s activities and is recorded net of value-added tax (“VAT”). To achieve that core principle, the Company applies the following steps: Step 1: Identify the contract (s) with a customer Step 2: Identify the performance obligations in the contract Step 3: Determine the transaction price Step 4: Allocate the transaction price to the performance obligations in the contract Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation Company generates revenues from sales of healthcare products, automobiles, online store sales and internet information and advertising services. No practical expedients were used when adoption ASC 606. Revenue recognition policies for each type of revenue stream are as follows: Healthcare products The Company sells nutraceutical and dietary supplements to third-party distributors and experience stores. Experience stores are owned by third parties, which are located in tourist sites where the sales consultants gave in-depth presentation of the origin, tradition and history of the Company’s products. Tourists are guided to enjoy a presentation of traditional Chinese herb culture offered by the distributors in the experience store and be presented with the Company’s healthcare products. The Company is a principal for the healthcare product sales as i) the Company produce or obtain control of the specified goods before transferring to the customers; ii) the Company has the right to determine the sales price; iii) the Company bears the risk of inventories and collection of consideration. For all sales, the Company requires a signed contract and sales order, which specifies pricing, quantity and product specifications. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to transfer the control of the promised products to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those products, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The transfer of control of the products is satisfied at a point in time, which is the delivery of the products to distributors’ or the experience stores’ premises and evidenced by signed acknowledgment. The selling price, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the delivery of the products to distributors or experience stores and the signing of their acknowledgment. Distributors and experience stores are required to pay under the customary payment terms, which is generally less than six months. According to the sales agreement, the healthcare product sold cannot be returned after the acknowledgement.
Automobiles The Company sold automobiles in fiscal year 2023. For all sales, the Company requires a signed contract and sales order, which specifies pricing, quantity and product specifications. The Company is a principal for the automobiles sales as i) the Company produce or obtain control of the specified goods before transferring to the customers; ii) the Company has the right to determine the sales price; iii) the Company bears the risk of inventories and collection of consideration. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to transfer the control of the promised products to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those products, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The transfer of control of the products is satisfied at a point in time, which is the delivery of the products to customers’ premises and evidenced by signed customer acknowledgment. According to the contract, the automobile sold cannot be returned after the customer acknowledgement. The selling price, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the delivery of the products to customers and the signing of the customer acknowledgment, which is within 3 months after sales. Online store The Company sells various goods through its online store business in fiscal year 2023. For all sales, the Company requires a sales order generated by the online store platform, which specifies pricing, quantity and product specifications. The Company is a principal for the online store sales as i) the Company produce or obtain control of the specified goods before transferring to the customers; ii) the Company has the right to determine the sales price; iii) the Company bears the risk of inventories and collection of consideration. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to transfer the control of the promised products to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those products, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The transfer of control of the products is satisfied at a point in time, which is the delivery of the products to customers’ premises and evidenced by signed customer acknowledgment. The selling price, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the delivery of the products to customers and the signing of the customer acknowledgment unless the customers require sales return within 7 days after the acknowledgement. Customers are required to pay to the third-party platform before the goods were send out and the Company will receive the amount from the third-party platform after the customer sign off the acceptance form on the platform. Internet information and advertising service The Company provides internet information and advertising service online. For all sales, the Company requires a signed contract and sales order, which specifies the price and service range. The Company is a principal for the services as i) the Company has the right to determine the sales price; ii) the Company bears the collection risks; iii) the Company is responsible to the service provided. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to provide specified information and advertising service to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those services, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The information and advertising service provided is satisfied at a point in time, which is the time when the information and advertising service is performed. No sales return is permitted after the service performed according to the contract signed. The selling price per click, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the completion of the service. Customers are required to pay to the Company in advance according to the contract. All of the Company’s revenues from contracts with customers represent products transferred at a point in time as control is transferred to the customer and are generated in PRC. All of the Company’s revenues are recognized on a gross basis and presented as revenue on the consolidated statements of operations and comprehensive income/(loss).
The following table presents an overview of our sales from our product lines for the six months ended September 30, 2023 and 2022:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenues | Healthcare products The Company sells nutraceutical and dietary supplements to third-party distributors and experience stores. Experience stores are owned by third parties, which are located in tourist sites where the sales consultants gave in-depth presentation of the origin, tradition and history of the Company’s products. Tourists are guided to enjoy a presentation of traditional Chinese herb culture offered by the distributors in the experience store and be presented with the Company’s healthcare products. The Company is a principal for the healthcare product sales as i) the Company produce or obtain control of the specified goods before transferring to the customers; ii) the Company has the right to determine the sales price; iii) the Company bears the risk of inventories and collection of consideration. For all sales, the Company requires a signed contract and sales order, which specifies pricing, quantity and product specifications. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to transfer the control of the promised products to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those products, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The transfer of control of the products is satisfied at a point in time, which is the delivery of the products to distributors’ or the experience stores’ premises and evidenced by signed acknowledgment. The selling price, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the delivery of the products to distributors or experience stores and the signing of their acknowledgment. Distributors and experience stores are required to pay under the customary payment terms, which is generally less than six months. According to the sales agreement, the healthcare product sold cannot be returned after the acknowledgement.
Automobiles The Company sold automobiles in fiscal year 2023. For all sales, the Company requires a signed contract and sales order, which specifies pricing, quantity and product specifications. The Company is a principal for the automobiles sales as i) the Company produce or obtain control of the specified goods before transferring to the customers; ii) the Company has the right to determine the sales price; iii) the Company bears the risk of inventories and collection of consideration. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to transfer the control of the promised products to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those products, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The transfer of control of the products is satisfied at a point in time, which is the delivery of the products to customers’ premises and evidenced by signed customer acknowledgment. According to the contract, the automobile sold cannot be returned after the customer acknowledgement. The selling price, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the delivery of the products to customers and the signing of the customer acknowledgment, which is within 3 months after sales. Online store The Company sells various goods through its online store business in fiscal year 2023. For all sales, the Company requires a sales order generated by the online store platform, which specifies pricing, quantity and product specifications. The Company is a principal for the online store sales as i) the Company produce or obtain control of the specified goods before transferring to the customers; ii) the Company has the right to determine the sales price; iii) the Company bears the risk of inventories and collection of consideration. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to transfer the control of the promised products to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those products, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The transfer of control of the products is satisfied at a point in time, which is the delivery of the products to customers’ premises and evidenced by signed customer acknowledgment. The selling price, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the delivery of the products to customers and the signing of the customer acknowledgment unless the customers require sales return within 7 days after the acknowledgement. Customers are required to pay to the third-party platform before the goods were send out and the Company will receive the amount from the third-party platform after the customer sign off the acceptance form on the platform. Internet information and advertising service The Company provides internet information and advertising service online. For all sales, the Company requires a signed contract and sales order, which specifies the price and service range. The Company is a principal for the services as i) the Company has the right to determine the sales price; ii) the Company bears the collection risks; iii) the Company is responsible to the service provided. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to provide specified information and advertising service to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those services, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The information and advertising service provided is satisfied at a point in time, which is the time when the information and advertising service is performed. No sales return is permitted after the service performed according to the contract signed. The selling price per click, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the completion of the service. Customers are required to pay to the Company in advance according to the contract. All of the Company’s revenues from contracts with customers represent products transferred at a point in time as control is transferred to the customer and are generated in PRC. All of the Company’s revenues are recognized on a gross basis and presented as revenue on the consolidated statements of operations and comprehensive income/(loss).
The following table presents an overview of our sales from our product lines for the six months ended September 30, 2023 and 2022:
Cost of Revenues Healthcare products Cost of revenue of healthcare product is mainly composed of the cost of product sales, employees, depreciation expenses and other manufacturing overhead expenses that are directly attributable to the business. Automobile Cost of revenue of automobiles is mainly composed of the cost of automobiles and other miscellaneous expenses that are directly attributable to the business. Online store Cost of revenue of online store is mainly composed of the cost of goods sales and other miscellaneous expenses that are directly attributable to the business. Internet information and advertising service Cost of revenue of internet information and advertising service is mainly composed of the cost of service provide and other miscellaneous expenses that are directly attributable to the business. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Government Grants | Government Grants Government grants are recognized when received and all the conditions for their receipt have been met. Government grants as compensation for the Company’s research and development efforts. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Research and Development Costs | Research and Development Costs Research and development activities are directed toward the development of new products as well as improvements in existing processes. These costs, which primarily include salaries, contract services, raw materials, and supplies, are expensed as incurred. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shipping and Handling Costs | Shipping and Handling Costs Shipping and handling costs are expensed when incurred as selling and marketing expense. Shipping and handling costs were $4,183 and $18,543 for the six months ended September 30, 2023 and 2022, respectively. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Advertising Costs | Advertising Costs Advertising costs expensed as economic benefits are consumed in accordance with ASC 720-35, “Other Expenses-Advertising Costs”. Advertising costs were $9,952,033 and $15,943,891 or the six months ended September 30, 2023 and 2022, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock-Based Compensation | Stock-Based Compensation The Company accounts for stock-based compensation to employees in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including the equity incentive plan, based on the grant date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period. Stock option forfeitures are recognized at the date of employee termination. Effective April 1, 2019, the Company adopted ASU 2018-07 for the accounting of share-based payments granted to non-employees for goods and services and no material impacts to the Financial Statements. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Options | Options The fair value of options issued pursuant to the Company’s option plans at the grant date was estimated using the Black-Scholes option pricing model. This model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of highly subjective assumptions, including the expected term of the options, the estimated forfeiture rates and the expected stock price volatility. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The Group uses projected volatility rates based upon the Group’s historical volatility rates. These assumptions are inherently uncertain. Different assumptions and judgments would affect the Company’s calculation of the fair value of the underlying ordinary shares for the options granted, and the valuation results and the amount of option would also vary accordingly. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Taxes | Income Taxes The Company accounts for current income taxes in accordance with the laws of the relevant tax authorities. Deferred income taxes are recognized when temporary differences exist between the tax bases of assets and liabilities and their reported amounts in the consolidated financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period including the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provisions of ASC 740-10, “Accounting for Uncertainty in Income Taxes”, prescribe a more-likely-than-not threshold for consolidated financial statement recognition and measurement of a tax position taken (or expected to be taken) in a tax return. This interpretation also provides guidance on the recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, and related disclosures. The Company does not believe that there was any uncertain tax position at September 30, 2023 and March 31, 2023. To the extent applicable, the Company records interest and penalties as a general and administrative expense. All of the tax returns of the Company and its subsidiaries remain subject to examination by PRC tax authorities for five years from the date of filing. The Company is subject to Chinese tax laws. We are not subject to U.S. tax laws and local state tax laws. Our income and our related entities must be computed in accordance with Chinese and foreign tax laws, as applicable, and we are subject to Chinese tax laws, all of which may be changed in a manner that could adversely affect the amount of distributions to shareholders. There can be no assurance that Income Tax Laws of China will not be changed in a manner that adversely affects shareholders. In particular, any such change could increase the amount of tax payable by us, reducing the amount available to pay dividends to the holders of our ordinary shares.
We are a holding company with no material operations of our own. We conduct our operations through our subsidiaries in China. As a result, our ability to pay dividends and to finance any debt we may incur depends upon dividends paid by our subsidiaries. Under applicable PRC regulations, foreign-invested enterprises in China may pay dividends only out of their accumulated profits, if any, determined in accordance with PRC accounting standards and regulations. In addition, a foreign-invested enterprise in China is required to set aside at least 10% of its after-tax profit based on PRC accounting standards each year to its general reserves until the accumulative amount of such reserves reaches 50% of its registered capital. These reserves are not distributable as cash dividends. As of September 30, 2023, our PRC subsidiaries had an accumulated deficit of approximately RMB180.3 million (US$28.89 million) under PRC GAAP. With respect to retained earnings accrued after such date, our Board of Directors may declare dividends after taking into account our operations, earnings, financial condition, cash requirements and availability and other factors as it may deem relevant at such time. Any declaration and payment, as well as the amount, of dividends will be subject to our By-Laws, charter and applicable Chinese and U.S. state and federal laws and regulations, including the approval from the shareholders of each subsidiary which intends to declare such dividends, if applicable. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Value-added Tax | Value-added Tax Value-added taxes (“VAT”) collected from customers relating to product sales and remitted to governmental authorities are presented on a net basis. VAT collected from customers is excluded from revenue. The Company is generally subject to the VAT for merchandise sales and services performed. Before May 1, 2018, the applicable VAT rate was 17%, while after May 1, 2018 and before April 1, 2019, the Company is subject to a VAT rate of 16%. After April 1, 2019, the Company is subject to a VAT rate of 13% based on the new Chinese tax law. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings/ Loss per Share | Earnings/ Loss per Share Basic earnings/loss per share is computed by dividing net profit/loss attributable to holders of ordinary shares by the weighted average number of ordinary shares outstanding during the year using the two-class method. Using the two class method, net profit/loss is allocated between Class A ordinary shares, Class B ordinary shares and other participating securities (i.e. preferred shares) based on their participating rights. The Company computes earnings per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies with complex capital structures to present basic and diluted EPS. Basic EPS is measured as Net profit divided by the weighted average common shares outstanding for the period. Diluted earnings/loss per share is calculated by dividing net profit/loss attributable to ordinary shareholders as adjusted for the effect of dilutive ordinary equivalent shares, if any, by the weighted average number of ordinary and dilutive ordinary equivalents shares outstanding during the year/period. Dilutive equivalent shares are excluded from the computation of diluted earnings/loss per share if their effects would be anti-dilutive. Ordinary share equivalents consist of the ordinary shares issuable in connection with the Group’s convertible redeemable preferred shares using the if-converted method, and ordinary shares issuable upon the conversion of the stock options, using the treasury stock method. Except for voting rights, the Class A and Class B ordinary shares have all the same rights and therefore the earning/loss per share for both classes of shares are identical. The earning/loss per share amounts are the same for Class A and Class B ordinary shares because the holders of each class are entitled to equal per share dividends or distributions in liquidation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign Currency Translation | Foreign Currency Translation The Company and its subsidiaries’ principal country of operations is the PRC. The Company maintained its financial record using the United States dollar (“US dollar”) as the functional currency, while the subsidiaries of the Company in Hong Kong and mainland China maintained their financial records using RMB as the functional currencies. The consolidated statements of income and comprehensive income and cash flows denominated in foreign currency are translated at the average rate of exchange during the reporting period. Assets and liabilities denominated in foreign currencies at the balance sheet date are translated at the applicable rates of exchange in effect at that date. The equity denominated in the functional currency is translated at the historical rate of exchange at the time of capital contribution. Because cash flows are translated based on the average rate of exchange, amounts related to assets and liabilities reported on the consolidated statements of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets. Translation adjustments arising from the use of different exchange rates from period to period are included as a separate component of accumulated other comprehensive income (loss) included in consolidated statements of changes in shareholders’ equity. Gains and losses from foreign currency transactions are included in the consolidated statement of income and comprehensive income. The value of RMB against US$ and other currencies may fluctuate and is affected by, among other things, changes in the PRC’s political and economic conditions. Any significant revaluation of RMB may materially affect the Company’s financial condition in terms of US$ reporting. The following table outlines the currency exchange rates that were used in creating the consolidated financial statements in this report:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Comprehensive Income | Comprehensive Income Comprehensive income includes net income and foreign currency translation adjustments and is reported in the consolidated statements of income and comprehensive income. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting | Segment Reporting The Company uses the “management approach” in determining reportable operating segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision maker (“CODM”) for making operating decisions and assessing performance as the source for determining the Company’s reportable segments. The Company’s CODM has been identified as the chief executive officer of the Company who reviews financial information of separate operating segments based on U.S. GAAP. For the six months ended September 30, 2023, the CODM reviews financial information analyzed by customer, which only presented at the gross profit level with no allocation of operating expenses. Thus, the Company determined that it operates in four operating segments: (1) Healthcare products; (2) Automobiles; (3) Online store; and (4) Internet information and advertising service. The Company’s reportable segments are strategic business units that offer different products and services. They are managed separately because each business requires different marketing strategies. As the Company’s long-lived assets are substantially all located in the PRC and all of the Company’s revenue and expense are derived from within the PRC, no geographical segments are presented.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Concentration of Risks | Concentration of Risks Exchange Rate Risks The Company operates in China, which may give rise to significant foreign currency risks from fluctuations and the degree of volatility of foreign exchange rates between the US$ and the RMB. As of September 30, 2023 and March 31, 2023, cash and cash equivalents of $537,425 (RMB 3,858,606) and $2,198,694 (RMB 12,542,139), respectively, is denominated in RMB and is held in PRC. Currency Convertibility Risks Substantially all of the Company’s operating activities are transacted in RMB, which is not freely convertible into foreign currencies. All foreign exchange transactions take place either through the People’s Bank of China or other banks authorized to buy and sell foreign currencies at the exchange rates quoted by the People’s Bank of China. Approval of foreign currency payments by the People’s Bank of China or other regulatory institutions requires submitting a payment application form together with other information such as suppliers’ invoices, shipping documents and signed contracts. Concentration of Credit Risks Financial instruments that potentially subject the Company to concentration of credit risks consist primarily of cash and cash equivalents and accounts receivable, the balances of which are stated on the consolidated balance sheets which represent the Company’s maximum exposure. The Company places its cash and cash equivalents in good credit quality financial institutions in China. Concentration of credit risks with respect to accounts receivables is linked to the concentration of revenue. To manage credit risk, the Company performs ongoing credit evaluations of customers’ financial condition. Interest Rate Risks The Company is subject to interest rate risk. Bank interest bearing loans are charged at variable interest rates within the reporting period. The Company is subject to the risk of adverse changes in the interest rates charged by the banks when these loans are refinanced. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Risks and Uncertainties | Risks and Uncertainties The operations of the Company are located in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by political, economic, and legal environments in the PRC, as well as by the general state of the PRC economy. The Company’s results may be adversely affected by changes in the political, regulatory and social conditions in the PRC. Although the Company has not experienced losses from these situations and believes that it is in compliance with existing laws and regulations including its organization and structure disclosed in Note 1, this may not be indicative of future results. COVID-19 Pandemic The outbreak of COVID-19 began in January 2020 and was quickly declared as a Public Health Emergency of International Concern and subsequently a pandemic by the World Health Organization. A series of prevention and control measures including quarantines, travel restrictions, and the temporary closure of facilities were implemented across the country. The Company was impacted by the COVID-19 pandemic in many ways, including the plump of closures of experience stores, diving sales by distribution channels, and shut down or partly shut down of production facilities for several months. Despite the fact that China has largely brought the pandemic under control, there is still a high degree of uncertainty as to how the pandemic will evolve going forward. A new outbreak in China could cause new disruptions of our production, distribution and sales, and have an adverse impact on our business, financial condition and results of operations for the remainder of the six months ended September 30, 2023, which cannot be reasonably estimated at the current stage. The Company will regularly assess its business conditions and adopt measures to mitigate any new impact of the ongoing pandemic.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Related Parties | Related Parties The Company accounts for related party transactions in accordance with ASC 850 (“Related Party Disclosures”). A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party. There were no related party transactions as of September 30, 2023. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recent Accounting Pronouncements | Recent Accounting Pronouncements In August 2020, the FASB issued ASU No. 2020-06 (“ASU 2020-06”) “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.” ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. For public business entities, the amendments in ASU 2020-06 are effective for public entities which meet the definition of a smaller reporting company are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023. The Company will adopt ASU 2020-06 effective January 1, 2024. Management is currently evaluating the effect of the adoption of ASU 2020-06 on the consolidated financial statements. The effect will largely depend on the composition and terms of the financial instruments at the time of adoption. In October 2021, the FASB issued ASU No. 2021-08, “‘Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers” (“ASU 2021-08”). This ASU requires entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. The amendments improve comparability after the business combination by providing consistent recognition and measurement guidance for revenue contracts with customers acquired in a business combination and revenue contracts with customers not acquired in a business combination. The amendments are effective for the Company beginning after December 15, 2023, and are applied prospectively to business combinations that occur after the effective date. The Company does not expect the adoption of ASU 2021-04 will have a material effect on the consolidated financial statements. In June 2022, the FASB issued ASU 2022-03, “Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”, which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. This guidance also requires certain disclosures for equity securities subject to contractual sale restrictions. The new guidance is required to be applied prospectively with any adjustments from the adoption of the amendments recognized in earnings and disclosed on the date of adoption. This guidance is effective for the Company for the fiscal year ending March 31, 2025 and interim reporting periods during the fiscal year beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect that the adoption of this guidance will have a material impact on the financial position, results of operations and cash flows. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization and Nature of Operations (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Organization and Nature of Operations [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Operating Subsidiaries | During the reporting periods, the Company has
several subsidiaries in PRC. Details of the Company and its operating subsidiaries are set out below:
|
Significant Accounting Policies (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Property and Equipment Net | The straight-line depreciation method is used to compute depreciation over the estimated useful lives of the assets, as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Estimated Useful Lives of Intangible Assets | The estimated useful lives of intangible assets are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Our Sales from Our Product Lines | The following table presents an overview of our
sales from our product lines for the six months ended September 30, 2023 and 2022:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Foreign Currency Translation | The following table outlines the currency
exchange rates that were used in creating the consolidated financial statements in this report:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounts Receivable, Net (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounts Receivable, Net [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Accounts Receivable | Accounts receivable consisted of the following as of September 30,
2023 and March 31, 2023:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Allowance for Doubtful Accounts |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventories [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Inventories | All the inventories are located in China. Inventories consisted of
the following as of September 30, 2023 and March 31, 2023:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prepaid Expenses and Other Current Assets (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Prepaid Expenses and Other Current Assets [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Prepaid Expenses and Other Current Assets | Prepaid expenses and other current assets consisted of the following
as of September 30, 2023 and March 31, 2023:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property, Plant and Equipment, Net (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Property, Plant and Equipment, Net [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Property, Plant and Equipment | Property, plant and equipment consisted of the following as of September
30, 2023 and March 31, 2023:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Intangible Assets, Net (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill and Intangible Assets Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Intangible Assets, Net |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Estimated Future Amortization Expense | Estimated future amortization expense is as follows
as of September 30, 2023:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Goodwill | Goodwill consisted of the following as of September 30, 2023 and March
31, 2023:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Carrying Amount of Goodwill | The changes in the carrying amount of goodwill for the years ended
September 30, 2023 and March 31, 2023 were as follow:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prepaid Assets (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Prepaid Assets [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Prepaid Assets | Prepaid assets consisted of the following as of September 30, 2023
and March 31, 2023:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-Term Bank Borrowings (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Short-Term Bank Borrowings | Short-term bank borrowings consisted of the following as of September
30, 2023 and March 31, 2023:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Secure Short Term Borrowings | The carrying values of the Company’s pledged
assets to secure short-term borrowings by the Company are as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shareholders' Equity (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shareholders' Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Outstanding and Exercisable Warrants | The Company’s outstanding and exercisable
warrants as of September 30, 2023 are presented below:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Taxes (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Taxes [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Taxes Reconciles Rate | The following table reconciles the statutory rate
to the Company’s effective tax rate:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Income Tax | The provision for income tax consisted of the
following:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Deferred Income Tax Assets and Liabilities | The deferred income tax assets and liabilities as below:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Taxes Payable | The Company’s taxes payable as of September 30, 2023 and March
31, 2023 consisted of the following:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combination (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Combinations [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Discounted Cash Flow Method After Considering a Discount | According to the independent valuation report,
the purchase price was allocated to the assets acquired and liabilities assumed based on their fair values was as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued Operations (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Discontinued Operations [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Gain Resulting from the above-Mentioned Dispositions | The Company calculated a gain resulting from the above-mentioned dispositions
as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Assets and Liabilities for Discontinued Operations | The assets and liabilities for discontinued operations comprised the
following items as of March 31, 2023:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Operating Results from Discontinued Operations | The operating results from discontinued operations
included in the Company’s consolidated statements of comprehensive loss were as follows for the six months ended September 30, 2023
and 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Segment's Revenue and Gross Profit | The following tables present the summary of each
reportable segment’s revenue and gross profit, which is considered as a segment operating performance measure, for the six months
ended September 30, 2023:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Significant Accounting Policies (Details) |
6 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 01, 2019 |
May 01, 2018 |
Sep. 30, 2023
USD ($)
|
Sep. 30, 2022
USD ($)
|
Sep. 30, 2023
CNY (¥)
|
Aug. 28, 2023
USD ($)
|
Aug. 28, 2023
CNY (¥)
|
Apr. 10, 2023
USD ($)
|
Apr. 10, 2023
CNY (¥)
|
Mar. 31, 2023
USD ($)
|
Mar. 31, 2023
CNY (¥)
|
|
| Significant Accounting Policies (Details) [Line Items] | |||||||||||
| Business combination extend year | 1 year | ||||||||||
| Cash consideration | $ 700,000 | ¥ 5,000,000 | $ 11,300,000 | ¥ 78,000,000 | |||||||
| Government grants | $ 4,183 | $ 18,543 | |||||||||
| Advertising costs | $ 9,952,033 | $ 15,943,891 | |||||||||
| After tax profit | 10.00% | ||||||||||
| Accumulative amount of reserve | 50.00% | ||||||||||
| Accumulated deficit | $ (51,257,823) | $ (59,453,593) | |||||||||
| Fujian Happiness Biotech Co., Limited [Member] | |||||||||||
| Significant Accounting Policies (Details) [Line Items] | |||||||||||
| Equity interests | 100.00% | 100.00% | |||||||||
| Accumulated Deficit [Member] | |||||||||||
| Significant Accounting Policies (Details) [Line Items] | |||||||||||
| Accumulated deficit | 28,890,000 | ¥ 180,300,000 | |||||||||
| Maximum [Member] | |||||||||||
| Significant Accounting Policies (Details) [Line Items] | |||||||||||
| Value added tax, percentage | 16.00% | 17.00% | |||||||||
| Minimum [Member] | |||||||||||
| Significant Accounting Policies (Details) [Line Items] | |||||||||||
| Value added tax, percentage | 13.00% | 16.00% | |||||||||
| Cash and Cash Equivalents [Member] | |||||||||||
| Significant Accounting Policies (Details) [Line Items] | |||||||||||
| Cash and cash equivalents | $ 537,425 | ¥ 3,858,606 | $ 2,198,694 | ¥ 12,542,139 | |||||||
Significant Accounting Policies (Details) - Schedule of Property and Equipment Net |
Sep. 30, 2023 |
|---|---|
| Buildings [Member] | |
| Significant Accounting Policies (Details) - Schedule of Property and Equipment Net [Line Items] | |
| Estimated useful lives of the assets | 20 years |
| Machinery [Member] | |
| Significant Accounting Policies (Details) - Schedule of Property and Equipment Net [Line Items] | |
| Estimated useful lives of the assets | 10 years |
| Furniture, fixture and electronic equipment [Member] | Minimum [Member] | |
| Significant Accounting Policies (Details) - Schedule of Property and Equipment Net [Line Items] | |
| Estimated useful lives of the assets | 3 years |
| Furniture, fixture and electronic equipment [Member] | Maximum [Member] | |
| Significant Accounting Policies (Details) - Schedule of Property and Equipment Net [Line Items] | |
| Estimated useful lives of the assets | 10 years |
| Vehicles [Member] | |
| Significant Accounting Policies (Details) - Schedule of Property and Equipment Net [Line Items] | |
| Estimated useful lives of the assets | 4 years |
Significant Accounting Policies (Details) - Schedule of Estimated Useful Lives of Intangible Assets |
Sep. 30, 2023 |
|---|---|
| Land use right [Member] | |
| Significant Accounting Policies (Details) - Schedule of Estimated Useful Lives of Intangible Assets [Line Items] | |
| Estimated useful lives | 50 years |
| Licensed software [Member] | Minimum [Member] | |
| Significant Accounting Policies (Details) - Schedule of Estimated Useful Lives of Intangible Assets [Line Items] | |
| Estimated useful lives | 5 years |
| Licensed software [Member] | Maximum [Member] | |
| Significant Accounting Policies (Details) - Schedule of Estimated Useful Lives of Intangible Assets [Line Items] | |
| Estimated useful lives | 10 years |
| Trademark [Member] | |
| Significant Accounting Policies (Details) - Schedule of Estimated Useful Lives of Intangible Assets [Line Items] | |
| Estimated useful lives | 10 years |
| Customer relationship [Member] | |
| Significant Accounting Policies (Details) - Schedule of Estimated Useful Lives of Intangible Assets [Line Items] | |
| Estimated useful lives | 5 years |
| Proprietary technology [Member] | |
| Significant Accounting Policies (Details) - Schedule of Estimated Useful Lives of Intangible Assets [Line Items] | |
| Estimated useful lives | 5 years |
Significant Accounting Policies (Details) - Schedule of Our Sales from Our Product Lines - USD ($) |
6 Months Ended | |
|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|
| Significant Accounting Policies (Details) - Schedule of Our Sales from Our Product Lines [Line Items] | ||
| Revenue | $ 6,293,965 | $ 16,880,316 |
| Revenue from discontinued operations (Note 15) | (19,849,634) | (36,109,692) |
| Healthcare products [Member] | ||
| Significant Accounting Policies (Details) - Schedule of Our Sales from Our Product Lines [Line Items] | ||
| Revenue | 10,981,175 | 28,103,868 |
| Online store [Member] | ||
| Significant Accounting Policies (Details) - Schedule of Our Sales from Our Product Lines [Line Items] | ||
| Revenue | 8,868,459 | 8,093,778 |
| Internet information and advertising [Member] | ||
| Significant Accounting Policies (Details) - Schedule of Our Sales from Our Product Lines [Line Items] | ||
| Revenue | 754,600 | |
| Automobiles [Member] | ||
| Significant Accounting Policies (Details) - Schedule of Our Sales from Our Product Lines [Line Items] | ||
| Revenue | $ 6,293,965 | $ 16,037,762 |
Significant Accounting Policies (Details) - Schedule of Foreign Currency Translation |
6 Months Ended | 12 Months Ended | |
|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Mar. 31, 2023 |
|
| Period-end spot rate [Member] | |||
| Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items] | |||
| Currency exchange rates | US$1=RMB 7.1798 | US$1=RMB 7.0998 | US$1=RMB 6.8717 |
| Average Rate [Member] | |||
| Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items] | |||
| Currency exchange rates | US$1=RMB 7.1206 | US$1=RMB 6.7873 | US$1=RMB 6.8855 |
Accounts Receivable, Net (Details) - Schedule of Accounts Receivable - USD ($) |
Sep. 30, 2023 |
Mar. 31, 2023 |
|---|---|---|
| Schedule of Accounts Receivable [Abstract] | ||
| Accounts receivable | $ 16,505 | $ 2,560,894 |
| Less: allowance for doubtful accounts | (854,615) | |
| Accounts receivable from discontinued operations (Note 15) | (1,706,279) | |
| Accounts receivable, net | $ 16,505 |
Accounts Receivable, Net (Details) - Schedule of Allowance for Doubtful Accounts - USD ($) |
6 Months Ended | |
|---|---|---|
Sep. 30, 2023 |
Mar. 31, 2023 |
|
| Schedule of Allowance For Doubtful Accounts [Abstract] | ||
| Beginning balance | $ 854,615 | $ 463,514 |
| Provision for doubtful accounts | 854,615 | |
| Written-off | (854,615) | (463,514) |
| Allowance for doubtful accounts from discontinued operations | (854,615) | |
| Ending balance | ||
Inventories (Details) - USD ($) |
6 Months Ended | 12 Months Ended |
|---|---|---|
Sep. 30, 2023 |
Mar. 31, 2023 |
|
| Inventories (Details) [Line Items] | ||
| Net realizable value adjustment | ||
| Write-Downs [Member] | ||
| Inventories (Details) [Line Items] | ||
| Inventory provision |
Inventories (Details) - Schedule of Inventories - USD ($) |
Sep. 30, 2023 |
Mar. 31, 2023 |
|---|---|---|
| Schedule of inventories [Abstract] | ||
| Raw materials | $ 282,618 | |
| Work in process | ||
| Finished goods | 14,544 | 52,401 |
| Inventories from discontinued operations (Note 15) | (335,019) | |
| Total | $ 14,544 |
Prepaid Expenses and Other Current Assets (Details) - Schedule of Prepaid Expenses and Other Current Assets - USD ($) |
Sep. 30, 2023 |
Mar. 31, 2023 |
|---|---|---|
| Schedule of Prepaid Expenses and Other Current Assets [Abstract] | ||
| Prepayments to suppliers | $ 312,807 | $ 1,252,094 |
| Loans receivables (a) | 516,031 | 254,668 |
| Prepayments to technical provider | 618,479 | |
| VAT deductibles | 1,495 | |
| Investment receivables from the investors | 2,000,000 | |
| Others | 74,374 | 263,945 |
| Prepaid expenses and other current assets from discontinued operations (Note 15) | (1,314,523) | |
| Total | $ 904,707 | $ 3,074,663 |
Property, Plant and Equipment, Net (Details) - USD ($) |
6 Months Ended | 12 Months Ended | |
|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Mar. 31, 2023 |
|
| Property, Plant and Equipment, Net [Abstract] | |||
| Pledged its building with carrying value | $ 1,200,000 | ||
| Depreciation expense | $ 1,631,109 | $ 737,542 | |
| Capitalized depreciation in inventories | $ 90,636 | ||
Property, Plant and Equipment, Net (Details) - Schedule of Property, Plant and Equipment - USD ($) |
Sep. 30, 2023 |
Mar. 31, 2023 |
|---|---|---|
| Property, Plant and Equipment [Line Items] | ||
| Total property plant and equipment, at cost | $ 5,571 | $ 15,792,196 |
| Less: accumulated depreciation | (2,393) | (7,321,924) |
| Property, plant and equipment, net from discontinued operations (Note 15) | (8,456,802) | |
| Property, plant and equipment, net | 3,178 | 13,470 |
| Buildings [Member] | ||
| Property, Plant and Equipment [Line Items] | ||
| Total property plant and equipment, at cost | 14,111,170 | |
| Machinery [Member] | ||
| Property, Plant and Equipment [Line Items] | ||
| Total property plant and equipment, at cost | 1,585,671 | |
| Furniture, fixture and electronic equipment [Memebr] | ||
| Property, Plant and Equipment [Line Items] | ||
| Total property plant and equipment, at cost | 5,571 | 74,719 |
| Vehicles [Member] | ||
| Property, Plant and Equipment [Line Items] | ||
| Total property plant and equipment, at cost | $ 20,636 |
Intangible Assets, Net (Details) |
6 Months Ended | 12 Months Ended | |
|---|---|---|---|
|
Sep. 30, 2023
USD ($)
|
Sep. 30, 2022
USD ($)
|
Mar. 31, 2023
USD ($)
|
|
| Goodwill and Intangible Assets Disclosure [Abstract] | |||
| Carrying value | $ 83,520 | ||
| Land square meters | 12,120 | ||
| Amortization expense | $ 710,486 | $ 771,357 | |
Intangible Assets, Net (Details) - Schedule of Intangible Assets, Net - USD ($) |
Sep. 30, 2023 |
Mar. 31, 2023 |
|---|---|---|
| Schedule of Intangible Assets Net [Abstract] | ||
| Land use right, cost | $ 841,421 | |
| Customer relationship (Note 14) | 8,149,366 | |
| Proprietary technology | 1,900,000 | 1,900,000 |
| Trademark | 10,187 | |
| Software, cost | 1,041,799 | |
| Total | 1,900,000 | 11,942,773 |
| Less: accumulated amortization | (221,667) | (2,496,518) |
| Intangible assets, net from discontinued operations (Note 15) | (7,577,922) | |
| Intangible assets, net | $ 1,678,333 | $ 1,868,333 |
Intangible Assets, Net (Details) - Schedule of Estimated Future Amortization Expense |
Sep. 30, 2023
USD ($)
|
|---|---|
| Schedule of Estimated Future Amortization Expense [Abstract] | |
| 2024 | $ 380,000 |
| 2025 | 380,000 |
| 2026 | 380,000 |
| 2027 | 380,000 |
| 2028 | 158,333 |
| Total | $ 1,678,333 |
Goodwill (Details) - Schedule of Goodwill - USD ($) |
Sep. 30, 2023 |
Mar. 31, 2023 |
|---|---|---|
| Schedule of Goodwill [Abstract] | ||
| Goodwill, gross (Note 14) | $ 5,184,036 | $ 5,184,036 |
| Less: impairment | ||
| Goodwill, net | $ 5,184,036 | $ 5,184,036 |
Goodwill (Details) - Schedule of Carrying Amount of Goodwill - USD ($) |
6 Months Ended | 12 Months Ended |
|---|---|---|
Sep. 30, 2023 |
Mar. 31, 2023 |
|
| Schedule of Carrying Amount of Goodwill [Abstract] | ||
| Goodwill | $ 6,401,208 | $ 10,084,201 |
| Acquisitions (Note 14) | 5,184,036 | |
| Disposal | (1,217,172) | (168,555) |
| Impairment | (7,872,696) | |
| Exchange gain and loss | (771,204) | |
| Goodwill, net from discontinued operations (Note 15) | (1,271,746) | |
| Goodwill, net | $ 5,184,036 | $ 5,184,036 |
Prepaid Assets (Details) - Schedule of Prepaid Assets - USD ($) |
Sep. 30, 2023 |
Mar. 31, 2023 |
|---|---|---|
| Schedule of Prepaid Assets [Abstract] | ||
| Prepayments for advertising or marketing | $ 2,332,658 | $ 2,138,273 |
| Prepayment of celebrity endorsement fee | 43,656 | |
| Prepaid assets from discontinued operations (Note 15) | (2,181,678) | |
| Total | $ 2,332,658 | $ 251 |
Short-Term Bank Borrowings (Details) ¥ in Millions |
6 Months Ended | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jan. 12, 2022
CNY (¥)
|
Apr. 08, 2021
CNY (¥)
|
Apr. 06, 2021
CNY (¥)
|
Sep. 30, 2023
USD ($)
|
Sep. 30, 2022
USD ($)
|
Sep. 30, 2023
CNY (¥)
|
Jun. 01, 2022
USD ($)
|
Jun. 01, 2022
CNY (¥)
|
May 16, 2022
USD ($)
|
May 16, 2022
CNY (¥)
|
Jan. 13, 2022
USD ($)
|
Jan. 13, 2022
CNY (¥)
|
Jan. 12, 2022
USD ($)
|
Jan. 12, 2022
CNY (¥)
|
Jun. 09, 2021
USD ($)
|
Jun. 09, 2021
CNY (¥)
|
Jan. 15, 2021
CNY (¥)
|
Apr. 20, 2020
USD ($)
|
Apr. 20, 2020
CNY (¥)
|
Apr. 07, 2020
CNY (¥)
|
Jun. 24, 2019
USD ($)
|
Jun. 24, 2019
CNY (¥)
|
May 04, 2018
USD ($)
|
May 04, 2018
CNY (¥)
|
|
| Short-Term Bank Borrowings (Details) [Line Items] | ||||||||||||||||||||||||
| Loan agreement, description | In addition, the Company entered into a loan agreement of $1,065,238 (RMB 7.0 million) bearing interest rate at LPR plus 0.75% on June 9, 2021 and repaid it on June 5, 2022. | |||||||||||||||||||||||
| Bearing interest rate | 0.90% | 0.90% | 0.75% | 0.75% | ||||||||||||||||||||
| Loan agreement amount | $ 985,943 | ¥ 7.0 | ||||||||||||||||||||||
| Borrowing amount | $ 119,722 | ¥ 85.0 | ||||||||||||||||||||||
| Interest expense on short-term bank loans (in Dollars) | $ | $ 29,278 | $ 35,054 | ||||||||||||||||||||||
| Industrial Bank Co., Ltd [Member] | ||||||||||||||||||||||||
| Short-Term Bank Borrowings (Details) [Line Items] | ||||||||||||||||||||||||
| Short-term bank borrowings | $ 1,065,238 | ¥ 7.0 | $ 1,039,578 | ¥ 7.0 | ||||||||||||||||||||
| Interest rate, description | In April 2020, Fujian Happiness renewed the loan agreement with Industrial Bank Co. Ltd for $1,065,238 (RMB 7.0 million) bearing interest rate at LPR plus 1.45% per annum, payable monthly. | |||||||||||||||||||||||
| Maximum guaranteed amount | ¥ 7.0 | |||||||||||||||||||||||
| Maximum pledged amount for building and land use rights | ¥ 17.4 | |||||||||||||||||||||||
| Short-term loans bearing fixed interest rate | 1.45% | 1.45% | ||||||||||||||||||||||
| Bank loan agreement [Member] | ||||||||||||||||||||||||
| Short-Term Bank Borrowings (Details) [Line Items] | ||||||||||||||||||||||||
| Short-term bank borrowings | $ 1,065,238 | ¥ 7.0 | ||||||||||||||||||||||
| Postal Saving Bank of China [Member] | ||||||||||||||||||||||||
| Short-Term Bank Borrowings (Details) [Line Items] | ||||||||||||||||||||||||
| Short-term bank borrowings | $ 197,597 | ¥ 1.4 | $ 846,848 | ¥ 6.0 | ¥ 6.0 | ¥ 1.7 | $ 3,400,000 | ¥ 24.4 | ||||||||||||||||
| Short-term loans bearing fixed interest rate | 4.25% | 4.25% | 4.25% | 4.25% | ||||||||||||||||||||
| Debt repaid | ¥ 6.0 | ¥ 1.7 | ¥ 1.7 | |||||||||||||||||||||
| Bank loan agreement [Member] | ||||||||||||||||||||||||
| Short-Term Bank Borrowings (Details) [Line Items] | ||||||||||||||||||||||||
| Interest rate, description | The loan bears a fixed interest rate of 1-year Loan Prime Rate (“LPR”) +2.19% on the date of drawing per annum. | |||||||||||||||||||||||
Short-Term Bank Borrowings (Details) - Schedule of Short-Term Bank Borrowings - USD ($) |
Sep. 30, 2023 |
Mar. 31, 2023 |
|---|---|---|
| Short-Term Bank Borrowings (Details) - Schedule of Short-Term Bank Borrowings [Line Items] | ||
| Short-term bank borrowings | ||
| Short-term bank borrowings from discontinued operations (Note 15) | (2,241,076) | |
| Industrial Bank Co., Ltd [Member] | ||
| Short-Term Bank Borrowings (Details) - Schedule of Short-Term Bank Borrowings [Line Items] | ||
| Short-term bank borrowings | 1,018,672 | |
| Postal Saving Bank of China [Member] | ||
| Short-Term Bank Borrowings (Details) - Schedule of Short-Term Bank Borrowings [Line Items] | ||
| Short-term bank borrowings | 1,076,880 | |
| Rural Credit Cooperative (ShunChang) [Member] | ||
| Short-Term Bank Borrowings (Details) - Schedule of Short-Term Bank Borrowings [Line Items] | ||
| Short-term bank borrowings | $ 145,524 |
Short-Term Bank Borrowings (Details) - Schedule of Secure Short Term Borrowings - USD ($) |
Sep. 30, 2023 |
Mar. 31, 2023 |
|---|---|---|
| Short-Term Bank Borrowings (Details) - Schedule of Secure Short Term Borrowings [Line Items] | ||
| Pledged assets to secure short-term borrowings | $ 1,259,620 | |
| Buildings, net [Member] | ||
| Short-Term Bank Borrowings (Details) - Schedule of Secure Short Term Borrowings [Line Items] | ||
| Pledged assets to secure short-term borrowings | 1,176,100 | |
| Land use rights, net [Member] | ||
| Short-Term Bank Borrowings (Details) - Schedule of Secure Short Term Borrowings [Line Items] | ||
| Pledged assets to secure short-term borrowings | $ 83,520 |
Share Based Compensation (Details) |
1 Months Ended |
|---|---|
|
Feb. 28, 2022
shares
| |
| 2020 Equity Incentive Plan [Member] | |
| Share Based Compensation (Details) [Line Items] | |
| Purchase of ordinary shares | 3,500,000 |
Shareholders' Equity (Details) $ / shares in Units, ¥ in Millions |
1 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Mar. 14, 2022
USD ($)
|
Mar. 10, 2022
USD ($)
shares
|
Mar. 04, 2022
USD ($)
shares
|
Nov. 12, 2021
shares
|
Oct. 21, 2021
USD ($)
$ / shares
shares
|
Oct. 14, 2021
USD ($)
shares
|
Mar. 04, 2019
$ / shares
shares
|
Mar. 04, 2019
$ / shares
shares
|
Dec. 27, 2022
USD ($)
$ / shares
shares
|
Jan. 20, 2022
USD ($)
shares
|
Oct. 20, 2021
USD ($)
shares
|
Oct. 20, 2021
CNY (¥)
shares
|
Jun. 25, 2021
USD ($)
shares
|
Jun. 21, 2021
USD ($)
shares
|
May 31, 2018
USD ($)
|
May 31, 2018
CNY (¥)
|
Sep. 30, 2023
USD ($)
$ / shares
shares
|
Mar. 31, 2023
USD ($)
$ / shares
shares
|
Nov. 09, 2023
USD ($)
|
Mar. 31, 2023
CNY (¥)
shares
|
Mar. 28, 2023
USD ($)
shares
|
Apr. 21, 2022
shares
|
Mar. 07, 2022
USD ($)
|
Jan. 12, 2022
USD ($)
|
Mar. 15, 2021
USD ($)
shares
|
Oct. 25, 2019
USD ($)
$ / shares
shares
|
Mar. 31, 2019
shares
|
|
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Ordinary shares issued (in Shares) | shares | 10,000,000 | 90,000,000 | 5,100,000 | 381,580 | 23,000,000 | ||||||||||||||||||||||
| Ordinary shares par value (in Dollars per share) | $ / shares | $ 0.0005 | $ 0.0005 | $ 0.0005 | ||||||||||||||||||||||||
| Equity interest, percentage | 70.00% | 70.00% | 100.00% | ||||||||||||||||||||||||
| Ordinary shares authorized (in Shares) | shares | 100,000,000 | 100,000,000 | |||||||||||||||||||||||||
| Preferred stock, shares authorized (in Shares) | shares | 10,000,000 | 10,000,000 | 500,000 | 500,000 | 500,000 | ||||||||||||||||||||||
| Cancelled ordinary shares (in Shares) | shares | 77,223,100 | 77,223,100 | |||||||||||||||||||||||||
| Additional ordinary shares (in Shares) | shares | 223,100 | ||||||||||||||||||||||||||
| Share per price (in Dollars per share) | $ / shares | $ 2 | ||||||||||||||||||||||||||
| Total net proceeds | $ 750,000 | ||||||||||||||||||||||||||
| Total purchase consideration amounted | $ 12,000,000 | $ 10,965,703 | |||||||||||||||||||||||||
| Net proceeds | 10,725,700 | ||||||||||||||||||||||||||
| Compensation cost | $ 778,423 | ||||||||||||||||||||||||||
| Total consideration amount | $ 6,720,000 | $ 8,000,000 | $ 99,843 | $ 7,500,000 | ¥ 48.0 | $ 2,157,600 | $ 351,796 | ||||||||||||||||||||
| Net proceeds | $ 10,000,000 | $ 2,157,600 | |||||||||||||||||||||||||
| Consideration amount | $ 6,000,000 | $ 16,100,000 | ¥ 103.0 | ||||||||||||||||||||||||
| Issued an aggregate of ordinary shares (in Shares) | shares | 4,200,000 | ||||||||||||||||||||||||||
| Total compensation cost | $ 3,736,320 | $ 7,081,250 | $ 3,560,000 | $ 634,592 | |||||||||||||||||||||||
| Ordinary shares, par value | $ 0.0005 | ||||||||||||||||||||||||||
| Ordinary shares authorized (in Shares) | shares | 50,000 | ||||||||||||||||||||||||||
| Preferred stock, shares issued (in Shares) | shares | 10,000,000 | 0 | 0 | 0 | |||||||||||||||||||||||
| Preferred stock, par value | $ 0.0005 | ||||||||||||||||||||||||||
| Aggregate shares | $ 10,000,000 | ||||||||||||||||||||||||||
| Commissions and offering expenses | $ 6,720,000 | ||||||||||||||||||||||||||
| Company’s ordinary shares description | a Share Consolidation of the Company’s ordinary shares at a ratio of one-for-twenty (the “Share Consolidation”) was effected as determined by the Board of Directors. At the time the Share Consolidation is effective, our authorized ordinary shares will be consolidated at the same ratio. The authorized share capital of the Company shall be decreased from an authorized share capital of US$50,000 divided into 70,000,000 Class A ordinary shares, par value US$0.0005 each, 20,000,000 Class B ordinary shares, par value US$0.0005 each, and 10,000,000 preferred shares with a par value of US$0.0005 each to an authorized share capital of US$50,000 divided into 3,500,000 Class A ordinary shares, par value US$0.01 each, 1,000,000 Class B ordinary shares, par value US$0.01 each, and 500,000 preferred shares, par value US$0.01 each. | ||||||||||||||||||||||||||
| Gross proceeds | $ 6,000,000 | ||||||||||||||||||||||||||
| Purchase of equity interest | 100.00% | 100.00% | |||||||||||||||||||||||||
| Statutory surplus reserve percentage description | Appropriations to the statutory surplus reserve are required to be at least 10% of the after-tax net income determined in accordance with PRC GAAP until the reserve is equal to 50% of the entity’s registered capital. Appropriations to the discretionary surplus reserve are made at the discretion of the Board of Directors. In 2022, $5,558,669 was appropriated by Fujian Happiness to the statutory surplus reserve and the statutory reserve reached 50% of its registered capital. | ||||||||||||||||||||||||||
| Statutory reserve rate | 50.00% | ||||||||||||||||||||||||||
| Statutory reserve | $ 7,622,765 | ||||||||||||||||||||||||||
| Statutory laws amounted | 7,622,765 | ||||||||||||||||||||||||||
| Shennong [Member] | |||||||||||||||||||||||||||
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Consideration equity interests | 100.00% | 100.00% | |||||||||||||||||||||||||
| Hekangyuan [Member] | |||||||||||||||||||||||||||
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Equity interest, percentage | 100.00% | ||||||||||||||||||||||||||
| Consideration equity interests | 100.00% | ||||||||||||||||||||||||||
| 2lab3 LLC’s [Member] | |||||||||||||||||||||||||||
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Consideration equity interests | 100.00% | ||||||||||||||||||||||||||
| Ordinary Shares [Member] | |||||||||||||||||||||||||||
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Ordinary shares issued (in Shares) | shares | 50,000 | ||||||||||||||||||||||||||
| Ordinary shares par value (in Dollars per share) | $ / shares | $ 1 | $ 1 | $ 1 | ||||||||||||||||||||||||
| Additional Paid-in Capital [Member] | |||||||||||||||||||||||||||
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Statutory surplus reserve | $ 18,285,864 | 20,714,673 | |||||||||||||||||||||||||
| Minimum [Member] | |||||||||||||||||||||||||||
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Ordinary shares authorized (in Shares) | shares | 50,000 | 50,000 | |||||||||||||||||||||||||
| Percentage of subsidiaries | 30.00% | ||||||||||||||||||||||||||
| Maximum [Member] | |||||||||||||||||||||||||||
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Ordinary shares authorized (in Shares) | shares | 90,000,000 | 90,000,000 | |||||||||||||||||||||||||
| Percentage of subsidiaries | 49.00% | ||||||||||||||||||||||||||
| PRC [Member] | |||||||||||||||||||||||||||
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Retained earnings | $ 28,890,000 | ¥ 180.3 | |||||||||||||||||||||||||
| IPO [Member] | |||||||||||||||||||||||||||
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Ordinary shares par value (in Dollars per share) | $ / shares | $ 0.0005 | ||||||||||||||||||||||||||
| Ordinary shares authorized (in Shares) | shares | 2,000,000 | ||||||||||||||||||||||||||
| Share per price (in Dollars per share) | $ / shares | $ 5.5 | ||||||||||||||||||||||||||
| Total gross proceeds | $ 11,000,000 | ||||||||||||||||||||||||||
| Total net proceeds | $ 9,342,339 | ||||||||||||||||||||||||||
| Warrant [Member] | |||||||||||||||||||||||||||
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Description of warrant | the Company granted to the underwriters warrants to purchase up to a total of 184,000 ordinary shares (equal to 8% of the aggregate number of ordinary shares sold in the offering, if over-allotment shares are placed by the underwriters. Without over-allotment share issuance, a total of 160,000 warrants will be granted). The warrants will be exercisable at an exercise price equal to one hundred twenty percent (120%) of the offering price, in whole or in parts, at any time from issuance and expire five (5) years from the effective date of the offering. | ||||||||||||||||||||||||||
| Class A Ordinary Shares [Member] | |||||||||||||||||||||||||||
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Ordinary shares issued (in Shares) | shares | 19,200,000 | 70,000,000 | 3,000,000 | 12,500,000 | 4,200,000 | 4,200,000 | 1,240,000 | 231,445 | 6,724,675 | 7,724,675 | 7,724,675 | 1,375,000 | |||||||||||||||
| Ordinary shares par value (in Dollars per share) | $ / shares | $ 0.01 | $ 0.01 | |||||||||||||||||||||||||
| Ordinary shares authorized (in Shares) | shares | 350,000,000 | 350,000,000 | 350,000,000 | ||||||||||||||||||||||||
| Total consideration amount | $ 1,375,000 | $ 10,000,000 | |||||||||||||||||||||||||
| Aggregate amount (in Shares) | shares | 113,458 | ||||||||||||||||||||||||||
| Ordinary shares, par value | $ 0.0005 | $ 0.01 | |||||||||||||||||||||||||
| Aggregate shares | $ 1,133,200 | ||||||||||||||||||||||||||
| Purchase of equity interest | 70.00% | ||||||||||||||||||||||||||
| Preferred Stock [Member] | |||||||||||||||||||||||||||
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Preferred stock, shares issued (in Shares) | shares | 10,000,000 | ||||||||||||||||||||||||||
| Preferred stock, par value | $ 0.0005 | ||||||||||||||||||||||||||
| Class B Ordinary Shares [Member] | |||||||||||||||||||||||||||
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Ordinary shares issued (in Shares) | shares | 20,000,000 | 612,255 | 612,255 | 612,255 | |||||||||||||||||||||||
| Ordinary shares par value (in Dollars per share) | $ / shares | $ 0.01 | $ 0.0005 | |||||||||||||||||||||||||
| Ordinary shares authorized (in Shares) | shares | 100,000,000 | 100,000,000 | 100,000,000 | ||||||||||||||||||||||||
| Ordinary shares, par value | $ 0.0005 | ||||||||||||||||||||||||||
| Number of votes per share | (20) | ||||||||||||||||||||||||||
| Xuezhu Wang [Member] | Class B Ordinary Shares [Member] | |||||||||||||||||||||||||||
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Ordinary shares issued (in Shares) | shares | 150,000 | ||||||||||||||||||||||||||
| Two Investors[Member] | |||||||||||||||||||||||||||
| Shareholders' Equity [Line Items] | |||||||||||||||||||||||||||
| Cash received from investor | $ 627,628 | ¥ 4.0 | |||||||||||||||||||||||||
Shareholders' Equity (Details) - Schedule of Outstanding and Exercisable Warrants - USD ($) |
6 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2023 |
Mar. 31, 2023 |
Mar. 31, 2022 |
Mar. 31, 2021 |
|
| Schedule of Outstanding and Exercisable Warrants [Abstract] | ||||
| Number Outstanding, Warrants Outstanding, Beginning | 160,000 | 160,000 | 160,000 | 160,000 |
| Weighted Average Exercise Price, Warrants Outstanding, Beginning | $ 132 | $ 132 | $ 6.6 | $ 6.6 |
| Contractual Life in Years, Warrants Outstanding, Beginning | 4 years 7 months 6 days | |||
| Intrinsic Value, Warrants Outstanding, Beginning | ||||
| Number Outstanding, Warrants granted | ||||
| Weighted Average Exercise Price, Warrants granted | ||||
| Contractual Life in Years, Warrants granted | ||||
| Intrinsic Value, Warrants granted | ||||
| Number Outstanding, Warrants forfeited | ||||
| Weighted Average Exercise Price, Warrants forfeited | ||||
| Contractual Life in Years, Warrants forfeited | ||||
| Intrinsic Value, Warrants forfeited | ||||
| Number Outstanding, Warrants exercised | ||||
| Weighted Average Exercise Price, Warrants exercised | ||||
| Contractual Life in Years, Warrants exercised | ||||
| Intrinsic Value, Warrants exercised | ||||
| Number Outstanding, Warrants Outstanding, Ending | 160,000 | 160,000 | 160,000 | 160,000 |
| Weighted Average Exercise Price, Warrants Outstanding, Ending | $ 132 | $ 132 | $ 6.6 | $ 6.6 |
| Contractual Life in Years, Warrants Outstanding, Ending | 1 year 1 month 6 days | 1 year 7 months 6 days | 2 years 7 months 6 days | 3 years 7 months 6 days |
| Intrinsic Value, Warrants Outstanding, Ending | ||||
Taxes (Details) - USD ($) |
6 Months Ended | |
|---|---|---|
Sep. 30, 2023 |
Mar. 31, 2023 |
|
| Taxes (Details) [Line Items] | ||
| Income tax (''New EIT Law''), description | effective from January 1, 2008, both domestically-owned enterprises and foreign-invested enterprises are subject to a uniform tax rate of 25% while preferential tax rates, tax holidays and even tax exemption may be granted on case-by-case basis. EIT grants preferential tax treatment to High and New Technology Enterprises (“HNTEs”). Under this preferential tax treatment, HNTEs are entitled to an income tax rate of 15%, subject to a requirement that they re-apply for HNTE status every three years. Fujian Happiness, the Company’s main operating entity in PRC, was approved as HNTEs and is entitled to a reduced income tax rate of 15% from December 2019 to December 2023. | |
| Deferred tax assets | ||
| Deferred tax liabilities | $ 1,514,060 | |
| Hong Kong [Member] | ||
| Taxes (Details) [Line Items] | ||
| Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Percent | 16.50% |
Taxes (Details) - Schedule of Taxes Reconciles Rate |
6 Months Ended | |
|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|
| Schedule of Taxes Reconciles Rate [Abstract] | ||
| PRC statutory income tax rate | 25.00% | 25.00% |
| Effect of PRC preferential tax rate | (10.00%) | (10.00%) |
| Effect of other un-deductible expenses | (0.10%) | (2.30%) |
| Effect of other deductible expenses | 1.30% | 1.90% |
| Total | 16.20% | 14.60% |
Taxes (Details) - Schedule of Income Tax - USD ($) |
6 Months Ended | |
|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|
| Schedule of Income Tax [Abstract] | ||
| Current income tax provision | $ (95,564) | $ (59,486) |
| Deferred income tax provision | (2,836,942) | |
| Income tax expenses from discontinued operations (Note 15) | 95,564 | 2,852,148 |
| Total | $ (44,280) | |
Taxes (Details) - Schedule of Deferred Income Tax Assets and Liabilities - USD ($) |
Sep. 30, 2023 |
Mar. 31, 2023 |
|---|---|---|
| Schedule of Deferred Income Tax Assets and Liabilities [Abstract] | ||
| Net accumulated loss-carry forward | $ 20,634,308 | |
| Less: valuation allowance | (20,634,308) | |
| Net deferred tax assets | ||
| Intangible assets arising from acquisition | (1,514,060) | |
| Deferred tax liabilities from discontinued operations (Note 15) | 1,514,060 | |
| Total deferred tax liabilities |
Taxes (Details) - Schedule of Taxes Payable - USD ($) |
Sep. 30, 2023 |
Mar. 31, 2023 |
|---|---|---|
| Schedule of Taxes Payable [Abstract] | ||
| Income tax payable | $ 57,167 | |
| VAT payable | 31,600 | |
| Other tax payables | 102 | 54,593 |
| Other tax payables | (134,373) | |
| Total | $ 102 | $ 8,987 |
Business Combination (Details) $ / shares in Units, ¥ in Millions, $ in Millions |
12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
Mar. 28, 2023
$ / shares
shares
|
Mar. 14, 2022 |
Mar. 04, 2022
USD ($)
$ / shares
shares
|
Nov. 12, 2021
USD ($)
$ / shares
shares
|
Nov. 12, 2021
CNY (¥)
shares
|
Mar. 31, 2022
USD ($)
|
Mar. 31, 2022
CNY (¥)
|
Mar. 31, 2021
USD ($)
|
Mar. 31, 2021
CNY (¥)
|
|
| Business Combination (Details) [Line Items] | |||||||||
| Equity interest | 100.00% | 100.00% | |||||||
| Total cash consideration | $ 12.0 | $ 7.5 | ¥ 48.0 | ||||||
| Cash paid | $ 9.1 | ¥ 60.0 | |||||||
| Over paid | $ 1.9 | ¥ 12.0 | |||||||
| Exchange gain | $ | $ 0.3 | ||||||||
| Acquisition of Daji [Member] | |||||||||
| Business Combination (Details) [Line Items] | |||||||||
| Equity interest | 100.00% | ||||||||
| Class A Ordinary Shares [Member] | |||||||||
| Business Combination (Details) [Line Items] | |||||||||
| Ordinary shares (in Shares) | shares | 1,375,000 | 10,000,000 | 4,200,000 | 4,200,000 | |||||
| Price per share (in Dollars per share) | $ / shares | $ 5.15 | ||||||||
| Equity interest | 70.00% | 70.00% | |||||||
| Ordinary per share (in Dollars per share) | $ / shares | $ 0.365 | $ 0.8896 | |||||||
| Acquisition of Shennong [Member] | |||||||||
| Business Combination (Details) [Line Items] | |||||||||
| Total cash consideration | ¥ | ¥ 72.1 | ||||||||
| Acquisition of Hekangyuan [Member] | |||||||||
| Business Combination (Details) [Line Items] | |||||||||
| Total cash consideration | $ | $ 8.0 | ||||||||
Business Combination (Details) - Schedule of Discounted Cash Flow Method After Considering a Discount |
6 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
|
Sep. 30, 2023
USD ($)
| ||||||||
| Acquisition of 2Lab3 [Member] | ||||||||
| Fair value of total consideration transferred: | ||||||||
| Equity instrument | $ 7,081,250 | |||||||
| Subtotal | 7,081,250 | |||||||
| Recognized amounts of identifiable assets acquired and liability assumed: | ||||||||
| Cash | 555 | |||||||
| Intangible asset –proprietary technology | 1,900,000 | |||||||
| Current liabilities | (3,341) | |||||||
| Total identifiable net assets | 1,897,215 | |||||||
| Fair value of non-controlling interests | ||||||||
| Goodwill | 5,184,036 | [1] | ||||||
| Acquisition of Shennong [Member] | ||||||||
| Fair value of total consideration transferred: | ||||||||
| Equity instrument | 3,736,320 | |||||||
| Cash consideration | 7,492,391 | |||||||
| Subtotal | 11,228,711 | |||||||
| Recognized amounts of identifiable assets acquired and liability assumed: | ||||||||
| Cash | 59,091 | |||||||
| Current assets other than cash | 13,591,825 | |||||||
| Intangible asset – customer relationships | 4,214,470 | |||||||
| Current liabilities | (13,650,246) | |||||||
| Deferred tax liabilities | (1,053,617) | |||||||
| Total identifiable net assets | 3,161,523 | |||||||
| Fair value of non-controlling interests | 4,010,254 | [2] | ||||||
| Goodwill | 12,077,442 | [2] | ||||||
| Acquisition of Hekangyuan [Member] | ||||||||
| Fair value of total consideration transferred: | ||||||||
| Equity instrument | 3,650,000 | |||||||
| Cash consideration | 8,000,000 | |||||||
| Subtotal | 11,650,000 | |||||||
| Recognized amounts of identifiable assets acquired and liability assumed: | ||||||||
| Cash | 1,164 | |||||||
| Current assets other than cash | 1,882,139 | |||||||
| Property, plant and equipment, net | 187 | |||||||
| Intangible asset – customer relationships | 4,582,227 | |||||||
| Current liabilities | (1,829,733) | |||||||
| Deferred tax liabilities | (1,145,557) | |||||||
| Total identifiable net assets | 3,490,427 | |||||||
| Fair value of non-controlling interests | ||||||||
| Goodwill | $ 8,159,573 | [3] | ||||||
| ||||||||
Business Combination (Details) - Schedule of Discounted Cash Flow Method After Considering a Discount (Parentheticals) |
6 Months Ended |
|---|---|
|
Sep. 30, 2023
shares
| |
| Acquisition of 2Lab3 [Member] | |
| Business Combination (Details) - Schedule of Discounted Cash Flow Method After Considering a Discount (Parentheticals) [Line Items] | |
| Equity instrument shares issued | 1,374,000 |
| Acquisition of Shennong [Member] | |
| Business Combination (Details) - Schedule of Discounted Cash Flow Method After Considering a Discount (Parentheticals) [Line Items] | |
| Equity instrument shares issued | 4,200,000 |
| Acquisition of Hekangyuan [Member] | |
| Business Combination (Details) - Schedule of Discounted Cash Flow Method After Considering a Discount (Parentheticals) [Line Items] | |
| Equity instrument shares issued | 10,000,000 |
Discontinued Operations (Details) ¥ in Millions, $ in Millions |
1 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Jul. 31, 2023
USD ($)
|
Jul. 31, 2023
CNY (¥)
|
Sep. 30, 2023
USD ($)
|
Sep. 30, 2023
CNY (¥)
|
|
| Discontinued Operations [Line Items] | ||||
| Consideration and disposed amount | $ 11.3 | ¥ 78 | $ 0.7 | ¥ 5 |
Discontinued Operations (Details) - Schedule of Gain Resulting from the above-Mentioned Dispositions - Discontinued Operations [Member] |
6 Months Ended |
|---|---|
|
Sep. 30, 2023
USD ($)
| |
| Discontinued Operations (Details) - Schedule of Gain Resulting from the above-Mentioned Dispositions [Line Items] | |
| Consideration | $ 11,656,321 |
| Cash and cash equivalents | 408,239 |
| Accounts receivable, net | 4,016,356 |
| Prepaid expenses and other current assets | 4,098,502 |
| Property, plant and equipment, net | 6,203,413 |
| Intangible assets, net | 6,749,192 |
| Goodwill | 1,227,292 |
| Other assets | 3,047,886 |
| Accounts payable | (16,619,622) |
| Other payables and accrued liabilities | (16,436,012) |
| Income tax payable | 28,571 |
| Short-term bank borrowings | (2,162,739) |
| Deferred tax liability | (1,330,061) |
| Net assets of discontinued business | (10,826,125) |
| Non-controlling interest of discontinued business | (991,112) |
| Less: net assets of discontinued business contributable to the Company | 11,817,237 |
| Gain on disposal of discontinued business | $ 23,473,558 |
Discontinued Operations (Details) - Schedule of Assets and Liabilities for Discontinued Operations - Discontinued Operations [Member] |
Mar. 31, 2023
USD ($)
|
|---|---|
| Current assets for discontinued operations | |
| Cash and cash equivalents | $ 1,156,793 |
| Accounts receivable, net | 1,706,279 |
| Inventories | 335,019 |
| Prepaid expenses and other current assets | 1,314,523 |
| Total | 4,512,614 |
| Non-current assets for discontinued operations | |
| Property, plant and equipment, net | 8,456,802 |
| Intangible assets, net | 7,577,922 |
| Goodwill | 1,271,746 |
| Other assets | 2,181,678 |
| Total | 19,488,148 |
| Current liabilities for discontinued operations | |
| Accounts payable | 13,462,008 |
| Other payables and accrued liabilities | 5,106,634 |
| Income tax payable | 134,373 |
| Short-term bank borrowings | 2,241,076 |
| Total | 20,944,091 |
| Non-current liabilities for discontinued operations | |
| Deferred tax liability | 1,514,060 |
| Total | $ 1,514,060 |
Discontinued Operations (Details) - Schedule of Operating Results from Discontinued Operations - Discontinued Operations [Member] - USD ($) |
6 Months Ended | |
|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|
| Major classes of line items constituting pre-tax profit of discontinued operations | ||
| Revenues | $ 19,849,634 | $ 36,109,692 |
| Cost of revenues | (18,600,263) | (33,971,110) |
| Selling and marketing | (745,828) | (16,189,636) |
| General and administrative | (1,931,914) | (3,073,560) |
| Research and development | (190,581) | (396,803) |
| Other expense that are not major | (28,352) | (232,129) |
| Loss from discontinued operations, before income tax | (1,647,304) | (17,753,546) |
| Income tax benefit (expense) | 95,564 | (2,852,148) |
| Loss from discontinued operations, net of income tax | (1,551,740) | (20,605,694) |
| Gain on deconsolidation of the subsidiary, net of income tax | 23,473,558 | |
| Net gain (loss) from discontinued operations, net of income tax | $ 21,921,818 | $ (20,605,694) |
Segment Reporting (Details) - Schedule of Segment's Revenue and Gross Profit - USD ($) |
6 Months Ended | |
|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|
| Segment Reporting (Details) - Schedule of Segment's Revenue and Gross Profit [Line Items] | ||
| Revenues | $ 6,293,965 | $ 16,880,316 |
| Automobile [Member] | ||
| Segment Reporting (Details) - Schedule of Segment's Revenue and Gross Profit [Line Items] | ||
| Revenues | 6,293,965 | |
| Cost | (6,292,950) | |
| Segment gross profit | $ 1,015 | |
| Segment gross profit margin | 0.02% | |
| Healthcare products [Member] | ||
| Segment Reporting (Details) - Schedule of Segment's Revenue and Gross Profit [Line Items] | ||
| Revenues | $ 10,981,175 | |
| Cost | (9,945,305) | |
| Segment gross profit | $ 1,035,870 | |
| Segment gross profit margin | 9.43% | |
| Consolidated [Member] | ||
| Segment Reporting (Details) - Schedule of Segment's Revenue and Gross Profit [Line Items] | ||
| Revenues | $ 6,293,965 | |
| Cost | (6,288,714) | |
| Segment gross profit | $ 5,251 | |
| Segment gross profit margin | 0.08% | |
| Online Store [Member] | ||
| Segment Reporting (Details) - Schedule of Segment's Revenue and Gross Profit [Line Items] | ||
| Revenues | $ 8,868,459 | |
| Cost | (8,650,722) | |
| Segment gross profit | $ 217,737 | |
| Segment gross profit margin | 2.46% | |
| Discontinued Operations (Note 15) [Member] | ||
| Segment Reporting (Details) - Schedule of Segment's Revenue and Gross Profit [Line Items] | ||
| Revenues | $ (19,849,634) | |
| Cost | 18,600,263 | |
| Segment gross profit | $ (1,249,371) | |
| Segment gross profit margin | (6.29%) | |
Customer and Supplier Concentration (Details) |
6 Months Ended | 9 Months Ended |
|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|
| Customer and Supplier Concentration (Details) [Line Items] | ||
| Description of the risk factors | Significant customers and suppliers are those that account for greater than 10% of the Company’s revenues and purchases. | |
| Raw materials purchase percentage | 10.00% | |
| Percentage pf purchases | 10.00% | 10.00% |
| Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Maximum [Member] | ||
| Customer and Supplier Concentration (Details) [Line Items] | ||
| Total revenues, percentage | 23.00% | |
| Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Minimum [Member] | ||
| Customer and Supplier Concentration (Details) [Line Items] | ||
| Total revenues, percentage | 11.00% |
Subsequent Events (Details) - USD ($) |
6 Months Ended | |
|---|---|---|
Sep. 30, 2023 |
Nov. 09, 2023 |
|
| Subsequent Events (Details) [Line Items] | ||
| Principal amount | $ 750,000 | |
| Agreed to pay development fees | $ 1,500,000 | |
| Net revenue percent | 9.00% | |
| Subsequent Event [Member] | ||
| Subsequent Events (Details) [Line Items] | ||
| Interest rate | 8.00% | |
| IOS Release [Member] | ||
| Subsequent Events (Details) [Line Items] | ||
| Agreed to pay development fees | $ 400,000 |